
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Nanotherapeutic Strategies for Overcoming the Blood–Brain Barrier: Applications in Disease Modeling and Drug Delivery - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D7146689B748931C146600216C0166.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="acsomega">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332557/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="ACS Omega">
<meta name="citation_title" content="Nanotherapeutic Strategies for Overcoming the Blood–Brain Barrier: Applications in Disease Modeling and Drug Delivery">
<meta name="citation_author" content="Esen Kirit">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Ankara University, Golbasi, Ankara 06830, Turkey">
<meta name="citation_author" content="Cemile Gokce">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Ankara University, Golbasi, Ankara 06830, Turkey">
<meta name="citation_author" content="Buse Altun">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Ankara University, Golbasi, Ankara 06830, Turkey">
<meta name="citation_author" content="Açelya Yilmazer">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Ankara University, Golbasi, Ankara 06830, Turkey">
<meta name="citation_author_institution" content="Stem Cell Institute, Ankara University, Balgat, Ankara 06520, Turkey">
<meta name="citation_publication_date" content="2025 Jul 24">
<meta name="citation_volume" content="10">
<meta name="citation_issue" content="30">
<meta name="citation_firstpage" content="32606">
<meta name="citation_doi" content="10.1021/acsomega.5c02206">
<meta name="citation_pmid" content="40787345">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332557/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332557/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332557/pdf/ao5c02206.pdf">
<meta name="description" content="The blood–brain barrier (BBB) is the main obstacle preventing access to the central nervous system (CNS). It is therefore a major challenge in CNS studies, e.g., investigations of novel therapeutic agents for brain tumors, such as glioblastoma ...">
<meta name="og:title" content="Nanotherapeutic Strategies for Overcoming the Blood–Brain Barrier: Applications in Disease Modeling and Drug Delivery">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The blood–brain barrier (BBB) is the main obstacle preventing access to the central nervous system (CNS). It is therefore a major challenge in CNS studies, e.g., investigations of novel therapeutic agents for brain tumors, such as glioblastoma ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332557/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12332557">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1021/acsomega.5c02206"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ao5c02206.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332557%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12332557/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12332557/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332557/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-acsomega.png" alt="ACS Omega logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to ACS Omega" title="Link to ACS Omega" shape="default" href="https://pubs.acs.org/journal/acsodf" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">ACS Omega</button></div>. 2025 Jul 24;10(30):32606–32625. doi: <a href="https://doi.org/10.1021/acsomega.5c02206" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1021/acsomega.5c02206</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22ACS%20Omega%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22ACS%20Omega%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22ACS%20Omega%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22ACS%20Omega%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Nanotherapeutic
Strategies for Overcoming the Blood–Brain
Barrier: Applications in Disease Modeling and Drug Delivery</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kirit%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Esen Kirit</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Esen Kirit</span></h3>
<div class="p">
<sup>†</sup>
Department
of Biomedical Engineering, Ankara University, Golbasi, Ankara
06830, Turkey
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kirit%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Esen Kirit</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gokce%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Cemile Gokce</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Cemile Gokce</span></h3>
<div class="p">
<sup>†</sup>
Department
of Biomedical Engineering, Ankara University, Golbasi, Ankara
06830, Turkey
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gokce%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cemile Gokce</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Altun%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Buse Altun</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Buse Altun</span></h3>
<div class="p">
<sup>†</sup>
Department
of Biomedical Engineering, Ankara University, Golbasi, Ankara
06830, Turkey
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Altun%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Buse Altun</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yilmazer%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Açelya Yilmazer</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Açelya Yilmazer</span></h3>
<div class="p">
<sup>†</sup>
Department
of Biomedical Engineering, Ankara University, Golbasi, Ankara
06830, Turkey
</div>
<div class="p">
<sup>‡</sup>
Stem
Cell Institute, Ankara University, Balgat, Ankara
06520, Turkey
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yilmazer%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Açelya Yilmazer</span></a>
</div>
</div>
<sup>†,</sup><sup>‡,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>†</sup>
Department
of Biomedical Engineering, Ankara University, Golbasi, Ankara
06830, Turkey
</div>
<div id="aff2">
<sup>‡</sup>
Stem
Cell Institute, Ankara University, Balgat, Ankara
06520, Turkey
</div>
<div class="author-notes p"><div class="fn" id="cor1">
<sup>*</sup><p class="display-inline">
Email: <span>ayilmazer@ankara.edu.tr</span>.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 11; Accepted 2025 Jul 3; Revised 2025 Jun 22; Collection date 2025 Aug 5.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Authors. Published by American Chemical Society</div>
<p>This article is licensed under CC-BY 4.0</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12332557  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40787345/" class="usa-link">40787345</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The blood–brain barrier (BBB) is the main obstacle
preventing
access to the central nervous system (CNS). It is therefore a major
challenge in CNS studies, e.g., investigations of novel therapeutic
agents for brain tumors, such as glioblastoma multiforme (GBM). Ensuring
the structural and functional integrity of the BBB is essential for
such studies. Therefore, the BBB and blood–brain-tumor barrier
(BBTB) behaviors must be further investigated to enhance the treatment
effectiveness in neurodegenerative diseases (NDDs). Researchers are
striving to use nanoparticles (NPs) and/or develop nano delivery systems
(NDSs) to efficiently overcome the barriers to transporting neurotherapeutics
to the brain, focusing on targeting disease or tumor sites. In this
regard, BBB disease modeling enables examination of the transport
of these molecules and/or systems from the bloodstream to the brain.
Facilitating their transport is likely to enhance their investigation
in CNS studies and potentially lead to their use in treating various
NDDs. This review describes the BBB, NPs, and/or NDSs used in BBB
studies and evaluates the ability of existing BBB disease models to
precisely forecast the in vivo efficacy of NPs or NDSs.</p></section><section class="abstract" id="abstract2"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ed/12332557/90b1c073ab90/ao5c02206_0010.jpg" loading="lazy" height="372" width="553" alt="graphic file with name ao5c02206_0010.jpg"></p></section><section class="abstract" id="abstract3"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ed/12332557/90b1c073ab90/ao5c02206_0008.jpg" loading="lazy" id="tgr1" height="372" width="553" alt="graphic file with name ao5c02206_0008.jpg"></p></section><section id="sec1"><h2 class="pmc_sec_title">1. Introduction</h2>
<section id="sec1.1"><h3 class="pmc_sec_title">1.1. The Blood–Brain Barrier</h3>
<p>The
blood–brain barrier (BBB) is a dynamic, semipermeable, multifunctional
interface essential for preserving central nervous system (CNS) homeostasis
by controlling molecular transportation between blood vessels and
brain tissue. It is considered as a barrier
in the CNS system that regulates the transport of molecules, and/or
cells into and out of the brain.<em>
,
</em> The anatomical structure
of the BBB is formed depending on its functionality, and the BBB forms
an important protective structure and a barrier to therapeutic drug
delivery.</p>
<p>The BBB maintains the homeostasis of the brain by
acting as a physical barrier comprising members of the neurovascular
unit (NVU), which includes brain microvascular endothelial cells (BMECs),
pericytes, astrocytes, basement membrane components such as tight
junction (TJ) proteins (TJPs); and immune cells such as microglia. The BBB is a transport barrier based on several
pathways/mechanisms, and a metabolic barrier based on different cell
types, proteins, and enzymes.<em>
−


</em> BMECs form the inner lining of the cerebral vasculature
and are effectively sealed by TJPs, including claudins (e.g., CLDN5),
occludin (OCLN), and junctional adhesion molecules (JAMs).<em>
,
</em> These junctional complexes impede paracellular diffusion and generate
increased transendothelial electrical resistance (TEER), thus limiting
molecular transport across the barrier.
</p>
<p>Astrocytes encapsulate the vascular surface with their end-feet,
controlling water and ion homeostasis through aquaporin-4 (AQP4) and
other channels, while emitting regulatory chemicals like TGF-β
and GDNF, which control TJPs and increase BBB integrity. Pericytes,
placed in the basement membrane, modulate endothelial cell proliferation,
regulate capillary blood flow, and facilitate angiogenesis. They also
contribute to the composition of the extracellular matrix (ECM) by
synthesizing collagen and fibronectin.<em>
−

</em> The basement membrane
includes a bilayer ECM abundant in laminins, collagen IV, nidogen,
and heparan sulfate proteoglycans, providing structural support and
function as signaling platforms for cellular communication and adhesion.<em>
,
</em> The interaction between BMECs and ECM components is crucial for
the polarization and barrier function of endothelial cells. Microglia,
innate immune cells of the CNS, actively modulate BBB permeability.
Under standard environments, they enhance barrier integrity; nevertheless,
upon activation, they can produce inflammatory cytokines and reactive
oxygen species, which damage TJPs and increase BBB permeability.<em>
,
</em>
</p>
<p>The BBB exhibits heterogeneity throughout the CNS. Regional
heterogeneity
has been discovered, with capillaries and venules exhibiting unique
profiles of transporter genes and immune modulatory proteins. The
discovered heterogeneity suggests BBB function differs based on anatomical
location and disease state, transporting significant implications
for targeted CNS therapy (<a href="#fig1" class="usa-link">Figure 
</a>).
</p>
<figure class="fig xbox font-sm" id="fig1"><h4 class="obj_head">1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332557_ao5c02206_0001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ed/12332557/21b1058a996e/ao5c02206_0001.jpg" loading="lazy" id="gr1" height="526" width="750" alt="1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Anatomical and cellular
composition of the blood–brain Barrier
(Created in BioRender. Kirit,E. (2025) <a href="https://BioRender.com/qq95wsq" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com/qq95wsq</a>).</p></figcaption></figure><p>The BBB offers three fundamental levels of protection.
The physical
barrier is constituted by TJPs, including CLDN5, OCLN, and JAMs, which
tightly connect BMECs and restrict paracellular diffusion. The transport
barrier depends on selective influx and efflux transporters, including
P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and
numerous multidrug resistance-associated proteins (MRPs), to regulate
the transport of molecules over the barrier. The metabolic barrier
encompasses detoxifying enzymes, including monoamine oxidases and
cytochrome P450s, which neutralize potentially hazardous chemicals
before their impact on brain function.<em>
,,
</em> However, in certain CNS illnesses, the anatomical
and functional integrity of the BBB is disrupted. This disruption
usually presents as a breakdown of TJPs, the loss of pericyte and
astrocyte support, endothelial activation, and enhanced paracellular
permeability, permitting the passage of immune cells and damaging
substances into the brain.<em>
−


</em> Such modifications are observed across an extensive
range of neurodegenerative diseases (NDDs). <a href="#tbl1" class="usa-link">Table 
</a> provides a comprehensive list of in vitro
BBB models of disease, and mechanism of BBB disruptions.</p>
<section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">1. BBB Disruption across Neurological
Diseases<sup></sup>
.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">disease</th>
<th align="center" colspan="1" rowspan="1">mechanism
of BBB disruption</th>
<th align="center" colspan="1" rowspan="1">primary consequences</th>
<th align="center" colspan="1" rowspan="1">refs</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">MS</td>
<td align="left" colspan="1" rowspan="1">T-cell infiltration, cytokine release, TJP loss</td>
<td align="left" colspan="1" rowspan="1">demyelination, lesion formation</td>
<td align="left" colspan="1" rowspan="1">
<em>
,
</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NMOSD</td>
<td align="left" colspan="1" rowspan="1">AQP4-IgG + GRP78-Ab entry via compromised BBB</td>
<td align="left" colspan="1" rowspan="1">astrocyte cytotoxicity,
inflammation</td>
<td align="left" colspan="1" rowspan="1">
<em>
,
</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MOGAD</td>
<td align="left" colspan="1" rowspan="1">GRP78-Ab facilitated MOG-IgG crossing</td>
<td align="left" colspan="1" rowspan="1">perivenular demyelination</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AE</td>
<td align="left" colspan="1" rowspan="1">autoantibodies pass the
BBB, target synaptic receptors</td>
<td align="left" colspan="1" rowspan="1">neuropsychiatric symptoms</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">pericyte loss, LRP1 downregulation</td>
<td align="left" colspan="1" rowspan="1">impaired Aβ clearance,
chronic inflammation</td>
<td align="left" colspan="1" rowspan="1">
<em>
,
</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PD</td>
<td align="left" colspan="1" rowspan="1">transporter dysregulation,
endothelial stress</td>
<td align="left" colspan="1" rowspan="1">toxin accumulation, neuron
loss</td>
<td align="left" colspan="1" rowspan="1">
<em>
,
</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ALS</td>
<td align="left" colspan="1" rowspan="1">astrocyte/endothelial damage</td>
<td align="left" colspan="1" rowspan="1">accelerated neurodegeneration</td>
<td align="left" colspan="1" rowspan="1">
<em>
,
</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">stroke</td>
<td align="left" colspan="1" rowspan="1">ROS, MMP activation, EC
death</td>
<td align="left" colspan="1" rowspan="1">edema, infarct
expansion</td>
<td align="left" colspan="1" rowspan="1">
<em>
,
</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TBI</td>
<td align="left" colspan="1" rowspan="1">mechanical shear, tight
junction breakdown</td>
<td align="left" colspan="1" rowspan="1">edema, immune cell influx</td>
<td align="left" colspan="1" rowspan="1">
<em>
,
</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">epilepsy</td>
<td align="left" colspan="1" rowspan="1">seizure-induced TJ breakdown, albumin leakage</td>
<td align="left" colspan="1" rowspan="1">BBB leakage, enhanced excitability</td>
<td align="left" colspan="1" rowspan="1">
<em>
,
</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NPSLE</td>
<td align="left" colspan="1" rowspan="1">immune complex + complement activation</td>
<td align="left" colspan="1" rowspan="1">cognitive, behavioral dysfunction</td>
<td align="left" colspan="1" rowspan="1">
<em>
−

</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GBM</td>
<td align="left" colspan="1" rowspan="1">neovascular leakiness + partial BBB integrity</td>
<td align="left" colspan="1" rowspan="1">impaired drug access, therapeutic
resistance</td>
<td align="left" colspan="1" rowspan="1">
<em>
,
</em>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t1fn1">
<sup>a</sup><p class="display-inline">AD: Alzheimer’s disease;
AE: Autoimmune encephalitis; ALS: Amyotrophic lateral sclerosis; AQP4-IgG:
Aquaporin-4 immunoglobulin G; GBM: Glioblastoma multiforme; GRP78:
Glucose-regulated protein 78; MS: Multiple sclerosis; NMOSD: Neuromyelitis
optica spectrum disorder; PD: Parkinson’s disease; TBI: Traumatic
brain injury; TJPs: Tight junction proteins.</p>
</div></div></section><p>In inflammatory degenerative diseases such as multiple
sclerosis
(MS) and neuromyelitis optica spectrum disorder (NMOSD), BBB failure
enables immune cell infiltration and enhances the activity of autoantibodies
such as AQP4-IgG and GRP78, resulting in neuroinflammation and demyelination.<em>
,,
</em> In MOGAD, the same processes
facilitate the entrance of MOG-IgG into the CNS.
</p>
<p>In autoimmune encephalitis (AE), BBB permeability
increases and
allows the passage of neuronal autoantibodies that damage synaptic
function.<em>
,
</em> NDDs such as Alzheimer’s disease
(AD) and Parkinson’s disease (PD) are distinguished by gradual
BBB degradation, transporter dysregulation, and decreased clearance
of hazardous substances.<em>
,−

</em> Amyotrophic lateral sclerosis (ALS) exhibits BBB damage resulting
from astrocytic and endothelial dysfunction.
</p>
<p>Acute disorders, such as stroke, traumatic brain injury (TBI),
and epilepsy, produce acute barrier disruption due to oxidative stress,
mechanical injury, or seizure activity, leading to edema and inflammatory
damage.<em>
−

</em> In neuropsychiatric lupus (NPSLE), the deposition
of antibodies and activation of complement damage the BBB and lead
to cognitive and psychiatric symptoms.<em>
,
</em>
</p>
<p>In addition
to its biological benefits, such as safeguarding the
brain, the BBB presents an important obstacle for medical treatments
by limiting the entry of most pharmaceuticals into the CNS. This restriction
is most apparent in glioblastoma multiforme (GBM), where abnormal
neovascularization leads to various and partly dysfunctional BBB areas. Although some permeable zones may permit restricted
drug penetration, other areas remain unchanged, leading to irregular
drug distribution, decreased effectiveness, and eventually, therapeutic
resistance. Consequently, the BBB should be regarded as an essential
component in the development of targeted approaches for the treatment
of NDDs and brain malignancies, including GBM.</p>
<p>With the development
of nanomedicine, the use of NDSs as a treatment
modality for NDDs such as AD and BC has gained importance. Although
conventional treatment methods, such as chemotherapy, have substantial
adverse effects, and the passage of drugs across the BBB is restricted,
these methods continue to be considered the most effective cancer
treatments, particularly for BC. Therefore, new strategies must be
developed with unique physicochemical properties, low cytotoxicity,
and high functionality for drug transport; diminished adverse effects
and treatment resistance; lower dosing; and traceable therapeutic
agents that can cross the BBB.<em>
,
</em> This article first
aims to provide a brief review of the BBB. Subsequently, various BBB
models of NDDs in the literature that use NDSs for multiple purposes,
such as understanding NP efficiency and BC treatment, are described,
and their challenges are discussed.</p></section><section id="sec1.2"><h3 class="pmc_sec_title">1.2. In Vitro Modeling of BBB</h3>
<p>The in vitro
modeling of the BBB has advanced considerably, evolving from simple
monoculture experiments to complex, multicellular, and dynamic systems.
These advances aim to replicate the complex structure of the NVU and
its interconnections in both healthy and diseased conditions. As shown
in <a href="#fig2" class="usa-link">Figure 
</a>, recent
BBB models are classified as static (e.g., Transwell), dynamic (e.g.,
microfluidic), organoid-based, and tissue-engineered platforms, each
presenting distinctive benefits and drawbacks for nanotherapeutic
assessment and CNS disease modeling.<em>
,
</em> For further
information and recent examples of these models, readers can refer
to other review articles.<em>
−





</em>
</p>
<figure class="fig xbox font-sm" id="fig2"><h4 class="obj_head">2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332557_ao5c02206_0002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ed/12332557/627546e5310d/ao5c02206_0002.jpg" loading="lazy" id="gr2" height="514" width="750" alt="2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>In
vitro BBB modeling (Created in BioRender. Kirit, E. (2025) <a href="https://BioRender.com/im7gbyr" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com/im7gbyr</a>).</p></figcaption></figure></section><section id="sec1.3"><h3 class="pmc_sec_title">1.3. Studying Diseases with BBB Models</h3>
<p>The integrity of the BBB is modified and disrupted in various NDDs
such as AD, Huntington’s disease, and PD. The types and stages of CNS diseases affect both the function
and integrity of the BBB, and influence drug delivery across the BBB
and the therapeutic efficacy against the disease.<em>
,
</em> Because of changes in both BBB structure and function, developing
BBB models with diseases is critical for understanding barrier disruption,
dysfunction, and pathological proteins in drug delivery and disease
therapy studies.<em>
,,
</em> Conventional drug delivery systems are generally ineffective because
they are unable to cross the BBB. However, advances in research have
enabled the development of nanotheranostics. The BBB can be penetrated
by some nanoparticles (NPs).<em>
,
</em> In this context, researchers
continue to innovate in the field of nanomedicine by developing various
types of nanosystems. Because of the expense of testing nanoformulations
in vivo, most initial studies on nanoparticle formulation are performed
in vitro, in relevant cell models such as endothelial cells, neuronal
cells, or glial cells.
<a href="#tbl2" class="usa-link">Table 
</a> provides a comprehensive list
of the cell types used to establish in vitro BBB models of disease,
as well as examples of the nanoparticle formulations tested in these
models.</p>
<section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">2. BBB Disease Models in Nanomedicine<sup></sup>
.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">targeted
disease</th>
<th align="center" colspan="1" rowspan="1">study type</th>
<th align="center" colspan="1" rowspan="1">nanosystem</th>
<th align="center" colspan="1" rowspan="1">BBB model
type</th>
<th align="center" colspan="1" rowspan="1">targeted
cells</th>
<th align="center" colspan="1" rowspan="1">refs</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="5" align="left" colspan="1">Parkinson’s
disease</td>
<td align="left" colspan="1" rowspan="1">in vivo and
ex vivo</td>
<td align="left" colspan="1" rowspan="1">melatonin/polydopamine nanostructures (mPDAN)</td>
<td align="left" colspan="1" rowspan="1">3D organoid</td>
<td align="left" colspan="1" rowspan="1">SH-SY5Y and IMR-32 cells (human neuroblastoma cell lines)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vivo</td>
<td align="left" colspan="1" rowspan="1">dopamine-loaded blood exosomes</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">bEnd.3 cells (mouse brain
microvascular endothelial cell line)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vivo</td>
<td align="left" colspan="1" rowspan="1">Iron oxide nanoparticles
(IONPs)</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">bEnd.3</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">selenium
nanoparticle (SeNP)-loaded l-DOPA/dopamine</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">hBEC-5i cells (human brain
microvascular endothelial cell line)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vivo</td>
<td align="left" colspan="1" rowspan="1">mesoporous silica-encapsulated gold nanorods (MSN-AUNRs)</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">bEnd.3 cells</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">multiple
sclerosis</td>
<td align="left" colspan="1" rowspan="1">in vivo</td>
<td align="left" colspan="1" rowspan="1">curcumin-loaded HPPS nanoparticles</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">monocytes</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td rowspan="2" align="left" colspan="1">Huntington’s
disease</td>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">MnFe<sub>2</sub>O<sub>4</sub> nanoparticles</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">bEnd.3 cells</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">cyclodextrin nanoparticles
(CDs) loaded with small interfering RNAs</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">hCMEC/D3 cells (human
brain endothelial cell line)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td rowspan="7" align="left" colspan="1">Alzheimer’s
disease</td>
<td align="left" colspan="1" rowspan="1">in vivo</td>
<td align="left" colspan="1" rowspan="1">transferrin-modified Ost liposomes (Tf-Ost-Lip)</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">APP-SH-SY5Y cells</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">peptide functionalized hollow
gold nanospheres and gold nanorods</td>
<td align="left" colspan="1" rowspan="1">microporous polycarbonate
membrane filters</td>
<td align="left" colspan="1" rowspan="1">PBCE
cells (porcine brain
capillary endothelial cells)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vivo</td>
<td align="left" colspan="1" rowspan="1">nanoparticles (FTY@Man NP)
constructed from a PLGA–PEG skeleton
loaded with fingolimod (FTY) and externally modified with mannose</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">bEnd.3 and BV-2 cells (mouse microglial cell line)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vivo</td>
<td align="left" colspan="1" rowspan="1">protoporphyrin IX (PX)-modified oxidized mesoporous carbon nanospheres
(OMCN)</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">SH-SY5Y cells</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vivo</td>
<td align="left" colspan="1" rowspan="1">MEM–PEG–PLGA nanoparticles (NPs)</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">bEnd.3
cells and astrocytes</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">gold nanorod (GNR)-PEG-Ang2/D1</td>
<td align="left" colspan="1" rowspan="1">BBB-on-a-chip</td>
<td align="left" colspan="1" rowspan="1">human hippocampal astrocytes,
human brain-vascular pericytes, and hCMEC/D3 (human brain endothelial cell line)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">sialic acid (SA)-modified selenium (Se) nanoparticles</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">bEnd.3 cells</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td rowspan="3" align="left" colspan="1">stroke</td>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">edaravone loaded ceria nanoparticles (E-A/P-CeO<sub>2</sub>)</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">BCECs (brain capillary endothelial
cells)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vivo</td>
<td align="left" colspan="1" rowspan="1">Neuroprotectant (ZL006)
loaded liposomes (T7 and SHp-P-LPs/ZL006)</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">BCECs</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">Fe<sub>3</sub>O<sub>4</sub> nanoparticles (MNP) loaded with dexamethasone (dm@LMNP)</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">BCECs</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">many neurological diseases</td>
<td align="left" colspan="1" rowspan="1">in vivo</td>
<td align="left" colspan="1" rowspan="1">Tf-containing gold nanoparticles (AUNPs)</td>
<td align="left" colspan="1" rowspan="1">transwell</td>
<td align="left" colspan="1" rowspan="1">bEnd.3 cells</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t2fn1">
<sup>a</sup><p class="display-inline">Ang2: Angiopep-2.</p>
</div></div></section><p>Polylactide (PLA) NPs have been used as drug carriers
for the delivery
of flurbiprofen, an Aβ42-lowering drug, across the BBB in the
context of AD. The Aβ42 peptide has been implicated in AD pathogenesis
and drug development for AD, but has faced challenges of poor BBB
penetration. Flurbiprofen has been encapsulated
in PLA NPs, which might serve as effective carriers for delivering
flurbiprofen across the BBB and modulating Aβ42 levels; this
treatment holds promise in the development of novel AD therapies. Another study has focused on selenium NPs (SeNPs),
because of their small size, biocompatibility, low toxicity, easy
preparation, and photoreactive, anticancer, and biocidal properties. The study has described the PAMPA-BBB acellular
assay as an appropriate model for predicting cross-BBB permeability.
That study used nontoxic doses of SeNP for the active transport mechanism
in combination with l-DOPA or dopamine for BBB permeability studies.
In vitro evaluation with cell-free and cellular transwell models has
demonstrated that SeNP-loaded l-DOPA/dopamine is effectively internalized
by human brain ECs, thus highlighting the potential of SeNPs to serve
as drug delivery vehicles in PD therapy (<a href="#fig5" class="usa-link">Figure 
</a>). An innovative,
noninvasive gene therapy delivery system has been developed to treat
Huntington’s disease, a neurodegenerative disease caused by
a mutation of the huntingtin (HTT) gene. Gene therapies aimed at decreasing
levels of the mutant HTT protein have shown promise. Cyclodextrin
(CD)-based nanoparticles carrying small interfering RNAs (siRNAs)
have been functionalized with rabies virus glycoprotein (RVG) to facilitate
crossing of the BBB. Human cerebral microvascular endothelial cells
(hCMEC/D3) and rat striatal neuronal cells (ST14A) expressing a mutant
HTT gene have been used in in vitro models. These CD nanoparticles
successfully cross the BBB, release siRNAs into neuronal cells, and
efficiently decrease HTT gene expression. Furthermore, the integrity
of the BBB model is maintained, and the nanoparticles do not damage
endothelial cells. This CD-based delivery system is a notable noninvasive
and effective platform that might potentially increase the applicability
of siRNA therapies to Huntington’s disease. Ischemic stroke is an acute cerebrovascular disease with
substantial mortality and disability rates. However, the clinical
application of neuroprotective drugs remains limited by challenges
such as poor BBB penetration and rapid drug inactivation in circulation.
Nanomaterial-focused therapeutic studies have been reviewed previously. Nanomaterials have therapeutic potential in
treating ischemic stroke, facilitating drug delivery, increasing drug
bioavailability, achieving long drug half-lives, and enhancing dissolution.
A novel in vitro BBB penetration model has been used to evaluate the
efficacy of BBB-targeted lipid nanoparticles (T-LNPs) in the delivery
of Ferrostatin-1 (Fer1), a ferroptosis inhibitor. With a mouse brain
microvascular endothelial cell (bEnd3) monolayer, T-LNPs, compared
with nontargeted nanoparticles, show significantly enhanced penetration
under oxygen-glucose deprivation conditions mimicking ischemia. Encapsulation
of Fer1 in T-LNPs not only facilitates BBB penetration but also bioactivity
retention, thus achieving more favorable inhibition of ferroptosis,
decreased oxidative stress, and greater neuroprotection in ischemic
stroke models. These findings underline the efficacy of the in vitro
BBB model in developing drug delivery strategies and highlight T-LNPs
as a promising approach to overcome BBB-related challenges in stroke
therapy.
</p>
<figure class="fig xbox font-sm" id="fig5"><h4 class="obj_head">5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332557_ao5c02206_0005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ed/12332557/18153f83d52f/ao5c02206_0005.jpg" loading="lazy" id="gr5" height="502" width="750" alt="5"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>PVP-SeNP-loaded L-DOPA/dopamine, showing high potential
for drug
delivery and BBB permeability in vitro. (A) TEM image of PVP-SeNPs,
representation of PVP-SeNP-loaded L-DOPA/dopamine, and confocal image
of hBEC-5i cells treated with PVP-SeNP-loaded L-DOPA/dopamine, showing
its ability to cross the BBB in vitro. (B) Se presence in acceptor,
cells, gelatin, donor, and membrane, determined via Transwell assays
in vitro. Reprinted from Kalčec et al., Copyright American
Chemical Society (2015).</p></figcaption></figure></section><section id="sec1.4"><h3 class="pmc_sec_title">1.4. Nanoparticles Crossing the BBB</h3>
<p>The
number of cases of CNS diseases, particularly AD, PD, brain tumors,
and strokes, is growing; these diseases currently rank second among
fatal diseases in terms of numbers of deaths.<em>
,
</em> Nevertheless, the efficacy of CNS drug development is extremely
low. Initial research has shown substantial
promise for nanomedicines in CNS disease treatment. Nanotechnology
has been extensively used in the field of drug delivery and has shown
potential to significantly enhance the effectiveness and efficiency
of drugs.<em>
−

</em> A wide range of nanocarriers, such as polymeric
NPs, inorganic NPs, liposomes, nanofibers, and micelles, have been
designed to deliver therapeutic and diagnostic substances.<em>
,
</em> In <a href="#tbl3" class="usa-link">Table 
</a> an extensive
comparison of nanoparticle is shown. NPs can transport medications
across the BBB and have effects on the CNS. Through changes and including
chemical constituents, NPs can effectively cross the BBB and access
specific locations within the brain. This ability is crucial for delivering
drugs to the brain. These particles avoid phagocytosis by the reticuloendothelial
system, thereby enhancing drug delivery to the brain by allowing pharmaceuticals
to cross the BBB and significantly increasing the drug amounts present
in the brain. This aspect is crucial in both theoretical and clinical
studies on drug delivery systems.
</p>
<section class="tw xbox font-sm" id="tbl3"><h4 class="obj_head">3. Comparison of Nanoparticles.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332557_ao5c02206_0007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ed/12332557/7eab432698c1/ao5c02206_0007.jpg" loading="lazy" id="fx1" height="1075" width="646" alt="1.4."></a></p>
<div class="p text-right font-secondary"><a href="table/tbl3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Size, a critical factor determining the behavior of
NPs, affects
NPs’ ability to deliver drugs to specific tissues, be taken
up by cells, and interact with target proteins. Even chemical reactions
involving NPs are influenced by NP size. The precise location and
nature of the targeted tissue also influence the ideal NP size. For
instance, most cancers have a vascular pore cutoff size ranging from
380 to 780 nm. NPs are solid colloidal
particles consisting of a polymer or lipid. The particle size varies
from 10 to 1000 nm, and typically ranges from 50 to 300 nm. NPs are ideal for drug targeting to the BBB.</p>
<p>NPs encounter obstacles when crossing the BBB and entering the
brain. To address these issues, many techniques have been developed
to improve NP transport across the BBB by exploiting the physiological
mechanisms involved. A frequently used technique involves inducing
a transient increase in BBB permeability via the paracellular pathway,
often by breaking the tight junctions between nearby ECs; to do so,
ultrasound with microbubbles or osmotic pressure can be used to locally
increase BBB permeability and enhance NP entry. Other methods of transporting NPs include receptor-mediated
transcytosis, adsorptive transcytosis, carrier-mediated inflow, efflux
mechanisms, and the paracellular aqueous diffusion pathway.</p>
<p>NP-based drug carriers must meet the following requirements: (1)
they must be nontoxic, biodegradable, and biocompatible; (2) they
must have a particle diameter less than 100 nm; (3) they must be stable
in the bloodstream and not have a tendency to aggregate; (4) they
must have a streamlined and economical production process; and (5)
they must be resistant to uptake by the mononuclear phagocytic system,
thus preventing any conditioning effects and displaying prolonged
circulation times in the blood. Several NP-based formulations are
now under evaluation for the treatment of CNS diseases, as summarized
below. In <a href="#tbl4" class="usa-link">Tables 
</a> and  shows various nanoparticle treatments in preclinical
and clinical studies.</p>
<section class="tw xbox font-sm" id="tbl4"><h4 class="obj_head">4. Preclinical Studies on NPs for Brain
Tumor Treatment<sup></sup>
.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">study type</th>
<th align="center" colspan="1" rowspan="1">nanomaterial/nanoparticle/nanodelivery system</th>
<th align="center" colspan="1" rowspan="1">refs</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="2" align="left" colspan="1">in vitro and
in vivo</td>
<td align="left" colspan="1" rowspan="1">liposomes + DOX + CB5005</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">liposomes + paclitaxel (PTX) + Rg3</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">liposomes + super paramagnetic iron oxide NPs (SPIONs) + DOX + P1NS + TNC</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td rowspan="3" align="left" colspan="1">in vitro and
in vivo</td>
<td align="left" colspan="1" rowspan="1">liposomes + rapamycin + MTI-31 + VAP</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">siPLK micelle + TMZ + Angiopep-2 (Ang2)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">micelle + platinum + cyclic RGD (cRDG)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td rowspan="2" align="left" colspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">dendrimer (PAMAM) + DOX + Ang2</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PAMAM + arsenic trioxide + cRGD</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro
and in vivo</td>
<td align="left" colspan="1" rowspan="1">PAMAM + PEG+ TRAIL + transferrin (Tf)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">PAMAM + tamoxifen + DOX + PEG + Tf</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td rowspan="3" align="left" colspan="1">in vitro and
in vivo</td>
<td align="left" colspan="1" rowspan="1">cyclodextrin + butylidenephthalide</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">magnetic
double emulsion nanocapsules + lactoferrin</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">spherical nucleic acid NPs
(gold NPs)</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">SPION + HAPtS</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td rowspan="9" align="left" colspan="1">in vitro and
in vivo</td>
<td align="left" colspan="1" rowspan="1">silver (Ag) NPs + verapamil + AS1411</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">iron
oxide NPs + cisplatin + folic acid</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">poly(butylcyanoacrylate)
(PBCA) NPs + cisplatin</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PLGA NPs + methotrexate/PTX + poloxamer 188</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BSA NPs + DOX + PEG + lactoferrin</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ph-dye NPs + ApoE</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">poly(levodopamine) NPs + DOX + indocyanine green</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ag–In–S ternary quantum dots + cysteine + KLA</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">carbon nitride dots</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro and in vivo</td>
<td align="left" colspan="1" rowspan="1">graphene quantum dots</td>
<td align="left" colspan="1" rowspan="1">
<em>
,
</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro
and in vivo</td>
<td align="left" colspan="1" rowspan="1">carbon
dots (CDs)</td>
<td align="left" colspan="1" rowspan="1">
<em>
,−

</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">CDs + DOX + Tf</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td rowspan="3" align="left" colspan="1">in vitro
and
in vivo</td>
<td align="left" colspan="1" rowspan="1">iron-doped orange emissive CDs</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">boron CDs + exosome</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">sugar
CDs</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">in vitro</td>
<td align="left" colspan="1" rowspan="1">CDs + Pep1 + epirubicin + TMZ</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t4fn1">
<sup>a</sup><p class="display-inline">ApoE: Apolipoprotein E; CDs: Carbon
Dots; DOX: Doxorubicin; PTX: Paclitaxel; TNC: Tenascin-C; MTI-31:
Mitochondrial targeting inhibitor 31; VAP: Vascular adhesion protein;
cRGD: cyclic RGD peptide; PAMAM: Poly­(amidoamine) dendrimers; PEG:
Poly­(ethylene glycol); Tf: Transferrin; HAPtS: Hydroxyapatite shell;
PBCA: Poly­(butylcyanoacrylate); PLA: Poly­(lactic acid); PLGA: Poly­(lactic-<em>co</em>-glycolic acid).</p>
</div></div></section><section class="tw xbox font-sm" id="tbl5"><h4 class="obj_head">5. NPs Are Clinically Used in Brain Tumor
Treatment<sup></sup>
.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">national
clinical trial number</th>
<th align="center" colspan="1" rowspan="1">tumor type</th>
<th align="center" colspan="1" rowspan="1">nanoparticle/nanodelivery system</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02340156" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02340156</a></td>
<td rowspan="2" align="left" colspan="1">GBM</td>
<td align="left" colspan="1" rowspan="1">liposomes + temozolomide (TMZ) + SGT-53</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01906385" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01906385</a></td>
<td align="left" colspan="1" rowspan="1">liposomes + rhenium 186</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02861222" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02861222</a></td>
<td align="left" colspan="1" rowspan="1">refractory nonbrainstem
malignant glioma</td>
<td align="left" colspan="1" rowspan="1">liposomes + doxorubicin (DOX)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00019630" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00019630</a></td>
<td align="left" colspan="1" rowspan="1">refractory solid tumors</td>
<td align="left" colspan="1" rowspan="1">liposomes + HCL+ DOX</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01848652" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01848652</a></td>
<td align="left" colspan="1" rowspan="1">relapsed and refractory
primary CNS lymphoma</td>
<td align="left" colspan="1" rowspan="1">liposomes + PEG + DOX</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03328884" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03328884</a></td>
<td align="left" colspan="1" rowspan="1">brain metastases</td>
<td align="left" colspan="1" rowspan="1">liposomes + irinotecan (CPT-11)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03086616" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03086616</a></td>
<td align="left" colspan="1" rowspan="1">diffuse intrinsic pontine
glioma</td>
<td align="left" colspan="1" rowspan="1">convection-enhanced delivery of liposomes + irinotecan</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03818386" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03818386</a></td>
<td align="left" colspan="1" rowspan="1">brain metastases</td>
<td align="left" colspan="1" rowspan="1">gadolinium-based NP (AGuIX)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04881032" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04881032</a></td>
<td rowspan="3" align="left" colspan="1">GBM</td>
<td align="left" colspan="1" rowspan="1">AGuIX + TMZ</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03020017" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03020017</a></td>
<td align="left" colspan="1" rowspan="1">gold NPs + NU-0129</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03463265" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03463265</a></td>
<td align="left" colspan="1" rowspan="1">albumin-based NPs + rapamycin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03250520" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03250520</a></td>
<td align="left" colspan="1" rowspan="1">brainstem glioma</td>
<td align="left" colspan="1" rowspan="1">platinum acetylacetonate + titanfia (NPt-Ca)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t5fn1">
<sup>a</sup><p class="display-inline">AGuIX: Gadolinium-based nanoparticle.</p>
</div></div></section><section id="sec1.4.1"><h4 class="pmc_sec_title">1.4.1. Lipid-Based Nanoparticles</h4>
<section id="sec1.4.1.1"><h5 class="pmc_sec_title">1.4.1.1. Liposomes</h5>
<p>Liposomes, the first-generation
nanoparticulate drug delivery systems, include several vesicular bilayers (lamellae) composed of amphiphilic
lipids that encapsulate an interior aqueous compartment. The liposomal
lipid bilayer typically consists of biocompatible and biodegradable
lipids that are found in biological membranes. Key components of liposomes
include sphingomyelin, phosphatidylcholine, and glycerophospholipids.
Because of its ability to decrease membrane permeability and increase
liposome stability in living organisms, collagen is frequently incorporated
into liposomes. One beneficial characteristic
of liposomes is their amphiphilic properties, which allow for free
diffusion through cell membranes and targeting of brain cancer cells.</p>
<p>Liposome carrier systems have received approval from the Food and
Drug Administration for clinical use. This milestone was achieved
with the approval of Doxil (doxorubicin hydrochloride liposome injection)
produced by Sun Pharma Global FZE, based in Mumbai, India.<em>
−

</em> The study focused on improving glioma treatment with CB5005-modified
PEGylated liposomes. CB5005, a cell-penetrating peptide and NF-κB
inhibitor, was attached to modified liposomes. In vitro examinations
demonstrated that CB5005 significantly enhanced liposomal absorption
by glioma cells and elevated DOX liposome cytotoxicity against U87
tumor cells. In vivo imaging revealed that intravenous CB5005-LS accumulated
in the brain and targeted GBM areas. The dual-functional CB5005-LS/DOX
system significantly increased the survival rates of mice with intracranial
GBM. Liposomes have frequently been
used for delivering drugs to the brain to treat illnesses such as
cerebral ischemia (Lai et al.). For example, Ishii et al. have discovered
that FK506 liposomes efficiently repair cerebral ischemia/reperfusion
injury. If administered shortly after reperfusion, these liposomes,
compared with free FK506, significantly decrease neutrophil infiltration,
apoptotic cell death, and infarct volume in t-MCAO rats, thereby enhancing
motor function problems. Therefore, FK506 liposomes, which allow for
lower dosages without loss of efficacy, have considerable potential
as a neuroprotective drug if provided promptly after a stroke, and can deliver opioid peptides and target
brain tumors. Liposomes coated with
transferrin can cross the BBB. Mangostin, a polyphenolic xanthone
that preserves cerebral cortical neurons, can be effectively transported
across the BBB with transferrin liposomes. This technique, compared
with individual transport, improves drug bioavailability in the plasma.
Folate, epidermal growth factor (EGF) receptors, and avb3 integrin
are several potential target delivery systems for liposomes, including
active vascular targeting.
</p></section><section id="sec1.4.1.2"><h5 class="pmc_sec_title">1.4.1.2. Cationic Liposomes</h5>
<p>Cationic liposomes,
which consist of lipids with a positive charge, have been created
and used primarily as carriers for transfection. Their purpose is
to transport genetic material, such as DNA, into cells while preventing
degradation by lysosomes. The most frequently used cationic lipid
is 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), which is combined
with dioleoyl-phosphatidyl-ethanolamine (DOPE). Cholesterol also enhances
transfection levels and may decrease liposome instability in the presence
of serum. The cationic lipids and nucleic
acids interact and form complexes known as lipoplexes. Positively
charged liposomes adhere to the negatively charged phosphate molecules
on the DNA backbone through electrostatic interactions. When the pH
is lowered to 5–6, DOPE undergoes acidification and subsequently
combines with and collapses the endosome membrane. Consequently, the
contents of the endosome are released into the cytosol. Therefore,
drugs have the potential to be transported into endothelial cells,
similarly to DNA, thereby increasing their BBB crossing and targeting
of neurons.<em>
,
</em> Zhao et al. have demonstrated
that lipoplexes are considerably more efficient at transferring neuronal
SH-SY5Y cells than the frequently used transfectant Lipofectamine.
When cationic liposomes carrying photoreactive drugs are triggered
with a laser, they have lethal effects on glioblastoma cells. Furthermore,
these liposomes have been found to increase the distribution of the
cancer treatment drug paclitaxel to the brain in animals.<em>
,
</em> Studies have revealed that Lipid NPs with an inherent positive charge
confer advantages in drug delivery. Future
research should prioritize the development of cationic NPs for the
delivery of frequently used drugs.</p></section><section id="sec1.4.1.3"><h5 class="pmc_sec_title">1.4.1.3. Solid Lipid Nanoparticles</h5>
<p>Solid
lipid NPs (SLNs) are lipid-based nanocarriers with a stable hydrophobic
lipid core, which enable the dissolution or dispersion of drugs. They are composed of biocompatible lipids,
such as triglycerides, fatty acids, or waxes. Typically, nanoparticles
are modest in size, ranging from 40 to 200 nm. This size enables them
to cross the tight endothelial cells of the BBB and avoid being trapped
by the reticuloendothelial system. SLNs
have various advantages, including biocompatibility, more favorable
drug entrapment effectiveness than other nanoparticles, and the ability
to achieve sustained drug release over several weeks. Wang et al. have documented the synthesis of
3,5-dioctanoyl-5-fluoro-2-deoxyuridine (DO-FUdR) to address the limited
availability of the drug 5-fluoro-2-deoxyuridine (FUdR) and its integration
into SLNs. The results demonstrated that DOFUdR-SLN has almost twice
the brain-targeting efficacy of free FUdR in vivo. SLNs, therefore,
might enhance drugs’ ability to cross the BBB and serve as
a valuable system for targeting drugs to treat CNS illnesses.<em>
,
</em> The primary mechanism involved in malignant GBM is interference
with intracellular mRNA activity through the administration of siRNAs
via lipid NPs. The prominence and therapeutic
promise of tumor-targeted drug delivery are increasing. Given lipid
NPs’ ability to efficiently cross the BBB, the cytotoxicity
of these NPs must be considered. Lipid
NPs outperform other nanomaterials in terms of cargo therapeutic biodistribution
and bioavailability. Their limitations include particle accumulation,
unpredictable behavior and unexpected changes in polymer characteristics,
and sudden dissolution of the administered drugs.
</p></section></section><section id="sec1.4.2"><h4 class="pmc_sec_title">1.4.2. Polymer-Based Nanoparticles</h4>
<section id="sec1.4.2.1"><h5 class="pmc_sec_title">1.4.2.1. Polymeric Nanoparticles</h5>
<p>Polymeric
NPs consist of a core polymer matrix that can incorporate medicines,
typically 60–200 nm in size.<em>
,
</em> In recent
years, several polymers have been specifically engineered for medical
purposes and used in the field of controlled release of bioactive
substances. A substantial number of these materials have been specifically
engineered to undergo degradation within the human body. The most
frequently used polymers are PLA and polyglycolides. The materials
described are poly­(lactide-<em>co</em>-glycolides) (PLGA),
polyanhydrides, polycyanoacrylates, and polycaprolactone. Despite
advancements in synthetic and semisynthetic polymers, natural polymers
such as chitosan can still be used. Multiple studies have demonstrated
that substances such as ANG-PEG-NP can effectively address the problem
of limited permeability in the tumor blood barrier. Choonara et al. have used NPs composed of PLGA to encapsulate
antituberculosis medications (rifampicin, isoniazid, pyrazinamide,
and ethambutol) for targeted drug delivery to the brain. When provided
to mice, these NPs achieve sustained high drug levels in the plasma
for 5–8 days and in the brain for 9 days, significantly longer
than the duration achieved with administration of the free drugs. Pandey et al. have reported that administering
five doses of the NP formulation to mice infected with leads to bacterial removal
from the meninges after the administration of only 46 doses of common
drugs. Functional proteins have been
effectively delivered into neurons and neuronal cell lines with poly­(butylcyanoacrylate)
NPs in another study. Mangraviti et
al. have synthesized NPs by modifying poly­(1,4-butanediol diacrylate-<em>co</em>-4-amino-1-butanol) with 1-(3-aminopropyl)-4-methylpiperazine.
These NPs have been used to deliver herpes simplex virus type I thymidine
kinase (HSVtk) and ganciclovir (GCV) in a malignant glioma model (<a href="#fig3" class="usa-link">Figure 
</a>). Nonetheless, certain polymeric NPs have higher cytotoxicity
than other delivery techniques. As a result, a thorough analysis of
the safety risks is essential before any polymeric NPs are used in
clinical settings for the treatment of brain cancer.</p>
<figure class="fig xbox font-sm" id="fig3"><h6 class="obj_head">3.</h6>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332557_ao5c02206_0003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ed/12332557/1ea1dfab87ce/ao5c02206_0003.jpg" loading="lazy" id="gr3" height="583" width="700" alt="3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>PBAE/HSVtk/GCV biodegradable polymeric NPs conferring extended
survival in gliosarcoma both in vitro and in vivo. (A) TEM image of
fresh PBAE NPs; scale bar: 100 nm. (B) Transfection of malignant glioma
cells (9L and F98) with HSVtk and GCV elicits cancer-cell killing
in vitro. (C) Summary of the in vivo study approach. (D) Plots showing
substantial extension of the survival in F344 rats implanted with
9L gliosarcoma, after administration of PBAE/HSVtk/GCV. Reprinted
from Mangraviti et al., Copyright American Chemical Society (2015).</p></figcaption></figure></section><section id="sec1.4.2.2"><h5 class="pmc_sec_title">1.4.2.2. Polymeric Micelles</h5>
<p>Polymeric
micelles are created by amphiphilic copolymers that aggregate in aqueous
solution and form spherical structures. These structures have a hydrophilic
outer shell and a hydrophobic inner core and exhibit high stability
130. Polymeric micelles can respond to external stimuli. Such as pH,
light, temperature, and ultrasound, thereby enabling controlled release
of the pharmaceuticals contained within them. The potential of these NPs to deliver drugs to the brain
has been demonstrated. For example, mice injected intravenously with
chitosan-conjugated pluronic nanocarriers with a specific target peptide
for the brain (rabies virus glycoprotein; RVG29) have shown accumulation
of either a quantum dot (QD) fluorophore conjugated to the nanocarrier
or a protein loaded into the carrier in the brain.
</p></section><section id="sec1.4.2.3"><h5 class="pmc_sec_title">1.4.2.3. Dendrimers</h5>
<p>A dendrimer is usually
symmetrical concerning its core, and when it is sufficiently extended,
it tends to adopt a spherical three-dimensional shape in water. The
structure comprises a central core with a minimum of two similar chemical
functional groups. From these groups, other molecules can develop,
forming repeating units with at least one branching junction. The
recurrence of chains and branches leads to the formation of increasingly
dense concentric layers. The structure of dendrimers is densely packed
at the outside edges and less densely packed at the center, thus creating
gaps that are crucial for trapping drugs. These entities are classified as nanovectors, whose surface properties
can be varied to enable binding to hydrophobic or hydrophilic chemicals
with high molecular weight. Poly­(amidoamine),
often known as PAMAM, is widely recognized as the primary chemical
used for synthesizing dendrimers. The main component of PAMAM is a
diamine, often ethylenediamine, which reacts with methyl acrylate
before reacting again with ethylenediamine, thus producing generation-0
PAMAM. Subsequent reactions generate more advanced generations. Dendrimers
are currently being investigated for a variety of medical applications,
including the treatment of brain cancers with nanomedicine. However,
administering medicine with dendrimers poses toxicity issues. Therefore,
toxicity must be considered before dendrimers are used as a clinical
delivery vector. Albertazzi et al. have discovered that the functionalization
of PAMAM dendrimers has clinical effects on their ability to spread
across the CNS tissue of living organisms and enter live neurons.
This was observed after injection directly into the brain tissue (intraparenchymal)
or the brain ventricles (intraventricular). Vidal and Guzman et al. have described a drug intended to transfer
DNA into the brain by using serine-arginine-leucine (SRL) functionalized
PAMAM dendrimers. The SRL peptide was associated with G4 PAMAM dendrimers
via a double-functional poly­(ethylene glycol) (PEG). The modification
of dendrimers with SRL led to vulnerability to clathrin/caveolin energy-dependent
endocytosis in the brain capillary system, thereby improving rates
of transfer and decreasing toxicity. Zhao et al. have successfully developed a dendrimer-based delivery
system tailored to GBM. PEGylated CREKA-modified PAMAM dendrimers
have been demonstrated to cross GBM tissue and show greater retention
than untreated NPs. Therefore, modified dendrimers are highly appropriate
for delivering chemotherapy drugs. Somani
et al. have developed a 3-diaminobutyric polypropylenimine dendrimer
coated with lactoferrin to transport a therapeutic gene into the brain
(Somani et al.). Kannan et al. have demonstrated that polyamidoamine
dendrimers, when supplied systemically, aggregate solely in activated
microglia and astrocytes in the brains of newborn rabbits with cerebral
palsy. This research might suggest the potential of clinical applications
in the treatment of neuroinflammatory diseases in humans. In addition, Gao et al. have reported a gene-drug
delivery system based on transferrin Tf-modified PAMAM for glioma
treatment (<a href="#fig4" class="usa-link">Figure 
</a>). The approach includes a plasmid that encodes the tumor necrosis
factor-induced apoptosis-inducing ligand (trail) and produces NPs
through condensation with Tf-modified PAMAM. PAMAM–PEG-Tf/DNA
NPs outperform PAMAM–PEG/DNA NPs in terms of cellular uptake,
in vitro gene expression, and cytotoxicity in C6 glioma cells. Ex
vivo fluorescence imaging has indicated the potential of Tf-modified
NPs to target certain tumors.
</p>
<figure class="fig xbox font-sm" id="fig4"><h6 class="obj_head">4.</h6>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332557_ao5c02206_0004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ed/12332557/a8fd6303420a/ao5c02206_0004.jpg" loading="lazy" id="gr4" height="491" width="696" alt="4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>PAMAM–PEG-Tf/Trail dendrimers efficiently
target glioma
for gene therapy. (a) Uptake and gene expression of the dendrimers
in C6 glioma cells in vitro; the red signal is EMA-labeled TRAIL,
whereas the green signal is GFP. (b) Flow cytometry data showing cell
apoptosis in vitro. (c) Survival plot of C6-bearing rats in vivo, <em>n</em> = 10. (d) Distribution of gene expression in C6-bearing
rats treated with the dendrimer. (e) MR imaging of a C6-bearing rat
brain, with a red arrow indicating decreased tumor volume after treatment.
Reprinted from Gao et. al, 2015, with permission from Taylor &amp;
Francis.</p></figcaption></figure></section><section id="sec1.4.2.4"><h5 class="pmc_sec_title">1.4.2.4. Polymersomes</h5>
<p>Polymersomes, such
as lipids, are amphiphilic compounds that contain hydrophilic (water-loving)
and hydrophobic (water-repelling) components. These amphiphilic qualities
enable self-assembly into vesicles in water, with hydrophobic blocks
clustering to avoid water and hydrophilic blocks facing the surrounding
solution. Whereas lipids are naturally generated and biocompatible,
thus making them ideal for drug delivery applications, liposomes have
drawbacks such as uncontrolled release, biodistribution, and systemic
toxicity.<em>
,
</em> These particles resemble liposomes
but have a thicker bilayer membrane that can be PEGylated; consequently,
they are more stable than liposomes and have enhanced blood circulation
capability. Polymersomes can hold more
hydrophobic medicines than liposomes, because of their larger apolar
compartments. Preparing polymeric carriers for efficient transport
across the BBB into the brain is highly beneficial for CNS medicines,
which are often hydrophobic. Georgiva et al. have created a polymersome
nanocarrier containing a small dodecamer peptide (1645 g mol<sup>–1</sup>) that successfully crosses the BBB in vitro and in vivo. Phage display
was used to identify the peptide G23, which targeted the ganglioside
GM1. The G23 peptide, known for binding
gangliosides, has been used to increase nanocarrier transport across
the BBB. One study designed a penetrating-targeting
polymersome to enhance transport across the BBB/BTB and targeting
of glioma cells, thereby improving treatment efficacy in tumor-bearing
mouse models. This polymersome was used to encapsulate Dox, and was
conjugated with des-octanoyl ghrelin and folate as a penetrating-targeting
carrier to improve BBB/BTB transport and tumor accumulation. The des-octanoyl
ghrelin ligand is crucial for transporting polymersomal Dox across
the BBB/BTB, and folate aids in the targeting of glioma cells. With
bifunctional ligands on the surface of polymersomal Dox, BBB/BTB transport
and glioma growth suppression have been found to significantly improve,
owing to the synergistic action of two separate endocytosis pathways
via des-octanoyl ghrelin and folate.
</p></section></section><section id="sec1.4.3"><h4 class="pmc_sec_title">1.4.3. Metal-Based Nanoparticles</h4>
<section id="sec1.4.3.1"><h5 class="pmc_sec_title">1.4.3.1. Gold Nanoparticles</h5>
<p>In recent
decades, the study of gold NPs (AuNPs) has attracted interest for
their potential implications in nanomedicine, particularly in brain-targeting
and delivery. AuNPs have a promising
ability to traverse the BBB, exhibiting greater efficacy in targeting
the brain than numerous other delivery strategies. Nevertheless, the
use of these tools remains restricted, and further investigation is
needed to expand and optimize their ability to cross barriers. AuNPs
have exceptional light absorption and scattering capabilities, and
therefore are highly valuable in applications such as early identification
of cancer cells through tumor imaging. This ability is anticipated
to induce the movement of electrons on the surface of the metal, as
well as the collective oscillation known as surface plasmon resonance,
thus leading to stimulation by light at specific wavelengths. For example, versatile AuNPs coated with the
chemotherapy drug cisplatin have been developed to enhance radiation
sensitivity. Cisplatin is effectively transported to the brain; moreover,
gold and platinum atoms can also absorb the high-energy radiation
emitted by electrons and subsequently generate cytotoxic reactive
oxygen species. This process enhances the in vivo cytotoxicity and
therapeutic effectiveness of this NDS for malignant brain tumors. One clinical trial has examined the safety
of NU-0129, an innovative drug based on spherical nucleic acid technology,
in patients with recurrent GBM or gliosarcoma. NU-0129 is a compound
composed of nucleic acids bound to a tiny spherical gold NP to cross
the BBB. Once inside the tumor, NU-0129 targets the Bcl2L12 gene,
which has been associated with tumor growth and prevents programmed
cell death (apoptosis). Blocking this gene is expected to halt the
growth of cancer cells. This study is the first human trial of NU-0129
to determine its safety (<a href="https://clinicaltrials.gov/ct2/show/NCT03020017" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03020017</a>).</p></section><section id="sec1.4.3.2"><h5 class="pmc_sec_title">1.4.3.2. Magnetic Nanoparticles</h5>
<p>Magnetic
NPs use a magnetic field gradient to deliver drugs, and are typically
based on metal elements such as iron, nickel, and cobalt. The strong
field irreversibility and high saturation field of these magnetic
NPs offer potential benefits. In addition, a significant superparamagnetic
presence is characterized by the occurrence of additional anisotropy
contributions or shifted loops during field cooling.<em>
,
</em> Typically, biodegradable polymers are used to encase magnetic NPs,
and the effectiveness of these NPs greatly relies on the material
used for brain cancer treatment. Cobalt and nickel are extremely susceptible
to oxidation. Magnetic NPs have higher toxicity than iron oxide compounds.
The ideal candidates for this form of nanomedicine are individuals
with high surface areas, diminished sedimentation, and elevated tissular
diffusion. Magnetic NPs provide unique benefits for delivering drugs
to the brain: magnetic NPs with enhanced surface effectiveness significantly
decrease magnetic dipole–dipole interactions. The location
of the delivered drug can be adjusted depending on the equilibrium
between the magnetic forces and the forces exerted by the blood compartment. Magnetic NPs are also useful in imaging brain
tumors. Gadolinium compounds, which are rare earth metals, have been
successfully used in MRI scanning to detect NPs that accumulate in
tumor areas.
</p></section><section id="sec1.4.3.3"><h5 class="pmc_sec_title">1.4.3.3. Microbubble Nanoparticles</h5>
<p>Microbubble
NPs are theragnostic agents with a unique ability to interact with
ultrasound. This characteristic makes them highly valuable in various
biological and medical applications. Every microbubble NP consists
of a gas core enveloped by proteins, lipids, or polymers. Molecular
imaging uses the sensitive effects of the acoustic backscattering
of light rays. This method shows significantly higher echogenicity
than conventional ultrasonography. Lower acoustic pressure induces
steady oscillation, thereby increasing the permeability of tight junctions
in the BBB to allow penetration of NPs. Under high acoustic pressure,
the microbubble initiates a process of splitting into smaller bubbles
known as daughter bubbles.<em>
,
</em> The process of breaking
microbubbles into smaller fragments has a wide range of practical
uses in medical applications. One example is the use of the inertial
cavitation technique to deliver drugs specifically to tumors during
therapy. These microbubbles are designed with chemical compositions
to facilitate targeted drug delivery. Protein shells, surfactant shells,
lipid shells, polymer shells, and polyelectrolyte multilayer shells
are among the many types of shells used to construct microbubbles
to provide several advantages. Because of its ultrasound functionality
and ability to cross the BBB, made them important for studies.
</p></section><section id="sec1.4.3.4"><h5 class="pmc_sec_title">1.4.3.4. Quantum Dot Nanoparticles</h5>
<p>QDs
are semiconductor nanomaterials with dimensions in the nanometer range.
QDs can be constructed from a variety of materials, including metals
(such as gold), carbon-based materials (such as carbon dots and graphene),
and semiconductors (such as selenium and cadmium). These nanoscale
particles have high intrinsic luminescence, and their distinctive
quantum phenomena, which occur within a narrow size range, confer
distinct advantages in their optical properties.<em>
,
</em> Graphene quantum dots (GQDs), carbon quantum dots (CQDs), carbon
nanodots, and carbonized polymer dots are distinct types of QDs (<a href="#fig6" class="usa-link">Figure 
</a>). Their differences
result from various levels of carbonization, graphitization, and polymerization
throughout the synthesis process. QDs have various remarkable optical
features, including extraordinary resistance to photobleaching, a
high absorption cross-section, and relatively long fluorescence lifetimes. The optical and electrochemical features of
QDs make them ideal for biophotonic and nanomedicine research applications.
One study has evaluated the specificity and efficacy of QDs complexed
with MMP-9-siRNA (matrix-degrading metalloproteinase nanoplex) in
downregulating the expression of the MMP-9 gene in BMECs, which constitute
the BBB. Our findings have demonstrated that suppressing MMP-9 gene
expression increases levels of ECM proteins, including collagen I,
IV, and V, and decreases endothelial permeability, as indicated by
an increase in the TEER value in a well-established in vitro BBB model.
Furthermore, silencing of the MMP-9 gene increases the expression
of tissue inhibitor of metalloproteinase-1 (TIMP-1), thereby emphasizing
the importance of the balance between MMP-9 and its natural inhibitor
TIMP-1 in preserving basement membrane integrity. These findings highlight
the potential for this QD-based siRNA delivery technology to modulate
MMP-9 activity in BMECs and other MMP-9-producing cells. This technique
provides a promising framework for developing therapeutically meaningful
QD formulations aimed at avoiding neuroinflammation and maintaining
BBB integrity. Since the discovery of
the transferrin receptor protein’s high localization on the
brain’s endothelial surface, transferrin has been used to facilitate
receptor-mediated transport across the BBB. In a recent study, a transferrin-conjugated
quantum dot (Tf-QD) formulation has been developed and used to traverse
the in vitro BBB model through receptor-mediated transport mechanisms.
Fluorescence analysis of the lower medium revealed that some QD-Tf
bioconjugates successfully crossed the BBB. Furthermore, confocal
microscopy demonstrated QD staining on both the upper and lower sides
of the PET membrane after treatment with the Tf-QD bioconjugates,
thus indicating effective translocation of the functionalized QDs.
These results support that QDs can be efficiently guided to traverse
the in vitro model BBB. Patel and Shah
et al. have conducted both in vitro and in vivo studies to generate
water-soluble two-dimensional fluorescent GQD nanocrystals by using
bottom-up methods and a simple one-pot synthesis procedure. Spectrofluorimetry,
gel electrophoresis, FT-IR, and DLS investigations have demonstrated
that carbodiimide-activated amidation achieves a stable combination
between GQDs and antibodies/proteins than PEGylation. In silico molecular
docking has predicted frequent interactions during this conjugation.
In vitro testing revealed dose-dependent toxicity of GQDs and their
conjugates, including deadly hemolytic effects, whereas in vivo investigations
demonstrated that elevated CRP levels did not cause inflammation in
rats. Ethylnitrosourea led to modest brain tumor development, whereas
treatment with the GQD-Caspase 8 compound displayed considerable antitumor
and neuroprotective benefits in these mice. In recent years, NPs, particularly CDs, have been demonstrated to
be a viable drug delivery approach for CNS diseases. Another in vitro/in
vivo study has developed new carbon dots (MGA-CDs) for glioblastoma
treatment with metformin and gallic acid as precursors. MGA-CDs have
high BBB permeability and strong antitumor activity. They successfully
target tumor cell mitochondria without requiring additional targeting
agents, thus resulting in mitochondrial shrinkage and decreased cristae.
Transcriptome profiling has indicated that MGA-CDs impair the glycerophospholipid
metabolic pathway by suppressing PLPP4 expression and consequently
result in ferroptosis. Their therapeutic efficacy has been confirmed
in a human-derived orthotopic glioblastoma mouse model, wherein MGA-CDs
markedly decreased tumor development and increased survival. This
study emphasizes the potential of CD-based medicinal compounds for
glioblastoma treatment.
</p>
<figure class="fig xbox font-sm" id="fig6"><h6 class="obj_head">6.</h6>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332557_ao5c02206_0006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ed/12332557/4b4dafa33d60/ao5c02206_0006.jpg" loading="lazy" id="gr6" height="720" width="696" alt="6"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>GQD conjugated with Caspase
8 decreases neurodegeneration and demonstrates
anticancer behavior against GBM in vivo. (A) Representation of the
GQD-Caspase 8 interaction. (B) In vitro cell viability of SK-N-SH
and N2a cells 24 h after treatment with GQD and GQD-Caspase 8 separately,
with increasing concentrations of NPs. (C) In vivo brain tumor diagnostic
biomarker estimation in brain tumor-bearing rats treated with various
combinations of GQDs. (D) Histopathological and immunohistochemical
characterizations of brain tissues of GQD-treated brain tumor-bearing
rats. Reprinted from Patel and Shah, 2023, with permission from IOP
Publishing.</p></figcaption></figure></section><section id="sec1.4.3.5"><h5 class="pmc_sec_title">1.4.3.5. Mesoporous Silica Nanoparticles</h5>
<p>Mesoporous silica nanoparticles (MSNs), which are homogeneous mesopores
with simple functionalization and high biocompatibility, have recently
gained in popularity for biomedical applications.<em>
,
</em> The pore chambers and vast surface area provide a favorable foundation
for creating multifunctional theragnostic agents. The unusual architecture
of MSNs enables functionalization of three separate domains: the silica
framework, nanochannels/pores, and the nanoparticle’s outermost
surface. With various domains for (1) the contrast agent that allows
traceable imaging of theragnostic target, (2) the drug payload for
therapeutic intervention, and (3) the biomolecular ligand for highly
targeted delivery, MSNs are particularly well-suited to combining
the fundamental functions of a theragnostic platform in a single particle.
Beyond these characteristics, MSNs are readily taken up by cells,
enable simple surface functionalization, and have in vivo biocompatibility.<em>
−

</em> In a study, researchers evaluated MSNs with various forms and surface
coatings have been evaluated for possible application as brain drug
carriers. Spherical and rod-shaped MSNs (less than 100 nm) have been
evaluated with or without PEG–PEI coatings. The coated particles
demonstrated improved cellular absorption and were safe at the tested
amounts. Permeability tests revealed low transport rates across a
BBB model. Two-photon in vivo imaging revealed that the MSNs were
detectable in the brain vasculature without inducing BBB disruption. Another study has created ligand-free PEGylated
MSNs (RMSN25-PEG-TA) 25 nm in size and with a slight positive charge,
which showed enhanced BBB penetration. Two-photon imaging demonstrated
that these nanoparticles remained in the circulation for more than
24 h and successfully crossed the cerebrovascular area. When loaded
with DOX, the nanoparticles (DOX@RMSN25-PEG-TA) showed 6-fold greater
brain accumulation than free DOX, owing to the improved permeability
and retention effects. In vivo investigations demonstrated considerable
decreases in glioma growth and increases in the lifespan by more than
28% in brain tumor models, as well as improved biosafety. LC-MS/MS
revealed a distinct protein corona containing apolipoprotein E and
albumin, which is likely to contribute to BBB penetration.
</p></section></section></section></section><section id="sec2"><h2 class="pmc_sec_title">2. Conclusions and Future Perspectives</h2>
<p>In the CNS in the human body, the BBB is an important membrane
that surrounds the blood vessels of the brain and resists the exchange
of molecules and/or substances between the blood and the brain.</p>
<p>NDDs are not effectively treated because of the inability of drugs
to penetrate the BBB. For an administered medicine to exert effects
at the intended location, it must initially traverse this exceptionally
selective barrier. Research and testing remain ongoing to identify
medicines that are sufficiently small to cross this barrier. Conditions
such as AD currently lack treatments, because drug molecules are unable
to penetrate the BBB. Hence, nanotechnology may play a crucial role
in addressing CNS-associated illnesses by facilitating the targeted
delivery of drugs to the brain.</p>
<p>Drug delivery systems comprise
several types of polymeric NPs,
liposomes, dendrimers, and other such components. These nanocarriers
can deliver drugs to specific locations while protecting against enzymatic
breakdown, thus contributing to a decreased immune response, improved
stability, solubility in the bloodstream, and controlled and extended
drug absorption. Additionally, these nanocarriers are sufficiently
small to cross the BBB and avoid elimination by the reticuloendothelial
system. A deeper understanding of the mechanisms of NPs would facilitate
the development of novel therapeutic approaches for brain diseases,
thereby overcoming a current limitation in research on CNS conditions.
Furthermore, by specifically targeting the drug to the cerebral circulation,
increased absorption of a compound by the brain can be achieved while
minimizing toxicity to other organs in the body. To facilitate the
administration of drugs, nanocarriers must critically maintain stability
within the bloodstream, be able to overcome renal clearance and plasma
protein binding, and cross the BBB. Hence, a greater understanding
of the interactions among numerous factors associated with NP structure
would enable the development of more targeted and effective drug delivery
systems for the efficient transport of therapeutic drugs and diagnostic
compounds across the BBB. In summary, nanocarriers may significantly
contribute to the treatment of CNS diseases. The potential of these
nanocarriers in applications for the treatment of CNS-associated illnesses
and their ability to penetrate the BBB to deliver therapeutic amounts
of drug are highly encouraging.</p></section><section id="ACK-d14e1789-autogenerated" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>All unique figures are created
by BioRender.com, E.Kirit.
Authors would like to thank the funding received from the Scientific
and Technological Research Council of Turkey (TUBITAK) (project number
2247-123C581).</p></section><section id="notes-2"><h2>§.</h2>
<p>Department
of Mechanical Engineering, Marmara University, Maltepe,
34854 Istanbul, Turkey</p></section><section id="notes-1"><p>The authors
declare no competing financial interest.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="ref1">
<cite>Sweeney M. D., Sagare A. P., Zlokovic B. V.. Blood–brain barrier breakdown
in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 2018;14(3):133–150. doi: 10.1038/nrneurol.2017.188.</cite> [<a href="https://doi.org/10.1038/nrneurol.2017.188" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5829048/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29377008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Neurol.&amp;title=Blood%E2%80%93brain%20barrier%20breakdown%20in%20Alzheimer%20disease%20and%20other%20neurodegenerative%20disorders&amp;author=M.%20D.%20Sweeney&amp;author=A.%20P.%20Sagare&amp;author=B.%20V.%20Zlokovic&amp;volume=14&amp;issue=3&amp;publication_year=2018&amp;pages=133-150&amp;pmid=29377008&amp;doi=10.1038/nrneurol.2017.188&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref2">
<cite>Stebbins M. J., Wilson H. K., Canfield S. G., Qian T., Palecek S. P., Shusta E. V.. Differentiation
and characterization of human pluripotent
stem cell-derived brain microvascular endothelial cells. Methods. 2016;101:93–102. doi: 10.1016/j.ymeth.2015.10.016.</cite> [<a href="https://doi.org/10.1016/j.ymeth.2015.10.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4848177/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26518252/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Methods&amp;title=Differentiation%20and%20characterization%20of%20human%20pluripotent%20stem%20cell-derived%20brain%20microvascular%20endothelial%20cells&amp;author=M.%20J.%20Stebbins&amp;author=H.%20K.%20Wilson&amp;author=S.%20G.%20Canfield&amp;author=T.%20Qian&amp;author=S.%20P.%20Palecek&amp;volume=101&amp;publication_year=2016&amp;pages=93-102&amp;pmid=26518252&amp;doi=10.1016/j.ymeth.2015.10.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref3">
<cite>Canfield S. G., Stebbins M. J., Morales B. S., Asai S. W., Vatine G. D., Svendsen C. N., Palecek S. P., Shusta E. V.. An isogenic
blood–brain
barrier model comprising brain endothelial cells, astrocytes, and
neurons derived from human induced pluripotent stem cells. J. Neurochem. 2017;140(6):874–888. doi: 10.1111/jnc.13923.</cite> [<a href="https://doi.org/10.1111/jnc.13923" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5339046/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27935037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurochem.&amp;title=An%20isogenic%20blood%E2%80%93brain%20barrier%20model%20comprising%20brain%20endothelial%20cells,%20astrocytes,%20and%20neurons%20derived%20from%20human%20induced%20pluripotent%20stem%20cells&amp;author=S.%20G.%20Canfield&amp;author=M.%20J.%20Stebbins&amp;author=B.%20S.%20Morales&amp;author=S.%20W.%20Asai&amp;author=G.%20D.%20Vatine&amp;volume=140&amp;issue=6&amp;publication_year=2017&amp;pages=874-888&amp;pmid=27935037&amp;doi=10.1111/jnc.13923&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref4">
<cite>

Serlin, Y.
; 
Shelef, I.
; 
Knyazer, B.
; 
Friedman, A.
. 
Anatomy and Physiology
of the Blood–brain Barrier. In Seminars
in Cell &amp; Developmental Biology; Elsevier, 2015; Vol. 38, pp 2–6.
</cite> [<a href="https://doi.org/10.1016/j.semcdb.2015.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4397166/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25681530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Seminars%20in%20Cell%20&amp;%20Developmental%20Biology&amp;publication_year=2015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref5">
<cite>Stamatovic S. M., Keep R. F., Andjelkovic A. V.. Brain endothelial cell-cell junctions:
how to “open” the blood brain barrier. Curr. Neuropharmacol. 2008;6(3):179–192. doi: 10.2174/157015908785777210.</cite> [<a href="https://doi.org/10.2174/157015908785777210" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2687937/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19506719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Neuropharmacol.&amp;title=Brain%20endothelial%20cell-cell%20junctions:%20how%20to%20%E2%80%9Copen%E2%80%9D%20the%20blood%20brain%20barrier&amp;author=S.%20M.%20Stamatovic&amp;author=R.%20F.%20Keep&amp;author=A.%20V.%20Andjelkovic&amp;volume=6&amp;issue=3&amp;publication_year=2008&amp;pages=179-192&amp;pmid=19506719&amp;doi=10.2174/157015908785777210&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref6">
<cite>Kniesel U., Wolburg H.. Tight junctions of
the blood–brain barrier. Cell. Mol. Neurobiol. 2000;20(1):57–76. doi: 10.1023/A:1006995910836.</cite> [<a href="https://doi.org/10.1023/A:1006995910836" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11537529/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10690502/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell.%20Mol.%20Neurobiol.&amp;title=Tight%20junctions%20of%20the%20blood%E2%80%93brain%20barrier&amp;author=U.%20Kniesel&amp;author=H.%20Wolburg&amp;volume=20&amp;issue=1&amp;publication_year=2000&amp;pages=57-76&amp;pmid=10690502&amp;doi=10.1023/A:1006995910836&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref7">
<cite>Löscher W., Potschka H.. Drug resistance in brain diseases and the role of drug
efflux transporters. Nat. Rev. Neurosci. 2005;6(8):591–602. doi: 10.1038/nrn1728.</cite> [<a href="https://doi.org/10.1038/nrn1728" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16025095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Neurosci.&amp;title=Drug%20resistance%20in%20brain%20diseases%20and%20the%20role%20of%20drug%20efflux%20transporters&amp;author=W.%20L%C3%B6scher&amp;author=H.%20Potschka&amp;volume=6&amp;issue=8&amp;publication_year=2005&amp;pages=591-602&amp;pmid=16025095&amp;doi=10.1038/nrn1728&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref8">
<cite>

Lalatsa, A.
; 
Butt, A.
M.
. 
Physiology of the
Blood–brain Barrier and Mechanisms of Transport across the
BBB. In Nanotechnology-Based Targeted Drug
Delivery Systems for Brain Tumors; Elsevier, 2018; pp 49–74.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Nanotechnology-Based%20Targeted%20Drug%20Delivery%20Systems%20for%20Brain%20Tumors&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref9">
<cite>Mokgokong R., Wang S., Taylor C. J., Barrand M. A., Hladky S. B.. Ion transporters
in brain endothelial cells that contribute to formation of brain interstitial
fluid. Pflügers Arch. Eur. J. Physiol. 2014;466:887–901. doi: 10.1007/s00424-013-1342-9.</cite> [<a href="https://doi.org/10.1007/s00424-013-1342-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4006130/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24022703/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pfl%C3%BCgers%20Arch.%20Eur.%20J.%20Physiol.&amp;title=Ion%20transporters%20in%20brain%20endothelial%20cells%20that%20contribute%20to%20formation%20of%20brain%20interstitial%20fluid&amp;author=R.%20Mokgokong&amp;author=S.%20Wang&amp;author=C.%20J.%20Taylor&amp;author=M.%20A.%20Barrand&amp;author=S.%20B.%20Hladky&amp;volume=466&amp;publication_year=2014&amp;pages=887-901&amp;pmid=24022703&amp;doi=10.1007/s00424-013-1342-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref10">
<cite>Winkler L., Blasig R., Breitkreuz-Korff O., Berndt P., Dithmer S., Helms H. C., Puchkov D., Devraj K., Kaya M., Qin Z.. et al. Tight
junctions in the blood–brain barrier promote
edema formation and infarct size in stroke–ambivalent effects
of sealing proteins. J. Cereb. Blood Flow Metab. 2021;41(1):132–145. doi: 10.1177/0271678X20904687.</cite> [<a href="https://doi.org/10.1177/0271678X20904687" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7747158/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32054373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cereb.%20Blood%20Flow%20Metab.&amp;title=Tight%20junctions%20in%20the%20blood%E2%80%93brain%20barrier%20promote%20edema%20formation%20and%20infarct%20size%20in%20stroke%E2%80%93ambivalent%20effects%20of%20sealing%20proteins&amp;author=L.%20Winkler&amp;author=R.%20Blasig&amp;author=O.%20Breitkreuz-Korff&amp;author=P.%20Berndt&amp;author=S.%20Dithmer&amp;volume=41&amp;issue=1&amp;publication_year=2021&amp;pages=132-145&amp;pmid=32054373&amp;doi=10.1177/0271678X20904687&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref11">
<cite>Tait M. J., Saadoun S., Bell B. A., Papadopoulos M. C.. Water movements
in the brain: role of aquaporins. Trends Neurosci. 2008;31(1):37–43. doi: 10.1016/j.tins.2007.11.003.</cite> [<a href="https://doi.org/10.1016/j.tins.2007.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18054802/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Neurosci.&amp;title=Water%20movements%20in%20the%20brain:%20role%20of%20aquaporins&amp;author=M.%20J.%20Tait&amp;author=S.%20Saadoun&amp;author=B.%20A.%20Bell&amp;author=M.%20C.%20Papadopoulos&amp;volume=31&amp;issue=1&amp;publication_year=2008&amp;pages=37-43&amp;pmid=18054802&amp;doi=10.1016/j.tins.2007.11.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref12">
<cite>Alahmari A.. blood–brain
barrier overview: Structural and functional correlation. Neural Plast. 2021;2021(1):6564585.  doi: 10.1155/2021/6564585.</cite> [<a href="https://doi.org/10.1155/2021/6564585" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8668349/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34912450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neural%20Plast.&amp;title=blood%E2%80%93brain%20barrier%20overview:%20Structural%20and%20functional%20correlation&amp;author=A.%20Alahmari&amp;volume=2021&amp;issue=1&amp;publication_year=2021&amp;pages=6564585&amp;pmid=34912450&amp;doi=10.1155/2021/6564585&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref13">
<cite>Mo F., Pellerino A., Soffietti R., Rudà R.. Blood–brain
barrier in brain tumors: biology and clinical relevance. Int. J. Mol. Sci. 2021;22(23):12654.  doi: 10.3390/ijms222312654.</cite> [<a href="https://doi.org/10.3390/ijms222312654" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8657947/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34884457/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Blood%E2%80%93brain%20barrier%20in%20brain%20tumors:%20biology%20and%20clinical%20relevance&amp;author=F.%20Mo&amp;author=A.%20Pellerino&amp;author=R.%20Soffietti&amp;author=R.%20Rud%C3%A0&amp;volume=22&amp;issue=23&amp;publication_year=2021&amp;pages=12654&amp;pmid=34884457&amp;doi=10.3390/ijms222312654&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref14">
<cite>Hawkins B. T., Davis T. P.. The blood–brain
barrier/neurovascular unit in
health and disease. Pharmacol. Rev. 2005;57(2):173–185. doi: 10.1124/pr.57.2.4.</cite> [<a href="https://doi.org/10.1124/pr.57.2.4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15914466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.%20Rev.&amp;title=The%20blood%E2%80%93brain%20barrier/neurovascular%20unit%20in%20health%20and%20disease&amp;author=B.%20T.%20Hawkins&amp;author=T.%20P.%20Davis&amp;volume=57&amp;issue=2&amp;publication_year=2005&amp;pages=173-185&amp;pmid=15914466&amp;doi=10.1124/pr.57.2.4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref15">
<cite>Fonseca M. I., Chu S., Pierce A. L., Brubaker W. D., Hauhart R. E., Mastroeni D., Clarke E. V., Rogers J., Atkinson J. P., Tenner A. J.. Analysis
of the putative role of CR1 in Alzheimer’s disease: genetic
association, expression and function. PLoS One. 2016;11(2):e0149792.  doi: 10.1371/journal.pone.0149792.</cite> [<a href="https://doi.org/10.1371/journal.pone.0149792" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4767815/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26914463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Analysis%20of%20the%20putative%20role%20of%20CR1%20in%20Alzheimer%E2%80%99s%20disease:%20genetic%20association,%20expression%20and%20function&amp;author=M.%20I.%20Fonseca&amp;author=S.%20Chu&amp;author=A.%20L.%20Pierce&amp;author=W.%20D.%20Brubaker&amp;author=R.%20E.%20Hauhart&amp;volume=11&amp;issue=2&amp;publication_year=2016&amp;pages=e0149792&amp;pmid=26914463&amp;doi=10.1371/journal.pone.0149792&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref16">
<cite>Abbott N. J., Patabendige A. A., Dolman D. E., Yusof S. R., Begley D. J.. Structure
and function of the blood–brain barrier. Neurobiol. Dis. 2010;37(1):13–25. doi: 10.1016/j.nbd.2009.07.030.</cite> [<a href="https://doi.org/10.1016/j.nbd.2009.07.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19664713/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol.%20Dis.&amp;title=Structure%20and%20function%20of%20the%20blood%E2%80%93brain%20barrier&amp;author=N.%20J.%20Abbott&amp;author=A.%20A.%20Patabendige&amp;author=D.%20E.%20Dolman&amp;author=S.%20R.%20Yusof&amp;author=D.%20J.%20Begley&amp;volume=37&amp;issue=1&amp;publication_year=2010&amp;pages=13-25&amp;pmid=19664713&amp;doi=10.1016/j.nbd.2009.07.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref17">
<cite>Macdonald J. A., Murugesan N., Pachter J. S.. Endothelial cell
heterogeneity of
blood–brain barrier gene expression along the cerebral microvasculature. J. Neurosci. Res. 2010;88(7):1457–1474. doi: 10.1002/jnr.22316.</cite> [<a href="https://doi.org/10.1002/jnr.22316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20025060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurosci.%20Res.&amp;title=Endothelial%20cell%20heterogeneity%20of%20blood%E2%80%93brain%20barrier%20gene%20expression%20along%20the%20cerebral%20microvasculature&amp;author=J.%20A.%20Macdonald&amp;author=N.%20Murugesan&amp;author=J.%20S.%20Pachter&amp;volume=88&amp;issue=7&amp;publication_year=2010&amp;pages=1457-1474&amp;pmid=20025060&amp;doi=10.1002/jnr.22316&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref18">
<cite>Daneman R., Prat A.. The blood–brain
barrier. Cold Spring
Harbor Perspect. Biol. 2015;7(1):a020412.  doi: 10.1101/cshperspect.a020412.</cite> [<a href="https://doi.org/10.1101/cshperspect.a020412" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4292164/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25561720/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cold%20Spring%20Harbor%20Perspect.%20Biol.&amp;title=The%20blood%E2%80%93brain%20barrier&amp;author=R.%20Daneman&amp;author=A.%20Prat&amp;volume=7&amp;issue=1&amp;publication_year=2015&amp;pages=a020412&amp;pmid=25561720&amp;doi=10.1101/cshperspect.a020412&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref19">
<cite>Fock E., Parnova R.. Mechanisms of blood–brain
barrier protection
by microbiota-derived short-chain fatty acids. Cells. 2023;12(4):657.  doi: 10.3390/cells12040657.</cite> [<a href="https://doi.org/10.3390/cells12040657" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9954192/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36831324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Mechanisms%20of%20blood%E2%80%93brain%20barrier%20protection%20by%20microbiota-derived%20short-chain%20fatty%20acids&amp;author=E.%20Fock&amp;author=R.%20Parnova&amp;volume=12&amp;issue=4&amp;publication_year=2023&amp;pages=657&amp;pmid=36831324&amp;doi=10.3390/cells12040657&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref20">
<cite>Shimizu F., Nakamori M.. Blood–Brain Barrier Disruption in Neuroimmunological
Disease. Int. J. Mol. Sci. 2024;25(19):10625.  doi: 10.3390/ijms251910625.</cite> [<a href="https://doi.org/10.3390/ijms251910625" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11476930/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39408955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Blood%E2%80%93Brain%20Barrier%20Disruption%20in%20Neuroimmunological%20Disease&amp;author=F.%20Shimizu&amp;author=M.%20Nakamori&amp;volume=25&amp;issue=19&amp;publication_year=2024&amp;pages=10625&amp;pmid=39408955&amp;doi=10.3390/ijms251910625&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref21">
<cite>Archie S. R., Al Shoyaib A., Cucullo L.. blood–brain barrier dysfunction
in CNS disorders and putative therapeutic targets: an overview. Pharmaceutics. 2021;13(11):1779.  doi: 10.3390/pharmaceutics13111779.</cite> [<a href="https://doi.org/10.3390/pharmaceutics13111779" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8622070/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34834200/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=blood%E2%80%93brain%20barrier%20dysfunction%20in%20CNS%20disorders%20and%20putative%20therapeutic%20targets:%20an%20overview&amp;author=S.%20R.%20Archie&amp;author=A.%20Al%20Shoyaib&amp;author=L.%20Cucullo&amp;volume=13&amp;issue=11&amp;publication_year=2021&amp;pages=1779&amp;pmid=34834200&amp;doi=10.3390/pharmaceutics13111779&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref22">
<cite>Minagar A., Alexander J. S.. blood–brain
barrier disruption in multiple sclerosis. Mult.
Scler. J. 2003;9(6):540–549. doi: 10.1191/1352458503ms965oa.</cite> [<a href="https://doi.org/10.1191/1352458503ms965oa" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14664465/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mult.%20Scler.%20J.&amp;title=blood%E2%80%93brain%20barrier%20disruption%20in%20multiple%20sclerosis&amp;author=A.%20Minagar&amp;author=J.%20S.%20Alexander&amp;volume=9&amp;issue=6&amp;publication_year=2003&amp;pages=540-549&amp;pmid=14664465&amp;doi=10.1191/1352458503ms965oa&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref23">
<cite>Varatharaj A., Galea I.. The blood–brain barrier in
systemic inflammation. Brain, Behav., Immun. 2017;60:1–12. doi: 10.1016/j.bbi.2016.03.010.</cite> [<a href="https://doi.org/10.1016/j.bbi.2016.03.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26995317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain,%20Behav.,%20Immun.&amp;title=The%20blood%E2%80%93brain%20barrier%20in%20systemic%20inflammation&amp;author=A.%20Varatharaj&amp;author=I.%20Galea&amp;volume=60&amp;publication_year=2017&amp;pages=1-12&amp;pmid=26995317&amp;doi=10.1016/j.bbi.2016.03.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref24">
<cite>Jasiak-Zatońska M., Michalak S., Osztynowicz K., Kozubski W., Kalinowska-Łyszczarz A.. Relationship
between blood–brain permeability and antibodies against aquaporins
in neuromyelitis optica spectrum disorders and multiple sclerosis
patients. Neurol. Neurochir. Pol. 2022;56(4):308–317. doi: 10.5603/PJNNS.a2022.0007.</cite> [<a href="https://doi.org/10.5603/PJNNS.a2022.0007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35029294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurol.%20Neurochir.%20Pol.&amp;title=Relationship%20between%20blood%E2%80%93brain%20permeability%20and%20antibodies%20against%20aquaporins%20in%20neuromyelitis%20optica%20spectrum%20disorders%20and%20multiple%20sclerosis%20patients&amp;author=M.%20Jasiak-Zato%C5%84ska&amp;author=S.%20Michalak&amp;author=K.%20Osztynowicz&amp;author=W.%20Kozubski&amp;author=A.%20Kalinowska-%C5%81yszczarz&amp;volume=56&amp;issue=4&amp;publication_year=2022&amp;pages=308-317&amp;pmid=35029294&amp;doi=10.5603/PJNNS.a2022.0007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref25">
<cite>Tanaka S., Hashimoto B., Izaki S., Oji S., Fukaura H., Nomura K.. Clinical and
immunological differences between MOG
associated disease and anti AQP4 antibody-positive neuromyelitis optica
spectrum disorders: Blood–brain barrier breakdown and peripheral
plasmablasts. Mult. Scler. Relat. Disord. 2020;41:102005.  doi: 10.1016/j.msard.2020.102005.</cite> [<a href="https://doi.org/10.1016/j.msard.2020.102005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32114369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mult.%20Scler.%20Relat.%20Disord.&amp;title=Clinical%20and%20immunological%20differences%20between%20MOG%20associated%20disease%20and%20anti%20AQP4%20antibody-positive%20neuromyelitis%20optica%20spectrum%20disorders:%20Blood%E2%80%93brain%20barrier%20breakdown%20and%20peripheral%20plasmablasts&amp;author=S.%20Tanaka&amp;author=B.%20Hashimoto&amp;author=S.%20Izaki&amp;author=S.%20Oji&amp;author=H.%20Fukaura&amp;volume=41&amp;publication_year=2020&amp;pages=102005&amp;pmid=32114369&amp;doi=10.1016/j.msard.2020.102005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref26">
<cite>Gospe S. M. III, Chen J. J., Bhatti M. T.. Neuromyelitis optica
spectrum disorder and myelin oligodendrocyte glycoprotein associated
disorder-optic neuritis: a comprehensive review of diagnosis and treatment. Eye. 2021;35(3):753–768. doi: 10.1038/s41433-020-01334-8.</cite> [<a href="https://doi.org/10.1038/s41433-020-01334-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8026985/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33323985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eye&amp;title=Neuromyelitis%20optica%20spectrum%20disorder%20and%20myelin%20oligodendrocyte%20glycoprotein%20associated%20disorder-optic%20neuritis:%20a%20comprehensive%20review%20of%20diagnosis%20and%20treatment&amp;author=S.%20M.%20Gospe&amp;author=J.%20J.%20Chen&amp;author=M.%20T.%20Bhatti&amp;volume=35&amp;issue=3&amp;publication_year=2021&amp;pages=753-768&amp;pmid=33323985&amp;doi=10.1038/s41433-020-01334-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref27">
<cite>Muller D. M., Pender M. P., Greer J. M.. Blood–brain
barrier disruption
and lesion localisation in experimental autoimmune encephalomyelitis
with predominant cerebellar and brainstem involvement. J. Neuroimmunol. 2005;160(1–2):162–169. doi: 10.1016/j.jneuroim.2004.11.011.</cite> [<a href="https://doi.org/10.1016/j.jneuroim.2004.11.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15710469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neuroimmunol.&amp;title=Blood%E2%80%93brain%20barrier%20disruption%20and%20lesion%20localisation%20in%20experimental%20autoimmune%20encephalomyelitis%20with%20predominant%20cerebellar%20and%20brainstem%20involvement&amp;author=D.%20M.%20Muller&amp;author=M.%20P.%20Pender&amp;author=J.%20M.%20Greer&amp;volume=160&amp;issue=1%E2%80%932&amp;publication_year=2005&amp;pages=162-169&amp;pmid=15710469&amp;doi=10.1016/j.jneuroim.2004.11.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref28">
<cite>Uprety A., Kang Y., Kim S. Y.. blood–brain
barrier dysfunction
as a potential therapeutic target for neurodegenerative disorders. Arch. Pharmacal. Res. 2021;44(5):487–498. doi: 10.1007/s12272-021-01332-8.</cite> [<a href="https://doi.org/10.1007/s12272-021-01332-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34028650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch.%20Pharmacal.%20Res.&amp;title=blood%E2%80%93brain%20barrier%20dysfunction%20as%20a%20potential%20therapeutic%20target%20for%20neurodegenerative%20disorders&amp;author=A.%20Uprety&amp;author=Y.%20Kang&amp;author=S.%20Y.%20Kim&amp;volume=44&amp;issue=5&amp;publication_year=2021&amp;pages=487-498&amp;pmid=34028650&amp;doi=10.1007/s12272-021-01332-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref29">
<cite>Zlokovic B. V.. The blood–brain
barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57(2):178–201. doi: 10.1016/j.neuron.2008.01.003.</cite> [<a href="https://doi.org/10.1016/j.neuron.2008.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18215617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=The%20blood%E2%80%93brain%20barrier%20in%20health%20and%20chronic%20neurodegenerative%20disorders&amp;author=B.%20V.%20Zlokovic&amp;volume=57&amp;issue=2&amp;publication_year=2008&amp;pages=178-201&amp;pmid=18215617&amp;doi=10.1016/j.neuron.2008.01.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref30">
<cite>Sweeney M. D., Zhao Z., Montagne A., Nelson A. R., Zlokovic B. V.. blood–brain
barrier: from physiology to disease and back. Physiol. Rev. 2019;99(1):21–78. doi: 10.1152/physrev.00050.2017.</cite> [<a href="https://doi.org/10.1152/physrev.00050.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6335099/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30280653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiol.%20Rev.&amp;title=blood%E2%80%93brain%20barrier:%20from%20physiology%20to%20disease%20and%20back&amp;author=M.%20D.%20Sweeney&amp;author=Z.%20Zhao&amp;author=A.%20Montagne&amp;author=A.%20R.%20Nelson&amp;author=B.%20V.%20Zlokovic&amp;volume=99&amp;issue=1&amp;publication_year=2019&amp;pages=21-78&amp;pmid=30280653&amp;doi=10.1152/physrev.00050.2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref31">
<cite>Aragón-González A., Shaw P. J., Ferraiuolo L.. Blood–brain
barrier disruption
and its involvement in neurodevelopmental and neurodegenerative disorders. Int. J. Mol. Sci. 2022;23(23):15271.  doi: 10.3390/ijms232315271.</cite> [<a href="https://doi.org/10.3390/ijms232315271" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9737531/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36499600/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Blood%E2%80%93brain%20barrier%20disruption%20and%20its%20involvement%20in%20neurodevelopmental%20and%20neurodegenerative%20disorders&amp;author=A.%20Arag%C3%B3n-Gonz%C3%A1lez&amp;author=P.%20J.%20Shaw&amp;author=L.%20Ferraiuolo&amp;volume=23&amp;issue=23&amp;publication_year=2022&amp;pages=15271&amp;pmid=36499600&amp;doi=10.3390/ijms232315271&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref32">
<cite>Qiu Y.-m., Zhang C.-l., Chen A.-q., Wang H.-l., Zhou Y.-f., Li Y.-n., Hu B.. Immune cells
in the BBB disruption
after acute ischemic stroke: targets for immune therapy? Front. Immunol. 2021;12:678744.  doi: 10.3389/fimmu.2021.678744.</cite> [<a href="https://doi.org/10.3389/fimmu.2021.678744" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8260997/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34248961/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Immunol.&amp;title=Immune%20cells%20in%20the%20BBB%20disruption%20after%20acute%20ischemic%20stroke:%20targets%20for%20immune%20therapy?&amp;author=Y.-m.%20Qiu&amp;author=C.-l.%20Zhang&amp;author=A.-q.%20Chen&amp;author=H.-l.%20Wang&amp;author=Y.-f.%20Zhou&amp;volume=12&amp;publication_year=2021&amp;pages=678744&amp;pmid=34248961&amp;doi=10.3389/fimmu.2021.678744&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref33">
<cite>Hay J. R., Johnson V. E., Young A. M., Smith D. H., Stewart W.. blood–brain
barrier disruption is an early event that may persist for many years
after traumatic brain injury in humans. J. Neuropathol.
Exp. Neurol. 2015;74(12):1147–1157. doi: 10.1097/nen.0000000000000261.</cite> [<a href="https://doi.org/10.1097/nen.0000000000000261" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8744142/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26574669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neuropathol.%20Exp.%20Neurol.&amp;title=blood%E2%80%93brain%20barrier%20disruption%20is%20an%20early%20event%20that%20may%20persist%20for%20many%20years%20after%20traumatic%20brain%20injury%20in%20humans&amp;author=J.%20R.%20Hay&amp;author=V.%20E.%20Johnson&amp;author=A.%20M.%20Young&amp;author=D.%20H.%20Smith&amp;author=W.%20Stewart&amp;volume=74&amp;issue=12&amp;publication_year=2015&amp;pages=1147-1157&amp;pmid=26574669&amp;doi=10.1097/nen.0000000000000261&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref34">
<cite>Klein P., Dingledine R., Aronica E., Bernard C., Blümcke I., Boison D., Brodie M. J., Brooks-Kayal A. R., Engel J. Jr, Forcelli P. A.. et al. Commonalities
in epileptogenic processes from different acute brain insults: Do
they translate? Epilepsia. 2018;59(1):37–66. doi: 10.1111/epi.13965.</cite> [<a href="https://doi.org/10.1111/epi.13965" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5993212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29247482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;title=Commonalities%20in%20epileptogenic%20processes%20from%20different%20acute%20brain%20insults:%20Do%20they%20translate?&amp;author=P.%20Klein&amp;author=R.%20Dingledine&amp;author=E.%20Aronica&amp;author=C.%20Bernard&amp;author=I.%20Bl%C3%BCmcke&amp;volume=59&amp;issue=1&amp;publication_year=2018&amp;pages=37-66&amp;pmid=29247482&amp;doi=10.1111/epi.13965&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref35">
<cite>Duarte-Delgado N. P., Vasquez G., Ortiz-Reyes B. L.. blood–brain barrier disruption
and neuroinflammation as pathophysiological mechanisms of the diffuse
manifestations of neuropsychiatric systemic lupus erythematosus. Autoimmun. Rev. 2019;18(4):426–432. doi: 10.1016/j.autrev.2018.12.004.</cite> [<a href="https://doi.org/10.1016/j.autrev.2018.12.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30763633/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Autoimmun.%20Rev.&amp;title=blood%E2%80%93brain%20barrier%20disruption%20and%20neuroinflammation%20as%20pathophysiological%20mechanisms%20of%20the%20diffuse%20manifestations%20of%20neuropsychiatric%20systemic%20lupus%20erythematosus&amp;author=N.%20P.%20Duarte-Delgado&amp;author=G.%20Vasquez&amp;author=B.%20L.%20Ortiz-Reyes&amp;volume=18&amp;issue=4&amp;publication_year=2019&amp;pages=426-432&amp;pmid=30763633&amp;doi=10.1016/j.autrev.2018.12.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref36">
<cite>Stock A. D., Wen J., Putterman C.. Neuropsychiatric
lupus, the blood brain barrier, and
the TWEAK/Fn14 pathway. Front. Immunol. 2013;4:484.  doi: 10.3389/fimmu.2013.00484.</cite> [<a href="https://doi.org/10.3389/fimmu.2013.00484" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3872310/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24400009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Immunol.&amp;title=Neuropsychiatric%20lupus,%20the%20blood%20brain%20barrier,%20and%20the%20TWEAK/Fn14%20pathway&amp;author=A.%20D.%20Stock&amp;author=J.%20Wen&amp;author=C.%20Putterman&amp;volume=4&amp;publication_year=2013&amp;pages=484&amp;pmid=24400009&amp;doi=10.3389/fimmu.2013.00484&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref37">
<cite>Kim S.-S., Harford J. B., Pirollo K. F., Chang E. H.. Effective
treatment
of glioblastoma requires crossing the blood–brain barrier and
targeting tumors including cancer stem cells: the promise of nanomedicine. Biochem. Biophys. Res. Commun. 2015;468(3):485–489. doi: 10.1016/j.bbrc.2015.06.137.</cite> [<a href="https://doi.org/10.1016/j.bbrc.2015.06.137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4690805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26116770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;title=Effective%20treatment%20of%20glioblastoma%20requires%20crossing%20the%20blood%E2%80%93brain%20barrier%20and%20targeting%20tumors%20including%20cancer%20stem%20cells:%20the%20promise%20of%20nanomedicine&amp;author=S.-S.%20Kim&amp;author=J.%20B.%20Harford&amp;author=K.%20F.%20Pirollo&amp;author=E.%20H.%20Chang&amp;volume=468&amp;issue=3&amp;publication_year=2015&amp;pages=485-489&amp;pmid=26116770&amp;doi=10.1016/j.bbrc.2015.06.137&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref38">
<cite>Zhang W., Sigdel G., Mintz K. J., Seven E. S., Zhou Y., Wang C., Leblanc R. M.. Carbon
dots: A future Blood–Brain
Barrier penetrating nanomedicine and drug nanocarrier. Int. J. Nanomed. 2021;16:5003–5016. doi: 10.2147/IJN.S318732.</cite> [<a href="https://doi.org/10.2147/IJN.S318732" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8316758/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34326638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Nanomed.&amp;title=Carbon%20dots:%20A%20future%20Blood%E2%80%93Brain%20Barrier%20penetrating%20nanomedicine%20and%20drug%20nanocarrier&amp;author=W.%20Zhang&amp;author=G.%20Sigdel&amp;author=K.%20J.%20Mintz&amp;author=E.%20S.%20Seven&amp;author=Y.%20Zhou&amp;volume=16&amp;publication_year=2021&amp;pages=5003-5016&amp;pmid=34326638&amp;doi=10.2147/IJN.S318732&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref39">
<cite>Zuo J., Jiang T., Zhao X., Xiong X., Xiao S., Zhu Z.. Preparation and application of fluorescent carbon dots. J. Nanomater. 2015;2015:787862.  doi: 10.1155/2015/787862.</cite> [<a href="https://doi.org/10.1155/2015/787862" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nanomater.&amp;title=Preparation%20and%20application%20of%20fluorescent%20carbon%20dots&amp;author=J.%20Zuo&amp;author=T.%20Jiang&amp;author=X.%20Zhao&amp;author=X.%20Xiong&amp;author=S.%20Xiao&amp;volume=2015&amp;publication_year=2015&amp;pages=787862&amp;doi=10.1155/2015/787862&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref40">
<cite>Ramaglia V., Sheikh-Mohamed S., Legg K., Park C., Rojas O. L., Zandee S., Fu F., Ornatsky O., Swanson E. C., Pitt D.. et al. Multiplexed
imaging of immune cells in staged multiple
sclerosis lesions by mass cytometry. eLife. 2019;8:e48051.  doi: 10.7554/eLife.48051.</cite> [<a href="https://doi.org/10.7554/eLife.48051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6707785/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31368890/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=eLife&amp;title=Multiplexed%20imaging%20of%20immune%20cells%20in%20staged%20multiple%20sclerosis%20lesions%20by%20mass%20cytometry&amp;author=V.%20Ramaglia&amp;author=S.%20Sheikh-Mohamed&amp;author=K.%20Legg&amp;author=C.%20Park&amp;author=O.%20L.%20Rojas&amp;volume=8&amp;publication_year=2019&amp;pages=e48051&amp;pmid=31368890&amp;doi=10.7554/eLife.48051&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref41">
<cite>Hartung H.-P.. Correction
to “Hartung HP. Neuromyelitis Optica Spectrum Disorder: Therapeutic
Innovations and Complex Decision-Making. Ann.
Neurol. 2021;89:1084–1087. doi: 10.1002/ana.26087.</cite> [<a href="https://doi.org/10.1002/ana.26087" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33871885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Neurol.&amp;title=Correction%20to%20%E2%80%9CHartung%20HP.%20Neuromyelitis%20Optica%20Spectrum%20Disorder:%20Therapeutic%20Innovations%20and%20Complex%20Decision-Making&amp;author=H.-P.%20Hartung&amp;volume=89&amp;publication_year=2021&amp;pages=1084-1087&amp;pmid=33871885&amp;doi=10.1002/ana.26087&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref42">
<cite>Jarius S., Franciotta D., Paul F., Ruprecht K., Bergamaschi R., Rommer P. S., Reuss R., Probst C., Kristoferitsch W., Wandinger K. P., Wildemann B.. Cerebrospinal fluid antibodies to
aquaporin-4 in neuromyelitis optica and related disorders: frequency,
origin, and diagnostic relevance. J. Neuroinflammation. 2010;7:52.  doi: 10.1186/1742-2094-7-52.</cite> [<a href="https://doi.org/10.1186/1742-2094-7-52" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2945323/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20825655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neuroinflammation&amp;title=Cerebrospinal%20fluid%20antibodies%20to%20aquaporin-4%20in%20neuromyelitis%20optica%20and%20related%20disorders:%20frequency,%20origin,%20and%20diagnostic%20relevance&amp;author=S.%20Jarius&amp;author=D.%20Franciotta&amp;author=F.%20Paul&amp;author=K.%20Ruprecht&amp;author=R.%20Bergamaschi&amp;volume=7&amp;publication_year=2010&amp;pages=52&amp;pmid=20825655&amp;doi=10.1186/1742-2094-7-52&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref43">
<cite>Sagare A. P., Bell R. D., Zhao Z., Ma Q., Winkler E. A., Ramanathan A., Zlokovic B. V.. RETRACTED ARTICLE: pericyte loss
influences Alzheimer-like neurodegeneration in mice. Nat. Commun. 2013;4(1):2932.  doi: 10.1038/ncomms3932.</cite> [<a href="https://doi.org/10.1038/ncomms3932" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3945879/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24336108/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=RETRACTED%20ARTICLE:%20pericyte%20loss%20influences%20Alzheimer-like%20neurodegeneration%20in%20mice&amp;author=A.%20P.%20Sagare&amp;author=R.%20D.%20Bell&amp;author=Z.%20Zhao&amp;author=Q.%20Ma&amp;author=E.%20A.%20Winkler&amp;volume=4&amp;issue=1&amp;publication_year=2013&amp;pages=2932&amp;pmid=24336108&amp;doi=10.1038/ncomms3932&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>] [<a href="/articles/PMC10991248/" class="text-red">Retracted</a>]</li>
<li id="ref44">
<cite>Ma Q., Zhao Z., Sagare A. P., Wu Y., Wang M., Owens N. C., Verghese P. B., Herz J., Holtzman D. M., Zlokovic B. V.. blood–brain barrier-associated pericytes internalize
and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein
E isoform-specific mechanism. Mol. Neurodegener. 2018;13:57.  doi: 10.1186/s13024-018-0286-0.</cite> [<a href="https://doi.org/10.1186/s13024-018-0286-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6194676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30340601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Neurodegener.&amp;title=blood%E2%80%93brain%20barrier-associated%20pericytes%20internalize%20and%20clear%20aggregated%20amyloid-%CE%B242%20by%20LRP1-dependent%20apolipoprotein%20E%20isoform-specific%20mechanism&amp;author=Q.%20Ma&amp;author=Z.%20Zhao&amp;author=A.%20P.%20Sagare&amp;author=Y.%20Wu&amp;author=M.%20Wang&amp;volume=13&amp;publication_year=2018&amp;pages=57&amp;pmid=30340601&amp;doi=10.1186/s13024-018-0286-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref45">
<cite>Hornykiewicz O.. Biochemical
aspects of Parkinson’s disease. Neurology. 1998;51(2):S2–S9. doi: 10.1212/WNL.51.2_Suppl_2.S2.</cite> [<a href="https://doi.org/10.1212/WNL.51.2_Suppl_2.S2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9711973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Biochemical%20aspects%20of%20Parkinson%E2%80%99s%20disease&amp;author=O.%20Hornykiewicz&amp;volume=51&amp;issue=2&amp;publication_year=1998&amp;pages=S2-S9&amp;pmid=9711973&amp;doi=10.1212/WNL.51.2_Suppl_2.S2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref46">
<cite>Levy O. A., Malagelada C., Greene L. A.. Cell death pathways in Parkinson’s
disease: proximal triggers, distal effectors, and final steps. Apoptosis. 2009;14:478–500. doi: 10.1007/s10495-008-0309-3.</cite> [<a href="https://doi.org/10.1007/s10495-008-0309-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2754154/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19165601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Apoptosis&amp;title=Cell%20death%20pathways%20in%20Parkinson%E2%80%99s%20disease:%20proximal%20triggers,%20distal%20effectors,%20and%20final%20steps&amp;author=O.%20A.%20Levy&amp;author=C.%20Malagelada&amp;author=L.%20A.%20Greene&amp;volume=14&amp;publication_year=2009&amp;pages=478-500&amp;pmid=19165601&amp;doi=10.1007/s10495-008-0309-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref47">
<cite>Qian K., Huang H., Peterson A., Hu B., Maragakis N. J., Ming G.-l., Chen H., Zhang S.-C.. Sporadic
ALS astrocytes
induce neuronal degeneration in vivo. Stem Cell
Rep. 2017;8(4):843–855. doi: 10.1016/j.stemcr.2017.03.003.</cite> [<a href="https://doi.org/10.1016/j.stemcr.2017.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5390239/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28366455/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cell%20Rep.&amp;title=Sporadic%20ALS%20astrocytes%20induce%20neuronal%20degeneration%20in%20vivo&amp;author=K.%20Qian&amp;author=H.%20Huang&amp;author=A.%20Peterson&amp;author=B.%20Hu&amp;author=N.%20J.%20Maragakis&amp;volume=8&amp;issue=4&amp;publication_year=2017&amp;pages=843-855&amp;pmid=28366455&amp;doi=10.1016/j.stemcr.2017.03.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref48">
<cite>Garbuzova-Davis S., Kurien C., Thomson A., Falco D., Ahmad S., Staffetti J., Steiner G., Abraham S., James G., Mahendrasah A.. et al. Endothelial and astrocytic
support by human
bone marrow stem cell grafts into symptomatic ALS mice towards blood-spinal
cord barrier repair. Sci. Rep. 2017;7(1):884.  doi: 10.1038/s41598-017-00993-0.</cite> [<a href="https://doi.org/10.1038/s41598-017-00993-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5429840/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28408761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Endothelial%20and%20astrocytic%20support%20by%20human%20bone%20marrow%20stem%20cell%20grafts%20into%20symptomatic%20ALS%20mice%20towards%20blood-spinal%20cord%20barrier%20repair&amp;author=S.%20Garbuzova-Davis&amp;author=C.%20Kurien&amp;author=A.%20Thomson&amp;author=D.%20Falco&amp;author=S.%20Ahmad&amp;volume=7&amp;issue=1&amp;publication_year=2017&amp;pages=884&amp;pmid=28408761&amp;doi=10.1038/s41598-017-00993-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref49">
<cite>Sun C., Lin L., Yin L., Hao X., Tian J., Zhang X., Ren Y., Li C., Yang Y.. Acutely inhibiting AQP4 with TGN-020
improves functional outcome by attenuating edema and peri-infarct
astrogliosis after cerebral ischemia. Front.
Immunol. 2022;13:870029.  doi: 10.3389/fimmu.2022.870029.</cite> [<a href="https://doi.org/10.3389/fimmu.2022.870029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9110854/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35592320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Immunol.&amp;title=Acutely%20inhibiting%20AQP4%20with%20TGN-020%20improves%20functional%20outcome%20by%20attenuating%20edema%20and%20peri-infarct%20astrogliosis%20after%20cerebral%20ischemia&amp;author=C.%20Sun&amp;author=L.%20Lin&amp;author=L.%20Yin&amp;author=X.%20Hao&amp;author=J.%20Tian&amp;volume=13&amp;publication_year=2022&amp;pages=870029&amp;pmid=35592320&amp;doi=10.3389/fimmu.2022.870029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref50">
<cite>Zhao B.-Q., Wang S., Kim H.-Y., Storrie H., Rosen B. R., Mooney D. J., Wang X., Lo E. H.. Role of matrix metalloproteinases
in delayed cortical responses after stroke. Nat. Med. 2006;12(4):441–445. doi: 10.1038/nm1387.</cite> [<a href="https://doi.org/10.1038/nm1387" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16565723/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&amp;title=Role%20of%20matrix%20metalloproteinases%20in%20delayed%20cortical%20responses%20after%20stroke&amp;author=B.-Q.%20Zhao&amp;author=S.%20Wang&amp;author=H.-Y.%20Kim&amp;author=H.%20Storrie&amp;author=B.%20R.%20Rosen&amp;volume=12&amp;issue=4&amp;publication_year=2006&amp;pages=441-445&amp;pmid=16565723&amp;doi=10.1038/nm1387&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref51">
<cite>Kempuraj D., Ahmed M. E., Selvakumar G. P., Thangavel R., Raikwar S. P., Zaheer S. A., Iyer S. S., Govindarajan R., Chandrasekaran P. N., Burton C.. et al. Acute traumatic brain
injury-induced neuroinflammatory response and neurovascular disorders
in the brain. Neurotoxic. Res. 2021;39:359–368. doi: 10.1007/s12640-020-00288-9.</cite> [<a href="https://doi.org/10.1007/s12640-020-00288-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7502806/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32955722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurotoxic.%20Res.&amp;title=Acute%20traumatic%20brain%20injury-induced%20neuroinflammatory%20response%20and%20neurovascular%20disorders%20in%20the%20brain&amp;author=D.%20Kempuraj&amp;author=M.%20E.%20Ahmed&amp;author=G.%20P.%20Selvakumar&amp;author=R.%20Thangavel&amp;author=S.%20P.%20Raikwar&amp;volume=39&amp;publication_year=2021&amp;pages=359-368&amp;pmid=32955722&amp;doi=10.1007/s12640-020-00288-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref52">
<cite>Liao J., Zhang M., Shi Z., Lu H., Wang L., Fan W., Tong X., Yan H.. Improving
the function of meningeal
lymphatic vessels to promote brain edema absorption after traumatic
brain injury. Journal of Neurotrauma. 2023;40(3–4):383–394. doi: 10.1089/neu.2022.0150.</cite> [<a href="https://doi.org/10.1089/neu.2022.0150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36106596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurotrauma&amp;title=Improving%20the%20function%20of%20meningeal%20lymphatic%20vessels%20to%20promote%20brain%20edema%20absorption%20after%20traumatic%20brain%20injury&amp;author=J.%20Liao&amp;author=M.%20Zhang&amp;author=Z.%20Shi&amp;author=H.%20Lu&amp;author=L.%20Wang&amp;volume=40&amp;issue=3%E2%80%934&amp;publication_year=2023&amp;pages=383-394&amp;pmid=36106596&amp;doi=10.1089/neu.2022.0150&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref53">
<cite>Morin-Brureau M., De Bock F., Lerner-Natoli M.. Organotypic brain slices: a model
to study the neurovascular unit micro-environment in epilepsies. Fluids Barriers CNS. 2013;10:11.  doi: 10.1186/2045-8118-10-11.</cite> [<a href="https://doi.org/10.1186/2045-8118-10-11" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3605299/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23391266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fluids%20Barriers%20CNS&amp;title=Organotypic%20brain%20slices:%20a%20model%20to%20study%20the%20neurovascular%20unit%20micro-environment%20in%20epilepsies&amp;author=M.%20Morin-Brureau&amp;author=F.%20De%20Bock&amp;author=M.%20Lerner-Natoli&amp;volume=10&amp;publication_year=2013&amp;pages=11&amp;pmid=23391266&amp;doi=10.1186/2045-8118-10-11&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref54">
<cite>

Friedman, A.
; 
Heinemann, U.
. 
Role of Blood–brain
Barrier Dysfunction in Epileptogenesis. In Jasper’s Basic Mechanisms of the Epilepsies, 4th ed.; Oxford University Press, 2012; pp 353–361.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Jasper%E2%80%99s%20Basic%20Mechanisms%20of%20the%20Epilepsies&amp;publication_year=2012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref55">
<cite>van
der Meulen S., Monahan R. C., Gelderman K. A., van Kooten C., Teng Y. O., Huizinga T. W., Steup-Beekman G. M., Trouw L. A.. Circulating levels of endogenous complement inhibitors
correlate inversely with complement consumption in systemic lupus
erythematosus. Eur. J. Immunol. 2024;54(11):2450998.  doi: 10.1002/eji.202450998.</cite> [<a href="https://doi.org/10.1002/eji.202450998" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39165045/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Immunol.&amp;title=Circulating%20levels%20of%20endogenous%20complement%20inhibitors%20correlate%20inversely%20with%20complement%20consumption%20in%20systemic%20lupus%20erythematosus&amp;author=S.%20van%20der%20Meulen&amp;author=R.%20C.%20Monahan&amp;author=K.%20A.%20Gelderman&amp;author=C.%20van%20Kooten&amp;author=Y.%20O.%20Teng&amp;volume=54&amp;issue=11&amp;publication_year=2024&amp;pages=2450998&amp;pmid=39165045&amp;doi=10.1002/eji.202450998&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref56">
<cite>West S. G.. Lupus and
the central nervous system. Curr. Opin. Rheumatol. 1996;8(5):408–414. doi: 10.1097/00002281-199609000-00004.</cite> [<a href="https://doi.org/10.1097/00002281-199609000-00004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8941443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Opin.%20Rheumatol.&amp;title=Lupus%20and%20the%20central%20nervous%20system&amp;author=S.%20G.%20West&amp;volume=8&amp;issue=5&amp;publication_year=1996&amp;pages=408-414&amp;pmid=8941443&amp;doi=10.1097/00002281-199609000-00004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref57">
<cite>Zhou Y., Chen L., Zheng X., Fang Q., Qian Y., Xu T., Liang J., Zhang H., Han X., Sun L.. Microglia
orchestrate synaptic and neuronal stripping: Implication in neuropsychiatric
lupus. J. Cell. Mol. Med. 2024;28(7):e18190.  doi: 10.1111/jcmm.18190.</cite> [<a href="https://doi.org/10.1111/jcmm.18190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10945089/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38494844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cell.%20Mol.%20Med.&amp;title=Microglia%20orchestrate%20synaptic%20and%20neuronal%20stripping:%20Implication%20in%20neuropsychiatric%20lupus&amp;author=Y.%20Zhou&amp;author=L.%20Chen&amp;author=X.%20Zheng&amp;author=Q.%20Fang&amp;author=Y.%20Qian&amp;volume=28&amp;issue=7&amp;publication_year=2024&amp;pages=e18190&amp;pmid=38494844&amp;doi=10.1111/jcmm.18190&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref58">
<cite>Wang D., Wang C., Wang L., Chen Y.. A comprehensive review
in improving delivery of small-molecule chemotherapeutic agents overcoming
the blood–brain/brain tumor barriers for glioblastoma treatment. Drug Delivery. 2019;26(1):551–565. doi: 10.1080/10717544.2019.1616235.</cite> [<a href="https://doi.org/10.1080/10717544.2019.1616235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6534214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31928355/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Delivery&amp;title=A%20comprehensive%20review%20in%20improving%20delivery%20of%20small-molecule%20chemotherapeutic%20agents%20overcoming%20the%20blood%E2%80%93brain/brain%20tumor%20barriers%20for%20glioblastoma%20treatment&amp;author=D.%20Wang&amp;author=C.%20Wang&amp;author=L.%20Wang&amp;author=Y.%20Chen&amp;volume=26&amp;issue=1&amp;publication_year=2019&amp;pages=551-565&amp;pmid=31928355&amp;doi=10.1080/10717544.2019.1616235&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref59">
<cite>Li S., Li X., Wang N., Zhang C., Sang Y., Sun Y., Xia X., Zheng M.. Brain targeted biomimetic siRNA nanoparticles for drug
resistance glioblastoma treatment. J. Controlled
Release. 2024;376:67–78. doi: 10.1016/j.jconrel.2024.10.004.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2024.10.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39368706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Brain%20targeted%20biomimetic%20siRNA%20nanoparticles%20for%20drug%20resistance%20glioblastoma%20treatment&amp;author=S.%20Li&amp;author=X.%20Li&amp;author=N.%20Wang&amp;author=C.%20Zhang&amp;author=Y.%20Sang&amp;volume=376&amp;publication_year=2024&amp;pages=67-78&amp;pmid=39368706&amp;doi=10.1016/j.jconrel.2024.10.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref60">
<cite>Garberg P., Ball M., Borg N., Cecchelli R., Fenart L., Hurst R., Lindmark T., Mabondzo A., Nilsson J., Raub T.. et al. In vitro models for
the blood–brain barrier. Toxicol. in
Vitro. 2005;19(3):299–334. doi: 10.1016/j.tiv.2004.06.011.</cite> [<a href="https://doi.org/10.1016/j.tiv.2004.06.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15713540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol.%20in%20Vitro&amp;title=In%20vitro%20models%20for%20the%20blood%E2%80%93brain%20barrier&amp;author=P.%20Garberg&amp;author=M.%20Ball&amp;author=N.%20Borg&amp;author=R.%20Cecchelli&amp;author=L.%20Fenart&amp;volume=19&amp;issue=3&amp;publication_year=2005&amp;pages=299-334&amp;pmid=15713540&amp;doi=10.1016/j.tiv.2004.06.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref61">
<cite>

Vernon, H.
; 
Clark, K.
; 
Bressler, J. P.
. 
In Vitro Models to Study the
Blood Brain Barrier. In Methods in Molecular
Biology; Springer, 2011; Vol. 758, pp 153–168.
</cite> [<a href="https://doi.org/10.1007/978-1-61779-170-3_10" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21815064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Methods%20in%20Molecular%20Biology&amp;publication_year=2011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref62">
<cite>Monteiro A. R., Barbosa D. J., Remião F., Silva R.. Co-Culture Models:
Key Players in In Vitro Neurotoxicity, Neurodegeneration and BBB Modeling
Studies. Biomedicines. 2024;12(3):626.  doi: 10.3390/biomedicines12030626.</cite> [<a href="https://doi.org/10.3390/biomedicines12030626" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10967866/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38540242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicines&amp;title=Co-Culture%20Models:%20Key%20Players%20in%20In%20Vitro%20Neurotoxicity,%20Neurodegeneration%20and%20BBB%20Modeling%20Studies&amp;author=A.%20R.%20Monteiro&amp;author=D.%20J.%20Barbosa&amp;author=F.%20Remi%C3%A3o&amp;author=R.%20Silva&amp;volume=12&amp;issue=3&amp;publication_year=2024&amp;pages=626&amp;pmid=38540242&amp;doi=10.3390/biomedicines12030626&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref63">
<cite>Soliman Y., Al-khodor J., Köken G. Y., Mustafaoglu N.. A guide for
blood–brain barrier models. FEBS Lett. 2025;599(5):599–644. doi: 10.1002/1873-3468.15053.</cite> [<a href="https://doi.org/10.1002/1873-3468.15053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39533665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Lett.&amp;title=A%20guide%20for%20blood%E2%80%93brain%20barrier%20models&amp;author=Y.%20Soliman&amp;author=J.%20Al-khodor&amp;author=G.%20Y.%20K%C3%B6ken&amp;author=N.%20Mustafaoglu&amp;volume=599&amp;issue=5&amp;publication_year=2025&amp;pages=599-644&amp;pmid=39533665&amp;doi=10.1002/1873-3468.15053&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref64">
<cite>Shamul J. G., Wang Z., Gong H., Ou W., White A. M., Moniz-Garcia D. P., Gu S., Clyne A. M., Quiñones-Hinojosa A., He X.. Meta-analysis of the make-up and properties of in vitro models of
the healthy and diseased blood–brain barrier. Nat. Biomed. Eng. 2024;9:566–598. doi: 10.1038/s41551-024-01250-2.</cite> [<a href="https://doi.org/10.1038/s41551-024-01250-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11922799/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39304761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Biomed.%20Eng.&amp;title=Meta-analysis%20of%20the%20make-up%20and%20properties%20of%20in%20vitro%20models%20of%20the%20healthy%20and%20diseased%20blood%E2%80%93brain%20barrier&amp;author=J.%20G.%20Shamul&amp;author=Z.%20Wang&amp;author=H.%20Gong&amp;author=W.%20Ou&amp;author=A.%20M.%20White&amp;volume=9&amp;publication_year=2024&amp;pages=566-598&amp;pmid=39304761&amp;doi=10.1038/s41551-024-01250-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref65">
<cite>Eltanameli B., Piñeiro-Llanes J., Cristofoletti R.. Recent advances
in cell-based in vitro models for predicting drug permeability across
brain, intestinal, and pulmonary barriers. Exp.
Opin. Drug Metab. Toxicol. 2024;20(6):439–458. doi: 10.1080/17425255.2024.2366390.</cite> [<a href="https://doi.org/10.1080/17425255.2024.2366390" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38850058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp.%20Opin.%20Drug%20Metab.%20Toxicol.&amp;title=Recent%20advances%20in%20cell-based%20in%20vitro%20models%20for%20predicting%20drug%20permeability%20across%20brain,%20intestinal,%20and%20pulmonary%20barriers&amp;author=B.%20Eltanameli&amp;author=J.%20Pi%C3%B1eiro-Llanes&amp;author=R.%20Cristofoletti&amp;volume=20&amp;issue=6&amp;publication_year=2024&amp;pages=439-458&amp;pmid=38850058&amp;doi=10.1080/17425255.2024.2366390&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref66">
<cite>Alves P. A., Camargo L. C., de Souza G. M., Mortari M. R., Homem-de-Mello M.. Computational
Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain
Barrier. Pharmaceuticals. 2025;18(2):217.  doi: 10.3390/ph18020217.</cite> [<a href="https://doi.org/10.3390/ph18020217" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11860133/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40006031/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=Computational%20Modeling%20of%20Pharmaceuticals%20with%20an%20Emphasis%20on%20Crossing%20the%20Blood%E2%80%93Brain%20Barrier&amp;author=P.%20A.%20Alves&amp;author=L.%20C.%20Camargo&amp;author=G.%20M.%20de%20Souza&amp;author=M.%20R.%20Mortari&amp;author=M.%20Homem-de-Mello&amp;volume=18&amp;issue=2&amp;publication_year=2025&amp;pages=217&amp;pmid=40006031&amp;doi=10.3390/ph18020217&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref67">
<cite>Mathew-Schmitt S., Oerter S., Reitenbach E., Gätzner S., Höchner A., Jahnke H. G., Piontek J., Neuhaus W., Brachner A., Metzger M., Appelt-Menzel A.. Generation
of Advanced Blood–Brain Barrier Spheroids Using Human-Induced
Pluripotent Stem Cell-Derived Brain Capillary Endothelial-Like Cells. Adv. Biol. 2025;9:2400442.  doi: 10.1002/adbi.202400442.</cite> [<a href="https://doi.org/10.1002/adbi.202400442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12001013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39912766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Biol.&amp;title=Generation%20of%20Advanced%20Blood%E2%80%93Brain%20Barrier%20Spheroids%20Using%20Human-Induced%20Pluripotent%20Stem%20Cell-Derived%20Brain%20Capillary%20Endothelial-Like%20Cells&amp;author=S.%20Mathew-Schmitt&amp;author=S.%20Oerter&amp;author=E.%20Reitenbach&amp;author=S.%20G%C3%A4tzner&amp;author=A.%20H%C3%B6chner&amp;volume=9&amp;publication_year=2025&amp;pages=2400442&amp;pmid=39912766&amp;doi=10.1002/adbi.202400442&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref68">
<cite>Padti A. C., Bhavi S. M., Thokchom B., Singh S. R., Bhat S. S., Harini B., Sillanpää M., Yarajarla R. B.. Nanoparticle
Interactions with the Blood Brain Barrier: Insights from Drosophila
and Implications for Human Astrocyte Targeted Therapies. Neurochem. Res. 2025;50(1):80.  doi: 10.1007/s11064-025-04333-x.</cite> [<a href="https://doi.org/10.1007/s11064-025-04333-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39832031/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurochem.%20Res.&amp;title=Nanoparticle%20Interactions%20with%20the%20Blood%20Brain%20Barrier:%20Insights%20from%20Drosophila%20and%20Implications%20for%20Human%20Astrocyte%20Targeted%20Therapies&amp;author=A.%20C.%20Padti&amp;author=S.%20M.%20Bhavi&amp;author=B.%20Thokchom&amp;author=S.%20R.%20Singh&amp;author=S.%20S.%20Bhat&amp;volume=50&amp;issue=1&amp;publication_year=2025&amp;pages=80&amp;pmid=39832031&amp;doi=10.1007/s11064-025-04333-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref69">
<cite>Van
Tellingen O., Yetkin-Arik B., De Gooijer M., Wesseling P., Wurdinger T., De Vries H.. Overcoming the blood–brain
tumor barrier for effective glioblastoma treatment. Drug Resistance Updates. 2015;19:1–12. doi: 10.1016/j.drup.2015.02.002.</cite> [<a href="https://doi.org/10.1016/j.drup.2015.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25791797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Resistance%20Updates&amp;title=Overcoming%20the%20blood%E2%80%93brain%20tumor%20barrier%20for%20effective%20glioblastoma%20treatment&amp;author=O.%20Van%20Tellingen&amp;author=B.%20Yetkin-Arik&amp;author=M.%20De%20Gooijer&amp;author=P.%20Wesseling&amp;author=T.%20Wurdinger&amp;volume=19&amp;publication_year=2015&amp;pages=1-12&amp;pmid=25791797&amp;doi=10.1016/j.drup.2015.02.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref70">
<cite>Obermeier B., Daneman R., Ransohoff R. M.. Development,
maintenance and disruption
of the blood–brain barrier. Nat. Med. 2013;19(12):1584–1596. doi: 10.1038/nm.3407.</cite> [<a href="https://doi.org/10.1038/nm.3407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4080800/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24309662/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&amp;title=Development,%20maintenance%20and%20disruption%20of%20the%20blood%E2%80%93brain%20barrier&amp;author=B.%20Obermeier&amp;author=R.%20Daneman&amp;author=R.%20M.%20Ransohoff&amp;volume=19&amp;issue=12&amp;publication_year=2013&amp;pages=1584-1596&amp;pmid=24309662&amp;doi=10.1038/nm.3407&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref71">
<cite>de
Rus Jacquet A., Denis H. L., Cicchetti F., Alpaugh M.. Current and future applications of induced pluripotent
stem cell-based models to study pathological proteins in neurodegenerative
disorders. Mol. Psychiatry. 2021;26(7):2685–2706. doi: 10.1038/s41380-020-00999-7.</cite> [<a href="https://doi.org/10.1038/s41380-020-00999-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8505258/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33495544/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Psychiatry&amp;title=Current%20and%20future%20applications%20of%20induced%20pluripotent%20stem%20cell-based%20models%20to%20study%20pathological%20proteins%20in%20neurodegenerative%20disorders&amp;author=A.%20de%20Rus%20Jacquet&amp;author=H.%20L.%20Denis&amp;author=F.%20Cicchetti&amp;author=M.%20Alpaugh&amp;volume=26&amp;issue=7&amp;publication_year=2021&amp;pages=2685-2706&amp;pmid=33495544&amp;doi=10.1038/s41380-020-00999-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref72">
<cite>Kulavi S., Kaur R., Iyer K., Bandyopadhyay J., Sengupta T.. A smart &amp; precise approach with
nanoparticles-based
therapeutic intervention in neurodegenerative diseases. Nanomed. J. 2023;10(2):96–106.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomed.%20J.&amp;title=A%20smart%20&amp;%20precise%20approach%20with%20nanoparticles-based%20therapeutic%20intervention%20in%20neurodegenerative%20diseases&amp;author=S.%20Kulavi&amp;author=R.%20Kaur&amp;author=K.%20Iyer&amp;author=J.%20Bandyopadhyay&amp;author=T.%20Sengupta&amp;volume=10&amp;issue=2&amp;publication_year=2023&amp;pages=96-106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref73">
<cite>Puranik N., Yadav D., Song M.. Advancements in the Application of
Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective. Int. J. Mol. Sci. 2023;24(18):14044.  doi: 10.3390/ijms241814044.</cite> [<a href="https://doi.org/10.3390/ijms241814044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10530821/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37762346/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Advancements%20in%20the%20Application%20of%20Nanomedicine%20in%20Alzheimer%E2%80%99s%20Disease:%20A%20Therapeutic%20Perspective&amp;author=N.%20Puranik&amp;author=D.%20Yadav&amp;author=M.%20Song&amp;volume=24&amp;issue=18&amp;publication_year=2023&amp;pages=14044&amp;pmid=37762346&amp;doi=10.3390/ijms241814044&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref74">
<cite>Carthy D. J. M., Malhotra M., O’Mahony A. M., Cryan J. F., O’Driscoll C.
M.. Nanoparticles
and the blood–brain barrier: advancing from in-vitro models
towards therapeutic significance. Pharm. Res. 2015;32:1161–1185. doi: 10.1007/s11095-014-1545-6.</cite> [<a href="https://doi.org/10.1007/s11095-014-1545-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25446769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharm.%20Res.&amp;title=Nanoparticles%20and%20the%20blood%E2%80%93brain%20barrier:%20advancing%20from%20in-vitro%20models%20towards%20therapeutic%20significance&amp;author=D.%20J.%20M.%20Carthy&amp;author=M.%20Malhotra&amp;author=A.%20M.%20O%E2%80%99Mahony&amp;author=J.%20F.%20Cryan&amp;author=C.%20M.%20O%E2%80%99Driscoll&amp;volume=32&amp;publication_year=2015&amp;pages=1161-1185&amp;pmid=25446769&amp;doi=10.1007/s11095-014-1545-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref75">
<cite>Meister S., Zlatev I., Stab J., Docter D., Baches S., Stauber R. H., Deutsch M., Schmidt R., Ropele S., Windisch M.. et al. Nanoparticulate
flurbiprofen reduces amyloid-β
42 generation in an in vitro blood–brain barrier model. Alzheimer’s Res. Ther. 2013;5:51.  doi: 10.1186/alzrt225.</cite> [<a href="https://doi.org/10.1186/alzrt225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3978673/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24280275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimer%E2%80%99s%20Res.%20Ther.&amp;title=Nanoparticulate%20flurbiprofen%20reduces%20amyloid-%CE%B2%2042%20generation%20in%20an%20in%20vitro%20blood%E2%80%93brain%20barrier%20model&amp;author=S.%20Meister&amp;author=I.%20Zlatev&amp;author=J.%20Stab&amp;author=D.%20Docter&amp;author=S.%20Baches&amp;volume=5&amp;publication_year=2013&amp;pages=51&amp;pmid=24280275&amp;doi=10.1186/alzrt225&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref76">
<cite>Nelson A.
R., Sweeney M. D., Sagare A. P., Zlokovic B. V.. Neurovascular dysfunction
and neurodegeneration in dementia and Alzheimer’s disease. Biochim. Biophys. Acta, Mol. Basis Dis. 2016;1862(5):887–900. doi: 10.1016/j.bbadis.2015.12.016.</cite> [<a href="https://doi.org/10.1016/j.bbadis.2015.12.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4821735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26705676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.%20Biophys.%20Acta,%20Mol.%20Basis%20Dis.&amp;title=Neurovascular%20dysfunction%20and%20neurodegeneration%20in%20dementia%20and%20Alzheimer%E2%80%99s%20disease&amp;author=A.%20R.%20Nelson&amp;author=M.%20D.%20Sweeney&amp;author=A.%20P.%20Sagare&amp;author=B.%20V.%20Zlokovic&amp;volume=1862&amp;issue=5&amp;publication_year=2016&amp;pages=887-900&amp;pmid=26705676&amp;doi=10.1016/j.bbadis.2015.12.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref77">
<cite>Kalčec N., Peranić N., Mamić I., Beus M., Hall C. R., Smith T. A., Sani M. A., Turčić P., Separovic F., Vrček I. V.. Selenium nanoparticles as potential
drug-delivery systems for the treatment of Parkinson’s disease. ACS Appl. Nano Mater. 2023;6(19):17581–17592. doi: 10.1021/acsanm.3c02749.</cite> [<a href="https://doi.org/10.1021/acsanm.3c02749" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl.%20Nano%20Mater.&amp;title=Selenium%20nanoparticles%20as%20potential%20drug-delivery%20systems%20for%20the%20treatment%20of%20Parkinson%E2%80%99s%20disease&amp;author=N.%20Kal%C4%8Dec&amp;author=N.%20Perani%C4%87&amp;author=I.%20Mami%C4%87&amp;author=M.%20Beus&amp;author=C.%20R.%20Hall&amp;volume=6&amp;issue=19&amp;publication_year=2023&amp;pages=17581-17592&amp;doi=10.1021/acsanm.3c02749&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref78">
<cite>Mendonça M. C., Cronin M. F., Cryan J. F., O’Driscoll C. M.. Modified
cyclodextrin-based nanoparticles mediated delivery of siRNA for huntingtin
gene silencing across an in vitro BBB model. Eur. J. Pharm. Biopharm. 2021;169:309–318. doi: 10.1016/j.ejpb.2021.11.003.</cite> [<a href="https://doi.org/10.1016/j.ejpb.2021.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34793942/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Pharm.%20Biopharm.&amp;title=Modified%20cyclodextrin-based%20nanoparticles%20mediated%20delivery%20of%20siRNA%20for%20huntingtin%20gene%20silencing%20across%20an%20in%20vitro%20BBB%20model&amp;author=M.%20C.%20Mendon%C3%A7a&amp;author=M.%20F.%20Cronin&amp;author=J.%20F.%20Cryan&amp;author=C.%20M.%20O%E2%80%99Driscoll&amp;volume=169&amp;publication_year=2021&amp;pages=309-318&amp;pmid=34793942&amp;doi=10.1016/j.ejpb.2021.11.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref79">
<cite>Ji P., Xu Q., Li J., Wang Z., Mao W., Yan P.. Advances in
nanoparticle-based therapeutics for ischemic stroke: Enhancing drug
delivery and efficacy. Biomed. Pharmacother. 2024;180:117564.  doi: 10.1016/j.biopha.2024.117564.</cite> [<a href="https://doi.org/10.1016/j.biopha.2024.117564" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39405899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed.%20Pharmacother.&amp;title=Advances%20in%20nanoparticle-based%20therapeutics%20for%20ischemic%20stroke:%20Enhancing%20drug%20delivery%20and%20efficacy&amp;author=P.%20Ji&amp;author=Q.%20Xu&amp;author=J.%20Li&amp;author=Z.%20Wang&amp;author=W.%20Mao&amp;volume=180&amp;publication_year=2024&amp;pages=117564&amp;pmid=39405899&amp;doi=10.1016/j.biopha.2024.117564&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref80">
<cite>Shi W., Yuan S., Cheng G., Zhang H., Liu K. J., Ji X., Du L., Qi Z.. Blood brain barrier-targeted lipid
nanoparticles improved the neuroprotection of Ferrostatin-1 against
cerebral ischemic damage in an experimental stroke model. Exp. Neurol. 2024;379:114849.  doi: 10.1016/j.expneurol.2024.114849.</cite> [<a href="https://doi.org/10.1016/j.expneurol.2024.114849" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38857748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp.%20Neurol.&amp;title=Blood%20brain%20barrier-targeted%20lipid%20nanoparticles%20improved%20the%20neuroprotection%20of%20Ferrostatin-1%20against%20cerebral%20ischemic%20damage%20in%20an%20experimental%20stroke%20model&amp;author=W.%20Shi&amp;author=S.%20Yuan&amp;author=G.%20Cheng&amp;author=H.%20Zhang&amp;author=K.%20J.%20Liu&amp;volume=379&amp;publication_year=2024&amp;pages=114849&amp;pmid=38857748&amp;doi=10.1016/j.expneurol.2024.114849&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref81">
<cite>Srivastava A. K., Choudhury S. R., Karmakar S.. Melatonin/polydopamine nanostructures
for collective neuroprotection-based Parkinson’s disease therapy. Biomater. Sci. 2020;8(5):1345–1363. doi: 10.1039/C9BM01602C.</cite> [<a href="https://doi.org/10.1039/C9BM01602C" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31912833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomater.%20Sci.&amp;title=Melatonin/polydopamine%20nanostructures%20for%20collective%20neuroprotection-based%20Parkinson%E2%80%99s%20disease%20therapy&amp;author=A.%20K.%20Srivastava&amp;author=S.%20R.%20Choudhury&amp;author=S.%20Karmakar&amp;volume=8&amp;issue=5&amp;publication_year=2020&amp;pages=1345-1363&amp;pmid=31912833&amp;doi=10.1039/C9BM01602C&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref82">
<cite>Qu M., Lin Q., Huang L., Fu Y., Wang L., He S., Fu Y., Yang S., Zhang Z., Zhang L., Sun X.. Dopamine-loaded
blood exosomes targeted to brain for better treatment of Parkinson’s
disease. J. Controlled Release. 2018;287:156–166. doi: 10.1016/j.jconrel.2018.08.035.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2018.08.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30165139/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Dopamine-loaded%20blood%20exosomes%20targeted%20to%20brain%20for%20better%20treatment%20of%20Parkinson%E2%80%99s%20disease&amp;author=M.%20Qu&amp;author=Q.%20Lin&amp;author=L.%20Huang&amp;author=Y.%20Fu&amp;author=L.%20Wang&amp;volume=287&amp;publication_year=2018&amp;pages=156-166&amp;pmid=30165139&amp;doi=10.1016/j.jconrel.2018.08.035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref83">
<cite>Sun Z., Worden M., Wroczynskyj Y., Yathindranath V., van Lierop J., Hegmann T., Miller D. W.. Magnetic
field enhanced
convective diffusion of iron oxide nanoparticles in an osmotically
disrupted cell culture model of the blood–brain barrier. Int. J. Nanomed. 2014:3013–3026. doi: 10.2147/IJN.S62260.</cite> [<a href="https://doi.org/10.2147/IJN.S62260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4073976/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25018630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Nanomed.&amp;title=Magnetic%20field%20enhanced%20convective%20diffusion%20of%20iron%20oxide%20nanoparticles%20in%20an%20osmotically%20disrupted%20cell%20culture%20model%20of%20the%20blood%E2%80%93brain%20barrier&amp;author=Z.%20Sun&amp;author=M.%20Worden&amp;author=Y.%20Wroczynskyj&amp;author=V.%20Yathindranath&amp;author=J.%20van%20Lierop&amp;publication_year=2014&amp;pages=3013-3026&amp;pmid=25018630&amp;doi=10.2147/IJN.S62260&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref84">
<cite>Liu Y., Zhu D., Luo J., Chen X., Gao L., Liu W., Chen T.. NIR-II-activated
yolk–shell nanostructures as an intelligent
platform for Parkinsonian therapy. ACS Appl.
Bio Mater. 2020;3(10):6876–6887. doi: 10.1021/acsabm.0c00794.</cite> [<a href="https://doi.org/10.1021/acsabm.0c00794" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35019349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl.%20Bio%20Mater.&amp;title=NIR-II-activated%20yolk%E2%80%93shell%20nanostructures%20as%20an%20intelligent%20platform%20for%20Parkinsonian%20therapy&amp;author=Y.%20Liu&amp;author=D.%20Zhu&amp;author=J.%20Luo&amp;author=X.%20Chen&amp;author=L.%20Gao&amp;volume=3&amp;issue=10&amp;publication_year=2020&amp;pages=6876-6887&amp;pmid=35019349&amp;doi=10.1021/acsabm.0c00794&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref85">
<cite>Lu L., Qi S., Chen Y., Luo H., Huang S., Yu X., Luo Q., Zhang Z.. Targeted immunomodulation of inflammatory monocytes
across the blood–brain barrier by curcumin-loaded nanoparticles
delays the progression of experimental autoimmune encephalomyelitis. Biomaterials. 2020;245:119987.  doi: 10.1016/j.biomaterials.2020.119987.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2020.119987" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32229332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Targeted%20immunomodulation%20of%20inflammatory%20monocytes%20across%20the%20blood%E2%80%93brain%20barrier%20by%20curcumin-loaded%20nanoparticles%20delays%20the%20progression%20of%20experimental%20autoimmune%20encephalomyelitis&amp;author=L.%20Lu&amp;author=S.%20Qi&amp;author=Y.%20Chen&amp;author=H.%20Luo&amp;author=S.%20Huang&amp;volume=245&amp;publication_year=2020&amp;pages=119987&amp;pmid=32229332&amp;doi=10.1016/j.biomaterials.2020.119987&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref86">
<cite>Zhang L., Wei P.-F., Song Y.-H., Dong L., Wu Y.-D., Hao Z.-Y., Fan S., Tai S., Meng J.-L., Lu Y.. et al. MnFe2O4 nanoparticles
accelerate the clearance of mutant
huntingtin selectively through ubiquitin-proteasome system. Biomaterials. 2019;216:119248.  doi: 10.1016/j.biomaterials.2019.119248.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2019.119248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31226569/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=MnFe2O4%20nanoparticles%20accelerate%20the%20clearance%20of%20mutant%20huntingtin%20selectively%20through%20ubiquitin-proteasome%20system&amp;author=L.%20Zhang&amp;author=P.-F.%20Wei&amp;author=Y.-H.%20Song&amp;author=L.%20Dong&amp;author=Y.-D.%20Wu&amp;volume=216&amp;publication_year=2019&amp;pages=119248&amp;pmid=31226569&amp;doi=10.1016/j.biomaterials.2019.119248&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref87">
<cite>Kong L., Li X.-t., Ni Y.-n., Xiao H.-h., Yao Y.-j., Wang Y.-y., Ju R.-j., Li H.-y., Liu J.-j., Fu M.. et al. Transferrin-modified
osthole PEGylated liposomes travel
the blood–brain barrier and mitigate Alzheimer’s disease-related
pathology in APP/PS-1 mice. Int. J. Nanomed. 2020:2841–2858. doi: 10.2147/ijn.s239608.</cite> [<a href="https://doi.org/10.2147/ijn.s239608" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7186891/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32425521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Nanomed.&amp;title=Transferrin-modified%20osthole%20PEGylated%20liposomes%20travel%20the%20blood%E2%80%93brain%20barrier%20and%20mitigate%20Alzheimer%E2%80%99s%20disease-related%20pathology%20in%20APP/PS-1%20mice&amp;author=L.%20Kong&amp;author=X.-t.%20Li&amp;author=Y.-n.%20Ni&amp;author=H.-h.%20Xiao&amp;author=Y.-j.%20Yao&amp;publication_year=2020&amp;pages=2841-2858&amp;pmid=32425521&amp;doi=10.2147/ijn.s239608&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref88">
<cite>Lei T., Yang Z., Jiang C., Wang X., Yang W., Yang X., Xie R., Tong F., Xia X., Huang Q.. et al. Mannose-integrated nanoparticle hitchhike glucose transporter
1 recycling to overcome various barriers of oral delivery for Alzheimer’s
disease therapy. ACS Nano. 2024;18(4):3234–3250. doi: 10.1021/acsnano.3c09715.</cite> [<a href="https://doi.org/10.1021/acsnano.3c09715" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38214975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Mannose-integrated%20nanoparticle%20hitchhike%20glucose%20transporter%201%20recycling%20to%20overcome%20various%20barriers%20of%20oral%20delivery%20for%20Alzheimer%E2%80%99s%20disease%20therapy&amp;author=T.%20Lei&amp;author=Z.%20Yang&amp;author=C.%20Jiang&amp;author=X.%20Wang&amp;author=W.%20Yang&amp;volume=18&amp;issue=4&amp;publication_year=2024&amp;pages=3234-3250&amp;pmid=38214975&amp;doi=10.1021/acsnano.3c09715&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref89">
<cite>Xu M., Zhou H., Liu Y., Sun J., Xie W., Zhao P., Liu J.. Ultrasound-excited protoporphyrin
IX-modified multifunctional nanoparticles as a strong inhibitor of
tau phosphorylation and β-amyloid aggregation. ACS Appl. Mater. Interfaces. 2018;10(39):32965–32980. doi: 10.1021/acsami.8b08230.</cite> [<a href="https://doi.org/10.1021/acsami.8b08230" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30192126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl.%20Mater.%20Interfaces&amp;title=Ultrasound-excited%20protoporphyrin%20IX-modified%20multifunctional%20nanoparticles%20as%20a%20strong%20inhibitor%20of%20tau%20phosphorylation%20and%20%CE%B2-amyloid%20aggregation&amp;author=M.%20Xu&amp;author=H.%20Zhou&amp;author=Y.%20Liu&amp;author=J.%20Sun&amp;author=W.%20Xie&amp;volume=10&amp;issue=39&amp;publication_year=2018&amp;pages=32965-32980&amp;pmid=30192126&amp;doi=10.1021/acsami.8b08230&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref90">
<cite>Sánchez-López E., Ettcheto M., Egea M. A., Espina M., Cano A., Calpena A. C., Camins A., Carmona N., Silva A. M., Souto E. B., Garcia M. L.. Memantine loaded PLGA PEGylated nanoparticles
for Alzheimer’s disease: In vitro and in vivo characterization. J. Nanobiotechnol. 2018;16:32.  doi: 10.1186/s12951-018-0356-z.</cite> [<a href="https://doi.org/10.1186/s12951-018-0356-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5870370/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29587747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nanobiotechnol.&amp;title=Memantine%20loaded%20PLGA%20PEGylated%20nanoparticles%20for%20Alzheimer%E2%80%99s%20disease:%20In%20vitro%20and%20in%20vivo%20characterization&amp;author=E.%20S%C3%A1nchez-L%C3%B3pez&amp;author=M.%20Ettcheto&amp;author=M.%20A.%20Egea&amp;author=M.%20Espina&amp;author=A.%20Cano&amp;volume=16&amp;publication_year=2018&amp;pages=32&amp;pmid=29587747&amp;doi=10.1186/s12951-018-0356-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref91">
<cite>Palma-Florez S., López-Canosa A., Moralez-Zavala F., Castaño O., Kogan M. J., Samitier J., Lagunas A., Mir M.. BBB-on-a-chip
with integrated micro-TEER for permeability evaluation of multi-functionalized
gold nanorods against Alzheimer’s disease. J. Nanobiotechnol. 2023;21(1):115.  doi: 10.1186/s12951-023-01798-2.</cite> [<a href="https://doi.org/10.1186/s12951-023-01798-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10053726/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36978078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nanobiotechnol.&amp;title=BBB-on-a-chip%20with%20integrated%20micro-TEER%20for%20permeability%20evaluation%20of%20multi-functionalized%20gold%20nanorods%20against%20Alzheimer%E2%80%99s%20disease&amp;author=S.%20Palma-Florez&amp;author=A.%20L%C3%B3pez-Canosa&amp;author=F.%20Moralez-Zavala&amp;author=O.%20Casta%C3%B1o&amp;author=M.%20J.%20Kogan&amp;volume=21&amp;issue=1&amp;publication_year=2023&amp;pages=115&amp;pmid=36978078&amp;doi=10.1186/s12951-023-01798-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref92">
<cite>Yin T., Yang L., Liu Y., Zhou X., Sun J., Liu J.. Sialic acid (SA)-modified
selenium nanoparticles coated with a high
blood–brain barrier permeability peptide-B6 peptide for potential
use in Alzheimer’s disease. Acta Biomater. 2015;25:172–183. doi: 10.1016/j.actbio.2015.06.035.</cite> [<a href="https://doi.org/10.1016/j.actbio.2015.06.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26143603/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Biomater.&amp;title=Sialic%20acid%20(SA)-modified%20selenium%20nanoparticles%20coated%20with%20a%20high%20blood%E2%80%93brain%20barrier%20permeability%20peptide-B6%20peptide%20for%20potential%20use%20in%20Alzheimer%E2%80%99s%20disease&amp;author=T.%20Yin&amp;author=L.%20Yang&amp;author=Y.%20Liu&amp;author=X.%20Zhou&amp;author=J.%20Sun&amp;volume=25&amp;publication_year=2015&amp;pages=172-183&amp;pmid=26143603&amp;doi=10.1016/j.actbio.2015.06.035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref93">
<cite>Bao Q., Hu P., Xu Y., Cheng T., Wei C., Pan L., Shi J.. Simultaneous
blood–brain barrier crossing and protection for
stroke treatment based on edaravone-loaded ceria nanoparticles. ACS Nano. 2018;12(7):6794–6805. doi: 10.1021/acsnano.8b01994.</cite> [<a href="https://doi.org/10.1021/acsnano.8b01994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29932327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Simultaneous%20blood%E2%80%93brain%20barrier%20crossing%20and%20protection%20for%20stroke%20treatment%20based%20on%20edaravone-loaded%20ceria%20nanoparticles&amp;author=Q.%20Bao&amp;author=P.%20Hu&amp;author=Y.%20Xu&amp;author=T.%20Cheng&amp;author=C.%20Wei&amp;volume=12&amp;issue=7&amp;publication_year=2018&amp;pages=6794-6805&amp;pmid=29932327&amp;doi=10.1021/acsnano.8b01994&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref94">
<cite>Zhao Y., Jiang Y., Lv W., Wang Z., Lv L., Wang B., Liu X., Liu Y., Hu Q., Sun W.. et al. Dual targeted nanocarrier
for brain ischemic stroke
treatment. J. Controlled Release. 2016;233:64–71. doi: 10.1016/j.jconrel.2016.04.038.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2016.04.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27142584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Dual%20targeted%20nanocarrier%20for%20brain%20ischemic%20stroke%20treatment&amp;author=Y.%20Zhao&amp;author=Y.%20Jiang&amp;author=W.%20Lv&amp;author=Z.%20Wang&amp;author=L.%20Lv&amp;volume=233&amp;publication_year=2016&amp;pages=64-71&amp;pmid=27142584&amp;doi=10.1016/j.jconrel.2016.04.038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref95">
<cite>Lu X., Zhang Y., Wang L., Li G., Gao J., Wang Y.. Development of L-carnosine functionalized iron oxide nanoparticles
loaded with dexamethasone for simultaneous therapeutic potential of
blood brain barrier crossing and ischemic stroke treatment. Drug Delivery. 2021;28(1):380–389. doi: 10.1080/10717544.2021.1883158.</cite> [<a href="https://doi.org/10.1080/10717544.2021.1883158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7891889/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33586561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Delivery&amp;title=Development%20of%20L-carnosine%20functionalized%20iron%20oxide%20nanoparticles%20loaded%20with%20dexamethasone%20for%20simultaneous%20therapeutic%20potential%20of%20blood%20brain%20barrier%20crossing%20and%20ischemic%20stroke%20treatment&amp;author=X.%20Lu&amp;author=Y.%20Zhang&amp;author=L.%20Wang&amp;author=G.%20Li&amp;author=J.%20Gao&amp;volume=28&amp;issue=1&amp;publication_year=2021&amp;pages=380-389&amp;pmid=33586561&amp;doi=10.1080/10717544.2021.1883158&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref96">
<cite>Clark A. J., Davis M. E.. Increased brain
uptake of targeted nanoparticles by
adding an acid-cleavable linkage between transferrin and the nanoparticle
core. Proc. Natl. Acad. Sci. U.S.A. 2015;112(40):12486–12491. doi: 10.1073/pnas.1517048112.</cite> [<a href="https://doi.org/10.1073/pnas.1517048112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4603510/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26392563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20U.S.A.&amp;title=Increased%20brain%20uptake%20of%20targeted%20nanoparticles%20by%20adding%20an%20acid-cleavable%20linkage%20between%20transferrin%20and%20the%20nanoparticle%20core&amp;author=A.%20J.%20Clark&amp;author=M.%20E.%20Davis&amp;volume=112&amp;issue=40&amp;publication_year=2015&amp;pages=12486-12491&amp;pmid=26392563&amp;doi=10.1073/pnas.1517048112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref97">
<cite>Sweeney M. D., Sagare A. P., Zlokovic B. V.. Cerebrospinal fluid biomarkers of
neurovascular dysfunction in mild dementia and Alzheimer’s
disease. J. Cereb. Blood Flow Metab. 2015;35(7):1055–1068. doi: 10.1038/jcbfm.2015.76.</cite> [<a href="https://doi.org/10.1038/jcbfm.2015.76" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4640280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25899298/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cereb.%20Blood%20Flow%20Metab.&amp;title=Cerebrospinal%20fluid%20biomarkers%20of%20neurovascular%20dysfunction%20in%20mild%20dementia%20and%20Alzheimer%E2%80%99s%20disease&amp;author=M.%20D.%20Sweeney&amp;author=A.%20P.%20Sagare&amp;author=B.%20V.%20Zlokovic&amp;volume=35&amp;issue=7&amp;publication_year=2015&amp;pages=1055-1068&amp;pmid=25899298&amp;doi=10.1038/jcbfm.2015.76&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref98">
<cite>Newland B., Newland H., Werner C., Rosser A., Wang W.. Prospects
for polymer therapeutics in Parkinson’s disease and other neurodegenerative
disorders. Prog. Polym. Sci. 2015;44:79–112. doi: 10.1016/j.progpolymsci.2014.12.002.</cite> [<a href="https://doi.org/10.1016/j.progpolymsci.2014.12.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prog.%20Polym.%20Sci.&amp;title=Prospects%20for%20polymer%20therapeutics%20in%20Parkinson%E2%80%99s%20disease%20and%20other%20neurodegenerative%20disorders&amp;author=B.%20Newland&amp;author=H.%20Newland&amp;author=C.%20Werner&amp;author=A.%20Rosser&amp;author=W.%20Wang&amp;volume=44&amp;publication_year=2015&amp;pages=79-112&amp;doi=10.1016/j.progpolymsci.2014.12.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref99">
<cite>Vilella A., Ruozi B., Belletti D., Pederzoli F., Galliani M., Semeghini V., Forni F., Zoli M., Vandelli M. A., Tosi G.. Endocytosis
of nanomedicines: the
case of glycopeptide engineered PLGA nanoparticles. Pharmaceutics. 2015;7(2):74–89. doi: 10.3390/pharmaceutics7020074.</cite> [<a href="https://doi.org/10.3390/pharmaceutics7020074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4491652/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26102358/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=Endocytosis%20of%20nanomedicines:%20the%20case%20of%20glycopeptide%20engineered%20PLGA%20nanoparticles&amp;author=A.%20Vilella&amp;author=B.%20Ruozi&amp;author=D.%20Belletti&amp;author=F.%20Pederzoli&amp;author=M.%20Galliani&amp;volume=7&amp;issue=2&amp;publication_year=2015&amp;pages=74-89&amp;pmid=26102358&amp;doi=10.3390/pharmaceutics7020074&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref100">
<cite>Wang X., Huang X., Yang Z., Gallego-Perez D., Ma J., Zhao X., Xie J., Nakano I., Lee L. J.. Targeted
delivery of tumor suppressor microRNA-1 by transferrin-conjugated
lipopolyplex nanoparticles to patient-derived glioblastoma stem cells. Curr. Pharm. Biotechnol. 2014;15(9):839–846. doi: 10.2174/1389201015666141031105234.</cite> [<a href="https://doi.org/10.2174/1389201015666141031105234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25374033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Pharm.%20Biotechnol.&amp;title=Targeted%20delivery%20of%20tumor%20suppressor%20microRNA-1%20by%20transferrin-conjugated%20lipopolyplex%20nanoparticles%20to%20patient-derived%20glioblastoma%20stem%20cells&amp;author=X.%20Wang&amp;author=X.%20Huang&amp;author=Z.%20Yang&amp;author=D.%20Gallego-Perez&amp;author=J.%20Ma&amp;volume=15&amp;issue=9&amp;publication_year=2014&amp;pages=839-846&amp;pmid=25374033&amp;doi=10.2174/1389201015666141031105234&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref101">
<cite>Yang X., Yang S., Chai H., Yang Z., Lee R. J., Liao W., Teng L.. A novel isoquinoline
derivative anticancer agent and its targeted delivery to tumor cells
using transferrin-conjugated liposomes. PLoS
One. 2015;10(8):e0136649.  doi: 10.1371/journal.pone.0136649.</cite> [<a href="https://doi.org/10.1371/journal.pone.0136649" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4550422/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26309138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=A%20novel%20isoquinoline%20derivative%20anticancer%20agent%20and%20its%20targeted%20delivery%20to%20tumor%20cells%20using%20transferrin-conjugated%20liposomes&amp;author=X.%20Yang&amp;author=S.%20Yang&amp;author=H.%20Chai&amp;author=Z.%20Yang&amp;author=R.%20J.%20Lee&amp;volume=10&amp;issue=8&amp;publication_year=2015&amp;pages=e0136649&amp;pmid=26309138&amp;doi=10.1371/journal.pone.0136649&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref102">
<cite>Yu B., Wang X., Zhou C., Teng L., Ren W., Yang Z., Shih C.-H., Wang T., Lee R. J., Tang S., Lee L. J.. Insight into mechanisms of cellular
uptake of lipid nanoparticles and intracellular release of small RNAs. Pharm. Res. 2014;31:2685–2695. doi: 10.1007/s11095-014-1366-7.</cite> [<a href="https://doi.org/10.1007/s11095-014-1366-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24740244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharm.%20Res.&amp;title=Insight%20into%20mechanisms%20of%20cellular%20uptake%20of%20lipid%20nanoparticles%20and%20intracellular%20release%20of%20small%20RNAs&amp;author=B.%20Yu&amp;author=X.%20Wang&amp;author=C.%20Zhou&amp;author=L.%20Teng&amp;author=W.%20Ren&amp;volume=31&amp;publication_year=2014&amp;pages=2685-2695&amp;pmid=24740244&amp;doi=10.1007/s11095-014-1366-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref103">
<cite>Zhang T.-T., Li W., Meng G., Wang P., Liao W.. Strategies for transporting nanoparticles
across the blood–brain
barrier. Biomater. Sci. 2016;4(2):219–229. doi: 10.1039/C5BM00383K.</cite> [<a href="https://doi.org/10.1039/C5BM00383K" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26646694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomater.%20Sci.&amp;title=Strategies%20for%20transporting%20nanoparticles%20across%20the%20blood%E2%80%93brain%20barrier&amp;author=T.-T.%20Zhang&amp;author=W.%20Li&amp;author=G.%20Meng&amp;author=P.%20Wang&amp;author=W.%20Liao&amp;volume=4&amp;issue=2&amp;publication_year=2016&amp;pages=219-229&amp;pmid=26646694&amp;doi=10.1039/C5BM00383K&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref104">
<cite>Wen Y., Kolonich H. R., Kruszewski K. M., Giannoukakis N., Gawalt E. S., Meng W. S.. Retaining antibodies
in tumors with
a self-assembling injectable system. Mol. Pharmaceutics. 2013;10(3):1035–1044. doi: 10.1021/mp300504z.</cite> [<a href="https://doi.org/10.1021/mp300504z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23419203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Pharmaceutics&amp;title=Retaining%20antibodies%20in%20tumors%20with%20a%20self-assembling%20injectable%20system&amp;author=Y.%20Wen&amp;author=H.%20R.%20Kolonich&amp;author=K.%20M.%20Kruszewski&amp;author=N.%20Giannoukakis&amp;author=E.%20S.%20Gawalt&amp;volume=10&amp;issue=3&amp;publication_year=2013&amp;pages=1035-1044&amp;pmid=23419203&amp;doi=10.1021/mp300504z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref105">
<cite>Fornaguera C., Dols-Pérez A., Calderó G., García-Celma M., Camarasa J., Solans C.. PLGA nanoparticles
prepared by nano-emulsion templating using low-energy methods as efficient
nanocarriers for drug delivery across the blood–brain barrier. J. Controlled Release. 2015;211:134–143. doi: 10.1016/j.jconrel.2015.06.002.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2015.06.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26057857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=PLGA%20nanoparticles%20prepared%20by%20nano-emulsion%20templating%20using%20low-energy%20methods%20as%20efficient%20nanocarriers%20for%20drug%20delivery%20across%20the%20blood%E2%80%93brain%20barrier&amp;author=C.%20Fornaguera&amp;author=A.%20Dols-P%C3%A9rez&amp;author=G.%20Calder%C3%B3&amp;author=M.%20Garc%C3%ADa-Celma&amp;author=J.%20Camarasa&amp;volume=211&amp;publication_year=2015&amp;pages=134-143&amp;pmid=26057857&amp;doi=10.1016/j.jconrel.2015.06.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref106">
<cite>Hobbs S. K., Monsky W. L., Yuan F.. et al. Regulation
of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. U.S.A. 1998;95:4607–4612. doi: 10.1073/pnas.95.8.4607.</cite> [<a href="https://doi.org/10.1073/pnas.95.8.4607" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC22537/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9539785/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20U.S.A.&amp;title=Regulation%20of%20transport%20pathways%20in%20tumor%20vessels:%20role%20of%20tumor%20type%20and%20microenvironment&amp;author=S.%20K.%20Hobbs&amp;author=W.%20L.%20Monsky&amp;author=F.%20Yuan&amp;volume=95&amp;publication_year=1998&amp;pages=4607-4612&amp;pmid=9539785&amp;doi=10.1073/pnas.95.8.4607&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref107">
<cite>Lalani J., Patil S., Kolate A., Lalani R., Misra A.. Protein-functionalized PLGA nanoparticles of lamotrigine for neuropathic
pain management. AAPS PharmSciTech. 2015;16:413–427. doi: 10.1208/s12249-014-0235-3.</cite> [<a href="https://doi.org/10.1208/s12249-014-0235-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4370975/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25354788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AAPS%20PharmSciTech&amp;title=Protein-functionalized%20PLGA%20nanoparticles%20of%20lamotrigine%20for%20neuropathic%20pain%20management&amp;author=J.%20Lalani&amp;author=S.%20Patil&amp;author=A.%20Kolate&amp;author=R.%20Lalani&amp;author=A.%20Misra&amp;volume=16&amp;publication_year=2015&amp;pages=413-427&amp;pmid=25354788&amp;doi=10.1208/s12249-014-0235-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref108">
<cite>

Meairs, S.

Drug Delivery across
the Blood–brain Barrier with Focused Ultrasound and Microbubbles. In Topics in Medicinal Chemistry; Springer, 2014; Vol. 10, pp 143–158.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Topics%20in%20Medicinal%20Chemistry&amp;publication_year=2014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref109">
<cite>Budai M., Szogyi M.. Liposomes as drug carrier systems.
Preparation, classification and therapeutic advantages of liposomes. Acta Pharm. Hung. 2001;71(1):114–118.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/11769091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Pharm.%20Hung.&amp;title=Liposomes%20as%20drug%20carrier%20systems.%20Preparation,%20classification%20and%20therapeutic%20advantages%20of%20liposomes&amp;author=M.%20Budai&amp;author=M.%20Szogyi&amp;volume=71&amp;issue=1&amp;publication_year=2001&amp;pages=114-118&amp;pmid=11769091&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref110">
<cite>da Cruz M. G., Simões S., de Lima M. C. P.. Improving lipoplex-mediated
gene transfer into C6 glioma cells and primary neurons. Exp. Neurol. 2004;187(1):65–75. doi: 10.1016/j.expneurol.2003.12.013.</cite> [<a href="https://doi.org/10.1016/j.expneurol.2003.12.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15081589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp.%20Neurol.&amp;title=Improving%20lipoplex-mediated%20gene%20transfer%20into%20C6%20glioma%20cells%20and%20primary%20neurons&amp;author=M.%20G.%20da%20Cruz&amp;author=S.%20Sim%C3%B5es&amp;author=M.%20C.%20P.%20de%20Lima&amp;volume=187&amp;issue=1&amp;publication_year=2004&amp;pages=65-75&amp;pmid=15081589&amp;doi=10.1016/j.expneurol.2003.12.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref111">
<cite>Gordillo-Galeano A., Mora-Huertas C. E.. Solid lipid
nanoparticles and nanostructured
lipid carriers: A review emphasizing on particle structure and drug
release. Eur. J. Pharm. Biopharm. 2018;133:285–308. doi: 10.1016/j.ejpb.2018.10.017.</cite> [<a href="https://doi.org/10.1016/j.ejpb.2018.10.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30463794/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Pharm.%20Biopharm.&amp;title=Solid%20lipid%20nanoparticles%20and%20nanostructured%20lipid%20carriers:%20A%20review%20emphasizing%20on%20particle%20structure%20and%20drug%20release&amp;author=A.%20Gordillo-Galeano&amp;author=C.%20E.%20Mora-Huertas&amp;volume=133&amp;publication_year=2018&amp;pages=285-308&amp;pmid=30463794&amp;doi=10.1016/j.ejpb.2018.10.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref112">
<cite>Md S., Ali M., Baboota S., Sahni J. K., Bhatnagar A., Ali J.. Preparation, characterization,
in vivo biodistribution and pharmacokinetic
studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug Dev. Ind. Pharm. 2014;40(2):278–287. doi: 10.3109/03639045.2012.758130.</cite> [<a href="https://doi.org/10.3109/03639045.2012.758130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23369094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Dev.%20Ind.%20Pharm.&amp;title=Preparation,%20characterization,%20in%20vivo%20biodistribution%20and%20pharmacokinetic%20studies%20of%20donepezil-loaded%20PLGA%20nanoparticles%20for%20brain%20targeting&amp;author=S.%20Md&amp;author=M.%20Ali&amp;author=S.%20Baboota&amp;author=J.%20K.%20Sahni&amp;author=A.%20Bhatnagar&amp;volume=40&amp;issue=2&amp;publication_year=2014&amp;pages=278-287&amp;pmid=23369094&amp;doi=10.3109/03639045.2012.758130&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref113">
<cite>Mishra B., Patel B. B., Tiwari S.. Colloidal nanocarriers:
a review on formulation technology, types and applications toward
targeted drug delivery. Nanomed.: Nanotechnol.,
Biol. Med. 2010;6(1):9–24. doi: 10.1016/j.nano.2009.04.008.</cite> [<a href="https://doi.org/10.1016/j.nano.2009.04.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19447208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomed.:%20Nanotechnol.,%20Biol.%20Med.&amp;title=Colloidal%20nanocarriers:%20a%20review%20on%20formulation%20technology,%20types%20and%20applications%20toward%20targeted%20drug%20delivery&amp;author=B.%20Mishra&amp;author=B.%20B.%20Patel&amp;author=S.%20Tiwari&amp;volume=6&amp;issue=1&amp;publication_year=2010&amp;pages=9-24&amp;pmid=19447208&amp;doi=10.1016/j.nano.2009.04.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref114">
<cite>Dhanikula R. S., Hammady T., Hildgen P.. On the mechanism and
dynamics of uptake and permeation of polyether-copolyester dendrimers
across an in vitro blood–brain barrier model. J. Pharm. Sci. 2009;98(10):3748–3760. doi: 10.1002/jps.21669.</cite> [<a href="https://doi.org/10.1002/jps.21669" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19156840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharm.%20Sci.&amp;title=On%20the%20mechanism%20and%20dynamics%20of%20uptake%20and%20permeation%20of%20polyether-copolyester%20dendrimers%20across%20an%20in%20vitro%20blood%E2%80%93brain%20barrier%20model&amp;author=R.%20S.%20Dhanikula&amp;author=T.%20Hammady&amp;author=P.%20Hildgen&amp;volume=98&amp;issue=10&amp;publication_year=2009&amp;pages=3748-3760&amp;pmid=19156840&amp;doi=10.1002/jps.21669&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref115">
<cite>Discher D. E., Ahmed F.. Polymersomes. Annu. Rev. Biomed. Eng. 2006;8(1):323–341. doi: 10.1146/annurev.bioeng.8.061505.095838.</cite> [<a href="https://doi.org/10.1146/annurev.bioeng.8.061505.095838" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16834559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu.%20Rev.%20Biomed.%20Eng.&amp;title=Polymersomes&amp;author=D.%20E.%20Discher&amp;author=F.%20Ahmed&amp;volume=8&amp;issue=1&amp;publication_year=2006&amp;pages=323-341&amp;pmid=16834559&amp;doi=10.1146/annurev.bioeng.8.061505.095838&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref116">
<cite>Setua S., Ouberai M., Piccirillo S. G., Watts C., Welland M.. Cisplatin-tethered gold nanospheres
for multimodal chemo-radiotherapy of glioblastoma. Nanoscale. 2014;6(18):10865–10873. doi: 10.1039/C4NR03693J.</cite> [<a href="https://doi.org/10.1039/C4NR03693J" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25117686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale&amp;title=Cisplatin-tethered%20gold%20nanospheres%20for%20multimodal%20chemo-radiotherapy%20of%20glioblastoma&amp;author=S.%20Setua&amp;author=M.%20Ouberai&amp;author=S.%20G.%20Piccirillo&amp;author=C.%20Watts&amp;author=M.%20Welland&amp;volume=6&amp;issue=18&amp;publication_year=2014&amp;pages=10865-10873&amp;pmid=25117686&amp;doi=10.1039/C4NR03693J&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref117">
<cite>Akbarzadeh A., Samiei M., Davaran S.. Magnetic nanoparticles:
preparation, physical properties, and applications in biomedicine. Nanoscale Res. Lett. 2012;7:144.  doi: 10.1186/1556-276X-7-144.</cite> [<a href="https://doi.org/10.1186/1556-276X-7-144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3312841/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22348683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale%20Res.%20Lett.&amp;title=Magnetic%20nanoparticles:%20preparation,%20physical%20properties,%20and%20applications%20in%20biomedicine&amp;author=A.%20Akbarzadeh&amp;author=M.%20Samiei&amp;author=S.%20Davaran&amp;volume=7&amp;publication_year=2012&amp;pages=144&amp;pmid=22348683&amp;doi=10.1186/1556-276X-7-144&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref118">
<cite>Li J., Kong J., Ma S., Li J., Mao M., Chen K., Chen Z., Zhang J., Chang Y., Yuan H.. et al. Exosome-coated 10b carbon
dots for precise boron neutron
capture therapy in a mouse model of glioma in situ. Adv. Funct. Mater. 2021;31(24):2100969.  doi: 10.1002/adfm.202100969.</cite> [<a href="https://doi.org/10.1002/adfm.202100969" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Funct.%20Mater.&amp;title=Exosome-coated%2010b%20carbon%20dots%20for%20precise%20boron%20neutron%20capture%20therapy%20in%20a%20mouse%20model%20of%20glioma%20in%20situ&amp;author=J.%20Li&amp;author=J.%20Kong&amp;author=S.%20Ma&amp;author=J.%20Li&amp;author=M.%20Mao&amp;volume=31&amp;issue=24&amp;publication_year=2021&amp;pages=2100969&amp;doi=10.1002/adfm.202100969&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref119">
<cite>Slowing I. I., Vivero-Escoto J. L., Trewyn B. G., Lin V. S.-Y.. Mesoporous
silica nanoparticles: structural design and applications. J. Mater. Chem. 2010;20(37):7924–7937. doi: 10.1039/c0jm00554a.</cite> [<a href="https://doi.org/10.1039/c0jm00554a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mater.%20Chem.&amp;title=Mesoporous%20silica%20nanoparticles:%20structural%20design%20and%20applications&amp;author=I.%20I.%20Slowing&amp;author=J.%20L.%20Vivero-Escoto&amp;author=B.%20G.%20Trewyn&amp;author=V.%20S.-Y.%20Lin&amp;volume=20&amp;issue=37&amp;publication_year=2010&amp;pages=7924-7937&amp;doi=10.1039/c0jm00554a&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref120">
<cite>Meairs S., Alonso A.. Ultrasound, microbubbles
and the
blood–brain barrier. Prog. Biophys. Mol.
Biol. 2007;93(1–3):354–362. doi: 10.1016/j.pbiomolbio.2006.07.019.</cite> [<a href="https://doi.org/10.1016/j.pbiomolbio.2006.07.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16959303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prog.%20Biophys.%20Mol.%20Biol.&amp;title=Ultrasound,%20microbubbles%20and%20the%20blood%E2%80%93brain%20barrier&amp;author=S.%20Meairs&amp;author=A.%20Alonso&amp;volume=93&amp;issue=1%E2%80%933&amp;publication_year=2007&amp;pages=354-362&amp;pmid=16959303&amp;doi=10.1016/j.pbiomolbio.2006.07.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref121">
<cite>Masserini M.. Nanoparticles for brain drug delivery. ISRN Biochem. 2013;2013:238428.  doi: 10.1155/2013/238428.</cite> [<a href="https://doi.org/10.1155/2013/238428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4392984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25937958/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ISRN%20Biochem.&amp;title=Nanoparticles%20for%20brain%20drug%20delivery&amp;author=M.%20Masserini&amp;volume=2013&amp;publication_year=2013&amp;pages=238428&amp;pmid=25937958&amp;doi=10.1155/2013/238428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref122">
<cite>del Burgo L. S., Hernández R. M., Orive G., Pedraz J. L.. Nanotherapeutic
approaches for brain cancer management. Nanomed.:
Nanotechnol., Biol. Med. 2014;10(5):e905–e919. doi: 10.1016/j.nano.2013.10.001.</cite> [<a href="https://doi.org/10.1016/j.nano.2013.10.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24135564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomed.:%20Nanotechnol.,%20Biol.%20Med.&amp;title=Nanotherapeutic%20approaches%20for%20brain%20cancer%20management&amp;author=L.%20S.%20del%20Burgo&amp;author=R.%20M.%20Hern%C3%A1ndez&amp;author=G.%20Orive&amp;author=J.%20L.%20Pedraz&amp;volume=10&amp;issue=5&amp;publication_year=2014&amp;pages=e905-e919&amp;pmid=24135564&amp;doi=10.1016/j.nano.2013.10.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref123">
<cite>Lin Q., Mao K.-L., Tian F.-R., Yang J.-J., Chen P.-P., Xu J., Fan Z.-L., Zhao Y.-P., Li W.-F., Zheng L.. et al. Brain tumor-targeted
delivery and therapy by focused ultrasound introduced
doxorubicin-loaded cationic liposomes. Cancer
Chemother. Pharmacol. 2016;77:269–280. doi: 10.1007/s00280-015-2926-1.</cite> [<a href="https://doi.org/10.1007/s00280-015-2926-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26666650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Chemother.%20Pharmacol.&amp;title=Brain%20tumor-targeted%20delivery%20and%20therapy%20by%20focused%20ultrasound%20introduced%20doxorubicin-loaded%20cationic%20liposomes&amp;author=Q.%20Lin&amp;author=K.-L.%20Mao&amp;author=F.-R.%20Tian&amp;author=J.-J.%20Yang&amp;author=P.-P.%20Chen&amp;volume=77&amp;publication_year=2016&amp;pages=269-280&amp;pmid=26666650&amp;doi=10.1007/s00280-015-2926-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref124">
<cite>Wei X., Gao J., Zhan C., Xie C., Chai Z., Ran D., Ying M., Zheng P., Lu W.. Liposome-based glioma
targeted drug delivery enabled by stable peptide ligands. J. Controlled Release. 2015;218:13–21. doi: 10.1016/j.jconrel.2015.09.059.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2015.09.059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26428462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Liposome-based%20glioma%20targeted%20drug%20delivery%20enabled%20by%20stable%20peptide%20ligands&amp;author=X.%20Wei&amp;author=J.%20Gao&amp;author=C.%20Zhan&amp;author=C.%20Xie&amp;author=Z.%20Chai&amp;volume=218&amp;publication_year=2015&amp;pages=13-21&amp;pmid=26428462&amp;doi=10.1016/j.jconrel.2015.09.059&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref125">
<cite>Zhang Y., Zhang L., Hu Y., Jiang K., Li Z., Lin Y.-Z., Wei G., Lu W.. Cell-permeable NF-κB
inhibitor-conjugated liposomes for treatment of glioma. J. Controlled Release. 2018;289:102–113. doi: 10.1016/j.jconrel.2018.09.016.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2018.09.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30243823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Cell-permeable%20NF-%CE%BAB%20inhibitor-conjugated%20liposomes%20for%20treatment%20of%20glioma&amp;author=Y.%20Zhang&amp;author=L.%20Zhang&amp;author=Y.%20Hu&amp;author=K.%20Jiang&amp;author=Z.%20Li&amp;volume=289&amp;publication_year=2018&amp;pages=102-113&amp;pmid=30243823&amp;doi=10.1016/j.jconrel.2018.09.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref126">
<cite>Ishii T., Asai T., Oyama D., Agato Y., Yasuda N., Fukuta T., Shimizu K., Minamino T., Oku N.. Treatment of cerebral ischemia-reperfusion injury with PEGylated
liposomes encapsulating FK506. FASEB J. 2013;27(4):1362–1370. doi: 10.1096/fj.12-221325.</cite> [<a href="https://doi.org/10.1096/fj.12-221325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23241312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J.&amp;title=Treatment%20of%20cerebral%20ischemia-reperfusion%20injury%20with%20PEGylated%20liposomes%20encapsulating%20FK506&amp;author=T.%20Ishii&amp;author=T.%20Asai&amp;author=D.%20Oyama&amp;author=Y.%20Agato&amp;author=N.%20Yasuda&amp;volume=27&amp;issue=4&amp;publication_year=2013&amp;pages=1362-1370&amp;pmid=23241312&amp;doi=10.1096/fj.12-221325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref127">
<cite>Orthmann A., Zeisig R., Süss R., Lorenz D., Lemm M., Fichtner I.. Treatment of experimental
brain metastasis with MTO-liposomes: impact of fluidity and LRP-targeting
on the therapeutic result. Pharm. Res. 2012;29:1949–1959. doi: 10.1007/s11095-012-0723-7.</cite> [<a href="https://doi.org/10.1007/s11095-012-0723-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22399388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharm.%20Res.&amp;title=Treatment%20of%20experimental%20brain%20metastasis%20with%20MTO-liposomes:%20impact%20of%20fluidity%20and%20LRP-targeting%20on%20the%20therapeutic%20result&amp;author=A.%20Orthmann&amp;author=R.%20Zeisig&amp;author=R.%20S%C3%BCss&amp;author=D.%20Lorenz&amp;author=M.%20Lemm&amp;volume=29&amp;publication_year=2012&amp;pages=1949-1959&amp;pmid=22399388&amp;doi=10.1007/s11095-012-0723-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref128">
<cite>Chen Z.-L., Huang M., Wang X.-R., Fu J., Han M., Shen Y.-Q., Xia Z., Gao J.-Q.. Transferrin-modified
liposome promotes α-mangostin to penetrate the blood–brain
barrier. Nanomed.: Nanotechnol., Biol. Med. 2016;12(2):421–430. doi: 10.1016/j.nano.2015.10.021.</cite> [<a href="https://doi.org/10.1016/j.nano.2015.10.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26711963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomed.:%20Nanotechnol.,%20Biol.%20Med.&amp;title=Transferrin-modified%20liposome%20promotes%20%CE%B1-mangostin%20to%20penetrate%20the%20blood%E2%80%93brain%20barrier&amp;author=Z.-L.%20Chen&amp;author=M.%20Huang&amp;author=X.-R.%20Wang&amp;author=J.%20Fu&amp;author=M.%20Han&amp;volume=12&amp;issue=2&amp;publication_year=2016&amp;pages=421-430&amp;pmid=26711963&amp;doi=10.1016/j.nano.2015.10.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref129">
<cite>Molinari A., Colone M., Calcabrini A., Stringaro A., Toccacieli L., Arancia G., Mannino S., Mangiola A., Maira G., Bombelli C., Mancini G.. Cationic liposomes,
loaded with m-THPC, in photodynamic therapy for malignant glioma. Toxicol. in Vitro. 2007;21(2):230–234. doi: 10.1016/j.tiv.2006.09.006.</cite> [<a href="https://doi.org/10.1016/j.tiv.2006.09.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17064875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol.%20in%20Vitro&amp;title=Cationic%20liposomes,%20loaded%20with%20m-THPC,%20in%20photodynamic%20therapy%20for%20malignant%20glioma&amp;author=A.%20Molinari&amp;author=M.%20Colone&amp;author=A.%20Calcabrini&amp;author=A.%20Stringaro&amp;author=L.%20Toccacieli&amp;volume=21&amp;issue=2&amp;publication_year=2007&amp;pages=230-234&amp;pmid=17064875&amp;doi=10.1016/j.tiv.2006.09.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref130">
<cite>Zhao M., Chang J., Fu X., Liang C., Liang S., Yan R., Li A.. Nano-sized cationic
polymeric magnetic liposomes significantly improves drug delivery
to the brain in rats. J. Drug Targeting. 2012;20(5):416–421. doi: 10.3109/1061186X.2011.651726.</cite> [<a href="https://doi.org/10.3109/1061186X.2011.651726" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22519867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Drug%20Targeting&amp;title=Nano-sized%20cationic%20polymeric%20magnetic%20liposomes%20significantly%20improves%20drug%20delivery%20to%20the%20brain%20in%20rats&amp;author=M.%20Zhao&amp;author=J.%20Chang&amp;author=X.%20Fu&amp;author=C.%20Liang&amp;author=S.%20Liang&amp;volume=20&amp;issue=5&amp;publication_year=2012&amp;pages=416-421&amp;pmid=22519867&amp;doi=10.3109/1061186X.2011.651726&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref131">
<cite>Obata Y., Ciofani G., Raffa V., Cuschieri A., Menciassi A., Dario P., Takeoka S.. Evaluation of cationic
liposomes composed of an amino acid–based lipid for neuronal
transfection. Nanomed.: Nanotechnol., Biol.
Med. 2010;6(1):70–77. doi: 10.1016/j.nano.2009.04.005.</cite> [<a href="https://doi.org/10.1016/j.nano.2009.04.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19447207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomed.:%20Nanotechnol.,%20Biol.%20Med.&amp;title=Evaluation%20of%20cationic%20liposomes%20composed%20of%20an%20amino%20acid%E2%80%93based%20lipid%20for%20neuronal%20transfection&amp;author=Y.%20Obata&amp;author=G.%20Ciofani&amp;author=V.%20Raffa&amp;author=A.%20Cuschieri&amp;author=A.%20Menciassi&amp;volume=6&amp;issue=1&amp;publication_year=2010&amp;pages=70-77&amp;pmid=19447207&amp;doi=10.1016/j.nano.2009.04.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref132">
<cite>Chirio D., Gallarate M., Peira E., Battaglia L., Muntoni E., Riganti C., Biasibetti E., Capucchio M. T., Valazza A., Panciani P.. et al. Positive-charged
solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma
treatment. Eur. J. Pharm. Biopharm. 2014;88(3):746–758. doi: 10.1016/j.ejpb.2014.10.017.</cite> [<a href="https://doi.org/10.1016/j.ejpb.2014.10.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25445304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Pharm.%20Biopharm.&amp;title=Positive-charged%20solid%20lipid%20nanoparticles%20as%20paclitaxel%20drug%20delivery%20system%20in%20glioblastoma%20treatment&amp;author=D.%20Chirio&amp;author=M.%20Gallarate&amp;author=E.%20Peira&amp;author=L.%20Battaglia&amp;author=E.%20Muntoni&amp;volume=88&amp;issue=3&amp;publication_year=2014&amp;pages=746-758&amp;pmid=25445304&amp;doi=10.1016/j.ejpb.2014.10.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref133">
<cite>Pardeshi C., Rajput P., Belgamwar V., Tekade A., Patil G., Chaudhary K., Sonje A.. Solid lipid based nanocarriers: An overview/Nanonosači na
bazi čvrstih lipida: Pregled. Acta Pharm. 2012;62(4):433–472. doi: 10.2478/v10007-012-0040-z.</cite> [<a href="https://doi.org/10.2478/v10007-012-0040-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23333884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Pharm.&amp;title=Solid%20lipid%20based%20nanocarriers:%20An%20overview/Nanonosa%C4%8Di%20na%20bazi%20%C4%8Dvrstih%20lipida:%20Pregled&amp;author=C.%20Pardeshi&amp;author=P.%20Rajput&amp;author=V.%20Belgamwar&amp;author=A.%20Tekade&amp;author=G.%20Patil&amp;volume=62&amp;issue=4&amp;publication_year=2012&amp;pages=433-472&amp;pmid=23333884&amp;doi=10.2478/v10007-012-0040-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref134">
<cite>Wang J.-X., Sun X., Zhang Z.-R.. Enhanced brain targeting
by synthesis of 3′, 5′-dioctanoyl-5-fluoro-2′-deoxyuridine
and incorporation into solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 2002;54(3):285–290. doi: 10.1016/S0939-6411(02)00083-8.</cite> [<a href="https://doi.org/10.1016/S0939-6411(02)00083-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12445558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Pharm.%20Biopharm.&amp;title=Enhanced%20brain%20targeting%20by%20synthesis%20of%203%E2%80%B2,%205%E2%80%B2-dioctanoyl-5-fluoro-2%E2%80%B2-deoxyuridine%20and%20incorporation%20into%20solid%20lipid%20nanoparticles&amp;author=J.-X.%20Wang&amp;author=X.%20Sun&amp;author=Z.-R.%20Zhang&amp;volume=54&amp;issue=3&amp;publication_year=2002&amp;pages=285-290&amp;pmid=12445558&amp;doi=10.1016/S0939-6411(02)00083-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref135">
<cite>Martins S., Tho I., Reimold I., Fricker G., Souto E., Ferreira D., Brandl M.. Brain delivery
of camptothecin
by means of solid lipid nanoparticles: formulation design, in vitro
and in vivo studies. Int. J. Pharm. 2012;439(1–2):49–62. doi: 10.1016/j.ijpharm.2012.09.054.</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2012.09.054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23046667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Pharm.&amp;title=Brain%20delivery%20of%20camptothecin%20by%20means%20of%20solid%20lipid%20nanoparticles:%20formulation%20design,%20in%20vitro%20and%20in%20vivo%20studies&amp;author=S.%20Martins&amp;author=I.%20Tho&amp;author=I.%20Reimold&amp;author=G.%20Fricker&amp;author=E.%20Souto&amp;volume=439&amp;issue=1%E2%80%932&amp;publication_year=2012&amp;pages=49-62&amp;pmid=23046667&amp;doi=10.1016/j.ijpharm.2012.09.054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref136">
<cite>Jin J., Bae K. H., Yang H., Lee S. J., Kim H., Kim Y., Joo K. M., Seo S. W., Park T. G., Nam D.-H.. In vivo
specific delivery of c-Met siRNA to glioblastoma using cationic solid
lipid nanoparticles. Bioconjugate Chem. 2011;22(12):2568–2572. doi: 10.1021/bc200406n.</cite> [<a href="https://doi.org/10.1021/bc200406n" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22070554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioconjugate%20Chem.&amp;title=In%20vivo%20specific%20delivery%20of%20c-Met%20siRNA%20to%20glioblastoma%20using%20cationic%20solid%20lipid%20nanoparticles&amp;author=J.%20Jin&amp;author=K.%20H.%20Bae&amp;author=H.%20Yang&amp;author=S.%20J.%20Lee&amp;author=H.%20Kim&amp;volume=22&amp;issue=12&amp;publication_year=2011&amp;pages=2568-2572&amp;pmid=22070554&amp;doi=10.1021/bc200406n&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref137">
<cite>Garanti T., Stasik A., Burrow A. J., Alhnan M. A., Wan K.-W.. Anti-glioma activity and the mechanism
of cellular
uptake of asiatic acid-loaded solid lipid nanoparticles. Int. J. Pharm. 2016;500(1–2):305–315. doi: 10.1016/j.ijpharm.2016.01.018.</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2016.01.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26775062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Pharm.&amp;title=Anti-glioma%20activity%20and%20the%20mechanism%20of%20cellular%20uptake%20of%20asiatic%20acid-loaded%20solid%20lipid%20nanoparticles&amp;author=T.%20Garanti&amp;author=A.%20Stasik&amp;author=A.%20J.%20Burrow&amp;author=M.%20A.%20Alhnan&amp;author=K.-W.%20Wan&amp;volume=500&amp;issue=1%E2%80%932&amp;publication_year=2016&amp;pages=305-315&amp;pmid=26775062&amp;doi=10.1016/j.ijpharm.2016.01.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref138">
<cite>Üner M., Yener G.. Importance of solid
lipid nanoparticles
(SLN) in various administration routes and future perspectives. Int. J. Nanomed. 2007;2(3):289–300.</cite> [<a href="/articles/PMC2676658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18019829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Nanomed.&amp;title=Importance%20of%20solid%20lipid%20nanoparticles%20(SLN)%20in%20various%20administration%20routes%20and%20future%20perspectives&amp;author=M.%20%C3%9Cner&amp;author=G.%20Yener&amp;volume=2&amp;issue=3&amp;publication_year=2007&amp;pages=289-300&amp;pmid=18019829&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref139">
<cite>Madan J., Pandey R. S., Jain V., Katare O. P., Chandra R., Katyal A.. Poly (ethylene)-glycol conjugated
solid lipid nanoparticles of noscapine improve biological half-life,
brain delivery and efficacy in glioblastoma cells. Nanomed.: Nanotechnol., Biol. Med. 2013;9(4):492–503. doi: 10.1016/j.nano.2012.10.003.</cite> [<a href="https://doi.org/10.1016/j.nano.2012.10.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23117045/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomed.:%20Nanotechnol.,%20Biol.%20Med.&amp;title=Poly%20(ethylene)-glycol%20conjugated%20solid%20lipid%20nanoparticles%20of%20noscapine%20improve%20biological%20half-life,%20brain%20delivery%20and%20efficacy%20in%20glioblastoma%20cells&amp;author=J.%20Madan&amp;author=R.%20S.%20Pandey&amp;author=V.%20Jain&amp;author=O.%20P.%20Katare&amp;author=R.%20Chandra&amp;volume=9&amp;issue=4&amp;publication_year=2013&amp;pages=492-503&amp;pmid=23117045&amp;doi=10.1016/j.nano.2012.10.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref140">
<cite>Xin H., Sha X., Jiang X., Zhang W., Chen L., Fang X.. Anti-glioblastoma efficacy
and safety of paclitaxel-loading Angiopep-conjugated
dual targeting PEG-PCL nanoparticles. Biomaterials. 2012;33(32):8167–8176. doi: 10.1016/j.biomaterials.2012.07.046.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2012.07.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22889488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Anti-glioblastoma%20efficacy%20and%20safety%20of%20paclitaxel-loading%20Angiopep-conjugated%20dual%20targeting%20PEG-PCL%20nanoparticles&amp;author=H.%20Xin&amp;author=X.%20Sha&amp;author=X.%20Jiang&amp;author=W.%20Zhang&amp;author=L.%20Chen&amp;volume=33&amp;issue=32&amp;publication_year=2012&amp;pages=8167-8176&amp;pmid=22889488&amp;doi=10.1016/j.biomaterials.2012.07.046&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref141">
<cite>Choonara Y. E., Pillay V., Ndesendo V. M., du Toit L. C., Kumar P., Khan R. A., Murphy C. S., Jarvis D.-L.. Polymeric
emulsion and crosslink-mediated synthesis of super-stable nanoparticles
as sustained-release anti-tuberculosis drug carriers. Colloids Surf., B. 2011;87(2):243–254. doi: 10.1016/j.colsurfb.2011.05.025.</cite> [<a href="https://doi.org/10.1016/j.colsurfb.2011.05.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21664111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Colloids%20Surf.,%20B&amp;title=Polymeric%20emulsion%20and%20crosslink-mediated%20synthesis%20of%20super-stable%20nanoparticles%20as%20sustained-release%20anti-tuberculosis%20drug%20carriers&amp;author=Y.%20E.%20Choonara&amp;author=V.%20Pillay&amp;author=V.%20M.%20Ndesendo&amp;author=L.%20C.%20du%20Toit&amp;author=P.%20Kumar&amp;volume=87&amp;issue=2&amp;publication_year=2011&amp;pages=243-254&amp;pmid=21664111&amp;doi=10.1016/j.colsurfb.2011.05.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref142">
<cite>Pandey R., Khuller G.. Oral nanoparticle-based
antituberculosis
drug delivery to the brain in an experimental model. J. Antimicrob. Chemother. 2006;57(6):1146–1152. doi: 10.1093/jac/dkl128.</cite> [<a href="https://doi.org/10.1093/jac/dkl128" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16597631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Antimicrob.%20Chemother.&amp;title=Oral%20nanoparticle-based%20antituberculosis%20drug%20delivery%20to%20the%20brain%20in%20an%20experimental%20model&amp;author=R.%20Pandey&amp;author=G.%20Khuller&amp;volume=57&amp;issue=6&amp;publication_year=2006&amp;pages=1146-1152&amp;pmid=16597631&amp;doi=10.1093/jac/dkl128&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref143">
<cite>Hasadsri L., Kreuter J., Hattori H., Iwasaki T., George J. M.. Functional protein delivery into
neurons using polymeric
nanoparticles. J. Biol. Chem. 2009;284(11):6972–6981. doi: 10.1074/jbc.M805956200.</cite> [<a href="https://doi.org/10.1074/jbc.M805956200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2652328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19129199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Functional%20protein%20delivery%20into%20neurons%20using%20polymeric%20nanoparticles&amp;author=L.%20Hasadsri&amp;author=J.%20Kreuter&amp;author=H.%20Hattori&amp;author=T.%20Iwasaki&amp;author=J.%20M.%20George&amp;volume=284&amp;issue=11&amp;publication_year=2009&amp;pages=6972-6981&amp;pmid=19129199&amp;doi=10.1074/jbc.M805956200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref144">
<cite>Mangraviti A., Tzeng S. Y., Kozielski K. L., Wang Y., Jin Y., Gullotti D., Pedone M., Buaron N., Liu A., Wilson D. R.. et al. Polymeric
nanoparticles for nonviral gene therapy extend brain tumor survival
in vivo. ACS Nano. 2015;9(2):1236–1249. doi: 10.1021/nn504905q.</cite> [<a href="https://doi.org/10.1021/nn504905q" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4342728/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25643235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Polymeric%20nanoparticles%20for%20nonviral%20gene%20therapy%20extend%20brain%20tumor%20survival%20in%20vivo&amp;author=A.%20Mangraviti&amp;author=S.%20Y.%20Tzeng&amp;author=K.%20L.%20Kozielski&amp;author=Y.%20Wang&amp;author=Y.%20Jin&amp;volume=9&amp;issue=2&amp;publication_year=2015&amp;pages=1236-1249&amp;pmid=25643235&amp;doi=10.1021/nn504905q&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref145">
<cite>Kabanov A. V., Batrakova E. V., Melik-Nubarov N. S., Fedoseev N. A., Dorodnich T. Y., Alakhov V. Y., Chekhonin V. P., Nazarova I. R., Kabanov V. A.. A new class of drug carriers: micelles
of poly (oxyethylene)-poly (oxypropylene) block copolymers as microcontainers
for drug targeting from blood in brain. J. Controlled
Release. 1992;22(2):141–157. doi: 10.1016/0168-3659(92)90199-2.</cite> [<a href="https://doi.org/10.1016/0168-3659(92)90199-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=A%20new%20class%20of%20drug%20carriers:%20micelles%20of%20poly%20(oxyethylene)-poly%20(oxypropylene)%20block%20copolymers%20as%20microcontainers%20for%20drug%20targeting%20from%20blood%20in%20brain&amp;author=A.%20V.%20Kabanov&amp;author=E.%20V.%20Batrakova&amp;author=N.%20S.%20Melik-Nubarov&amp;author=N.%20A.%20Fedoseev&amp;author=T.%20Y.%20Dorodnich&amp;volume=22&amp;issue=2&amp;publication_year=1992&amp;pages=141-157&amp;doi=10.1016/0168-3659(92)90199-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref146">
<cite>Kim J.-Y., Choi W. I., Kim Y. H., Tae G.. Brain-targeted
delivery of protein using chitosan-and RVG peptide-conjugated, pluronic-based
nano-carrier. Biomaterials. 2013;34(4):1170–1178. doi: 10.1016/j.biomaterials.2012.09.047.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2012.09.047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23122677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Brain-targeted%20delivery%20of%20protein%20using%20chitosan-and%20RVG%20peptide-conjugated,%20pluronic-based%20nano-carrier&amp;author=J.-Y.%20Kim&amp;author=W.%20I.%20Choi&amp;author=Y.%20H.%20Kim&amp;author=G.%20Tae&amp;volume=34&amp;issue=4&amp;publication_year=2013&amp;pages=1170-1178&amp;pmid=23122677&amp;doi=10.1016/j.biomaterials.2012.09.047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref147">
<cite>Bhojani M. S., Van Dort M., Rehemtulla A., Ross B. D.. Targeted imaging and therapy of brain cancer using
theranostic nanoparticles. Mol. Pharmaceutics. 2010;7(6):1921–1929. doi: 10.1021/mp100298r.</cite> [<a href="https://doi.org/10.1021/mp100298r" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3291122/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20964352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Pharmaceutics&amp;title=Targeted%20imaging%20and%20therapy%20of%20brain%20cancer%20using%20theranostic%20nanoparticles&amp;author=M.%20S.%20Bhojani&amp;author=M.%20Van%20Dort&amp;author=A.%20Rehemtulla&amp;author=B.%20D.%20Ross&amp;volume=7&amp;issue=6&amp;publication_year=2010&amp;pages=1921-1929&amp;pmid=20964352&amp;doi=10.1021/mp100298r&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref148">
<cite>Albertazzi L., Gherardini L., Brondi M., Sato S. S., Bifone A., Pizzorusso T., Ratto G. M., Bardi G.. In vivo distribution
and toxicity of PAMAM dendrimers in the central nervous system depend
on their surface chemistry. Mol. Pharmaceutics. 2013;10(1):249–260. doi: 10.1021/mp300391v.</cite> [<a href="https://doi.org/10.1021/mp300391v" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23163881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Pharmaceutics&amp;title=In%20vivo%20distribution%20and%20toxicity%20of%20PAMAM%20dendrimers%20in%20the%20central%20nervous%20system%20depend%20on%20their%20surface%20chemistry&amp;author=L.%20Albertazzi&amp;author=L.%20Gherardini&amp;author=M.%20Brondi&amp;author=S.%20S.%20Sato&amp;author=A.%20Bifone&amp;volume=10&amp;issue=1&amp;publication_year=2013&amp;pages=249-260&amp;pmid=23163881&amp;doi=10.1021/mp300391v&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref149">
<cite>Vidal F., Guzman L.. Dendrimer nanocarriers
drug action:
perspective for neuronal pharmacology. Neural
Regener. Res. 2015;10(7):1029–1031. doi: 10.4103/1673-5374.160063.</cite> [<a href="https://doi.org/10.4103/1673-5374.160063" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4541220/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26330812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neural%20Regener.%20Res.&amp;title=Dendrimer%20nanocarriers%20drug%20action:%20perspective%20for%20neuronal%20pharmacology&amp;author=F.%20Vidal&amp;author=L.%20Guzman&amp;volume=10&amp;issue=7&amp;publication_year=2015&amp;pages=1029-1031&amp;pmid=26330812&amp;doi=10.4103/1673-5374.160063&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref150">
<cite>Zhao J., Zhang B., Shen S., Chen J., Zhang Q., Jiang X., Pang Z.. CREKA peptide-conjugated
dendrimer nanoparticles for glioblastoma multiforme delivery. J. Colloid Interface Sci. 2015;450:396–403. doi: 10.1016/j.jcis.2015.03.019.</cite> [<a href="https://doi.org/10.1016/j.jcis.2015.03.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25863222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Colloid%20Interface%20Sci.&amp;title=CREKA%20peptide-conjugated%20dendrimer%20nanoparticles%20for%20glioblastoma%20multiforme%20delivery&amp;author=J.%20Zhao&amp;author=B.%20Zhang&amp;author=S.%20Shen&amp;author=J.%20Chen&amp;author=Q.%20Zhang&amp;volume=450&amp;publication_year=2015&amp;pages=396-403&amp;pmid=25863222&amp;doi=10.1016/j.jcis.2015.03.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref151">
<cite>Kannan S., Dai H., Navath R. S., Balakrishnan B., Jyoti A., Janisse J., Romero R., Kannan R. M.. Dendrimer-based
postnatal therapy for neuroinflammation and cerebral palsy in a rabbit
model. Sci. Transl. Med. 2012;4(130):130ra46.  doi: 10.1126/scitranslmed.3003162.</cite> [<a href="https://doi.org/10.1126/scitranslmed.3003162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3492056/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22517883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Transl.%20Med.&amp;title=Dendrimer-based%20postnatal%20therapy%20for%20neuroinflammation%20and%20cerebral%20palsy%20in%20a%20rabbit%20model&amp;author=S.%20Kannan&amp;author=H.%20Dai&amp;author=R.%20S.%20Navath&amp;author=B.%20Balakrishnan&amp;author=A.%20Jyoti&amp;volume=4&amp;issue=130&amp;publication_year=2012&amp;pages=130ra46&amp;pmid=22517883&amp;doi=10.1126/scitranslmed.3003162&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref152">
<cite>Gao S., Li J., Jiang C., Hong B., Hao B.. Plasmid pORF-hTRAIL
targeting to glioma using transferrin-modified polyamidoamine dendrimer. Drug Des., Dev. Ther. 2015:1–11. doi: 10.2147/DDDT.S95843.</cite> [<a href="https://doi.org/10.2147/DDDT.S95843" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4690643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26719669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Des.,%20Dev.%20Ther.&amp;title=Plasmid%20pORF-hTRAIL%20targeting%20to%20glioma%20using%20transferrin-modified%20polyamidoamine%20dendrimer&amp;author=S.%20Gao&amp;author=J.%20Li&amp;author=C.%20Jiang&amp;author=B.%20Hong&amp;author=B.%20Hao&amp;publication_year=2015&amp;pages=1-11&amp;pmid=26719669&amp;doi=10.2147/DDDT.S95843&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref153">
<cite>Sercombe L., Veerati T., Moheimani F., Wu S. Y., Sood A. K., Hua S.. Advances and challenges
of liposome assisted drug delivery. Front. Pharmacol. 2015;6:286.  doi: 10.3389/fphar.2015.00286.</cite> [<a href="https://doi.org/10.3389/fphar.2015.00286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4664963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26648870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Pharmacol.&amp;title=Advances%20and%20challenges%20of%20liposome%20assisted%20drug%20delivery&amp;author=L.%20Sercombe&amp;author=T.%20Veerati&amp;author=F.%20Moheimani&amp;author=S.%20Y.%20Wu&amp;author=A.%20K.%20Sood&amp;volume=6&amp;publication_year=2015&amp;pages=286&amp;pmid=26648870&amp;doi=10.3389/fphar.2015.00286&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref154">
<cite>Photos P. J., Bacakova L., Discher B., Bates F. S., Discher D. E.. Polymer vesicles in vivo: correlations with PEG molecular
weight. J. Controlled Release. 2003;90(3):323–334. doi: 10.1016/S0168-3659(03)00201-3.</cite> [<a href="https://doi.org/10.1016/S0168-3659(03)00201-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12880699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Polymer%20vesicles%20in%20vivo:%20correlations%20with%20PEG%20molecular%20weight&amp;author=P.%20J.%20Photos&amp;author=L.%20Bacakova&amp;author=B.%20Discher&amp;author=F.%20S.%20Bates&amp;author=D.%20E.%20Discher&amp;volume=90&amp;issue=3&amp;publication_year=2003&amp;pages=323-334&amp;pmid=12880699&amp;doi=10.1016/S0168-3659(03)00201-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref155">
<cite>

Pyykkö, I.
; 
Zou, J.
; 
Schrott-Fischer, A.
; 
Glueckert, R.
; 
Kinnunen, P.
. 
An
Overview of
Nanoparticle Based Delivery for Treatment of Inner Ear Disorders. In Methods in Molecular Biology; Springer, 2016; Vol. 1427, pp 363–415.
</cite> [<a href="https://doi.org/10.1007/978-1-4939-3615-1_21" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27259938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Methods%20in%20Molecular%20Biology&amp;publication_year=2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref156">
<cite>Georgieva J. V., Brinkhuis R. P., Stojanov K., Weijers C. A., Zuilhof H., Rutjes F. P., Hoekstra D., van Hest J. C., Zuhorn I. S.. Peptide-mediated blood–brain barrier transport
of polymersomes. Angew. Chem. 2012;124:8464–8467. doi: 10.1002/ange.201202001.</cite> [<a href="https://doi.org/10.1002/ange.201202001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22786792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Angew.%20Chem.&amp;title=Peptide-mediated%20blood%E2%80%93brain%20barrier%20transport%20of%20polymersomes&amp;author=J.%20V.%20Georgieva&amp;author=R.%20P.%20Brinkhuis&amp;author=K.%20Stojanov&amp;author=C.%20A.%20Weijers&amp;author=H.%20Zuilhof&amp;volume=124&amp;publication_year=2012&amp;pages=8464-8467&amp;pmid=22786792&amp;doi=10.1002/ange.201202001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref157">
<cite>Chen Y.-C., Chiang C.-F., Chen L.-F., Liang P.-C., Hsieh W.-Y., Lin W.-L.. Polymersomes conjugated with des-octanoyl
ghrelin and folate as a BBB-penetrating cancer cell-targeting delivery
system. Biomaterials. 2014;35(13):4066–4081. doi: 10.1016/j.biomaterials.2014.01.042.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2014.01.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24513319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Polymersomes%20conjugated%20with%20des-octanoyl%20ghrelin%20and%20folate%20as%20a%20BBB-penetrating%20cancer%20cell-targeting%20delivery%20system&amp;author=Y.-C.%20Chen&amp;author=C.-F.%20Chiang&amp;author=L.-F.%20Chen&amp;author=P.-C.%20Liang&amp;author=W.-Y.%20Hsieh&amp;volume=35&amp;issue=13&amp;publication_year=2014&amp;pages=4066-4081&amp;pmid=24513319&amp;doi=10.1016/j.biomaterials.2014.01.042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref158">
<cite>Wang T., Jiao Y., Chai Q., Yu X.. Gold nanoparticles:
synthesis and biological applications. Nano
LIFE. 2015;05(03):1542007.  doi: 10.1142/S1793984415420076.</cite> [<a href="https://doi.org/10.1142/S1793984415420076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20LIFE&amp;title=Gold%20nanoparticles:%20synthesis%20and%20biological%20applications&amp;author=T.%20Wang&amp;author=Y.%20Jiao&amp;author=Q.%20Chai&amp;author=X.%20Yu&amp;volume=05&amp;issue=03&amp;publication_year=2015&amp;pages=1542007&amp;doi=10.1142/S1793984415420076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref159">
<cite>Wu Z., Song N., Menz R., Pingali B., Yang Y.-W., Zheng Y.. Nanoparticles functionalized
with supramolecular host–guest
systems for nanomedicine and healthcare. Nanomedicine. 2015;10(9):1493–1514. doi: 10.2217/nnm.15.1.</cite> [<a href="https://doi.org/10.2217/nnm.15.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25996121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine&amp;title=Nanoparticles%20functionalized%20with%20supramolecular%20host%E2%80%93guest%20systems%20for%20nanomedicine%20and%20healthcare&amp;author=Z.%20Wu&amp;author=N.%20Song&amp;author=R.%20Menz&amp;author=B.%20Pingali&amp;author=Y.-W.%20Yang&amp;volume=10&amp;issue=9&amp;publication_year=2015&amp;pages=1493-1514&amp;pmid=25996121&amp;doi=10.2217/nnm.15.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref160">
<cite>Wang S., Zhou Y., Tan J., Xu J., Yang J., Liu Y.. Computational modeling of magnetic
nanoparticle targeting to stent surface under high gradient field. Comput. Mech. 2014;53:403–412. doi: 10.1007/s00466-013-0968-y.</cite> [<a href="https://doi.org/10.1007/s00466-013-0968-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3956080/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24653546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Comput.%20Mech.&amp;title=Computational%20modeling%20of%20magnetic%20nanoparticle%20targeting%20to%20stent%20surface%20under%20high%20gradient%20field&amp;author=S.%20Wang&amp;author=Y.%20Zhou&amp;author=J.%20Tan&amp;author=J.%20Xu&amp;author=J.%20Yang&amp;volume=53&amp;publication_year=2014&amp;pages=403-412&amp;pmid=24653546&amp;doi=10.1007/s00466-013-0968-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref161">
<cite>Faucher L., Guay-Bégin A.
A., Lagueux J., Côté M. F., Petitclerc E., Fortin M. A.. Ultra-small gadolinium oxide nanoparticles to image
brain cancer cells in vivo with MRI. Contrast
Media Mol. Imaging. 2011;6(4):209–218. doi: 10.1002/cmmi.420.</cite> [<a href="https://doi.org/10.1002/cmmi.420" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21861281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Contrast%20Media%20Mol.%20Imaging&amp;title=Ultra-small%20gadolinium%20oxide%20nanoparticles%20to%20image%20brain%20cancer%20cells%20in%20vivo%20with%20MRI&amp;author=L.%20Faucher&amp;author=A.%20A.%20Guay-B%C3%A9gin&amp;author=J.%20Lagueux&amp;author=M.%20F.%20C%C3%B4t%C3%A9&amp;author=E.%20Petitclerc&amp;volume=6&amp;issue=4&amp;publication_year=2011&amp;pages=209-218&amp;pmid=21861281&amp;doi=10.1002/cmmi.420&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref162">
<cite>Tsai H.-C., Tsai C.-H., Chen W.-S., Inserra C., Wei K.-C., Liu H.-L.. Safety evaluation of frequent application
of microbubble-enhanced focused ultrasound blood–brain-barrier
opening. Sci. Rep. 2018;8(1):17720.  doi: 10.1038/s41598-018-35677-w.</cite> [<a href="https://doi.org/10.1038/s41598-018-35677-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6286368/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30531863/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Safety%20evaluation%20of%20frequent%20application%20of%20microbubble-enhanced%20focused%20ultrasound%20blood%E2%80%93brain-barrier%20opening&amp;author=H.-C.%20Tsai&amp;author=C.-H.%20Tsai&amp;author=W.-S.%20Chen&amp;author=C.%20Inserra&amp;author=K.-C.%20Wei&amp;volume=8&amp;issue=1&amp;publication_year=2018&amp;pages=17720&amp;pmid=30531863&amp;doi=10.1038/s41598-018-35677-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref163">
<cite>Lee J. S., Youn Y. H., Kwon I. K., Ko N. R.. Recent
advances in quantum dots for biomedical applications. J. Pharm. Invest. 2018;48:209–214. doi: 10.1007/s40005-018-0387-3.</cite> [<a href="https://doi.org/10.1007/s40005-018-0387-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharm.%20Invest.&amp;title=Recent%20advances%20in%20quantum%20dots%20for%20biomedical%20applications&amp;author=J.%20S.%20Lee&amp;author=Y.%20H.%20Youn&amp;author=I.%20K.%20Kwon&amp;author=N.%20R.%20Ko&amp;volume=48&amp;publication_year=2018&amp;pages=209-214&amp;doi=10.1007/s40005-018-0387-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref164">
<cite>Sengupta S., Pal S., Pal A., Maity S., Sarkar K., Das M.. A review on synthesis, toxicity profile
and biomedical applications of graphene quantum dots (GQDs) Inorg. Chim. Acta. 2023;557:121677.  doi: 10.1016/j.ica.2023.121677.</cite> [<a href="https://doi.org/10.1016/j.ica.2023.121677" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Inorg.%20Chim.%20Acta&amp;title=A%20review%20on%20synthesis,%20toxicity%20profile%20and%20biomedical%20applications%20of%20graphene%20quantum%20dots%20(GQDs)&amp;author=S.%20Sengupta&amp;author=S.%20Pal&amp;author=A.%20Pal&amp;author=S.%20Maity&amp;author=K.%20Sarkar&amp;volume=557&amp;publication_year=2023&amp;pages=121677&amp;doi=10.1016/j.ica.2023.121677&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref165">
<cite>Yong K.-T., Roy I., Swihart M. T., Prasad P. N.. Multifunctional
nanoparticles as biocompatible targeted probes for human cancer diagnosis
and therapy. J. Mater. Chem. 2009;19(27):4655–4672. doi: 10.1039/b817667c.</cite> [<a href="https://doi.org/10.1039/b817667c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2841409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20305738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mater.%20Chem.&amp;title=Multifunctional%20nanoparticles%20as%20biocompatible%20targeted%20probes%20for%20human%20cancer%20diagnosis%20and%20therapy&amp;author=K.-T.%20Yong&amp;author=I.%20Roy&amp;author=M.%20T.%20Swihart&amp;author=P.%20N.%20Prasad&amp;volume=19&amp;issue=27&amp;publication_year=2009&amp;pages=4655-4672&amp;pmid=20305738&amp;doi=10.1039/b817667c&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref166">
<cite>Bonoiu A., Mahajan S. D., Ye L., Kumar R., Ding H., Yong K.-T., Roy I., Aalinkeel R., Nair B., Reynolds J. L.. et al. MMP-9
gene silencing
by a quantum dot–siRNA nanoplex delivery to maintain the integrity
of the blood brain barrier. Brain Res. 2009;1282:142–155. doi: 10.1016/j.brainres.2009.05.047.</cite> [<a href="https://doi.org/10.1016/j.brainres.2009.05.047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2762384/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19477169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Res.&amp;title=MMP-9%20gene%20silencing%20by%20a%20quantum%20dot%E2%80%93siRNA%20nanoplex%20delivery%20to%20maintain%20the%20integrity%20of%20the%20blood%20brain%20barrier&amp;author=A.%20Bonoiu&amp;author=S.%20D.%20Mahajan&amp;author=L.%20Ye&amp;author=R.%20Kumar&amp;author=H.%20Ding&amp;volume=1282&amp;publication_year=2009&amp;pages=142-155&amp;pmid=19477169&amp;doi=10.1016/j.brainres.2009.05.047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref167">
<cite>Xu G., Yong K.-T., Roy I., Mahajan S. D., Ding H., Schwartz S. A., Prasad P. N.. Bioconjugated
quantum rods as targeted
probes for efficient transmigration across an in vitro blood–
brain barrier. Bioconjugate Chem. 2008;19(6):1179–1185. doi: 10.1021/bc700477u.</cite> [<a href="https://doi.org/10.1021/bc700477u" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18473444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioconjugate%20Chem.&amp;title=Bioconjugated%20quantum%20rods%20as%20targeted%20probes%20for%20efficient%20transmigration%20across%20an%20in%20vitro%20blood%E2%80%93%20brain%20barrier&amp;author=G.%20Xu&amp;author=K.-T.%20Yong&amp;author=I.%20Roy&amp;author=S.%20D.%20Mahajan&amp;author=H.%20Ding&amp;volume=19&amp;issue=6&amp;publication_year=2008&amp;pages=1179-1185&amp;pmid=18473444&amp;doi=10.1021/bc700477u&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref168">
<cite>Patel V., Shah J.. Anti-cancer and neuroprotective
effects
of conjugated graphene quantum dot in brain tumor-bearing rat model. Nano Express. 2023;4(4):045010.  doi: 10.1088/2632-959X/ad100d.</cite> [<a href="https://doi.org/10.1088/2632-959X/ad100d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Express&amp;title=Anti-cancer%20and%20neuroprotective%20effects%20of%20conjugated%20graphene%20quantum%20dot%20in%20brain%20tumor-bearing%20rat%20model&amp;author=V.%20Patel&amp;author=J.%20Shah&amp;volume=4&amp;issue=4&amp;publication_year=2023&amp;pages=045010&amp;doi=10.1088/2632-959X/ad100d&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref169">
<cite>Deng K., Zhang L., Gao W., Lin X., Long X., Wang Y., Wu M.. A functional carbon
dots induce ferroptosis by suppressing PLPP4 activity to inhibit glioblastoma
growth. Chem. Eng. J. 2023;475:146473.  doi: 10.1016/j.cej.2023.146473.</cite> [<a href="https://doi.org/10.1016/j.cej.2023.146473" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Eng.%20J.&amp;title=A%20functional%20carbon%20dots%20induce%20ferroptosis%20by%20suppressing%20PLPP4%20activity%20to%20inhibit%20glioblastoma%20growth&amp;author=K.%20Deng&amp;author=L.%20Zhang&amp;author=W.%20Gao&amp;author=X.%20Lin&amp;author=X.%20Long&amp;volume=475&amp;publication_year=2023&amp;pages=146473&amp;doi=10.1016/j.cej.2023.146473&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref170">
<cite>He Q., Shi J.. Mesoporous silica nanoparticle
based nano drug delivery
systems: synthesis, controlled drug release and delivery, pharmacokinetics
and biocompatibility. J. Mater. Chem. 2011;21(16):5845–5855. doi: 10.1039/c0jm03851b.</cite> [<a href="https://doi.org/10.1039/c0jm03851b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mater.%20Chem.&amp;title=Mesoporous%20silica%20nanoparticle%20based%20nano%20drug%20delivery%20systems:%20synthesis,%20controlled%20drug%20release%20and%20delivery,%20pharmacokinetics%20and%20biocompatibility&amp;author=Q.%20He&amp;author=J.%20Shi&amp;volume=21&amp;issue=16&amp;publication_year=2011&amp;pages=5845-5855&amp;doi=10.1039/c0jm03851b&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref171">
<cite>Hudson S. P., Padera R. F., Langer R., Kohane D. S.. The biocompatibility
of mesoporous silicates. Biomaterials. 2008;29(30):4045–4055. doi: 10.1016/j.biomaterials.2008.07.007.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2008.07.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2602836/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18675454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=The%20biocompatibility%20of%20mesoporous%20silicates&amp;author=S.%20P.%20Hudson&amp;author=R.%20F.%20Padera&amp;author=R.%20Langer&amp;author=D.%20S.%20Kohane&amp;volume=29&amp;issue=30&amp;publication_year=2008&amp;pages=4045-4055&amp;pmid=18675454&amp;doi=10.1016/j.biomaterials.2008.07.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref172">
<cite>Brühwiler D.. Postsynthetic
functionalization of mesoporous silica. Nanoscale. 2010;2(6):887–892. doi: 10.1039/c0nr00039f.</cite> [<a href="https://doi.org/10.1039/c0nr00039f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20648283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale&amp;title=Postsynthetic%20functionalization%20of%20mesoporous%20silica&amp;author=D.%20Br%C3%BChwiler&amp;volume=2&amp;issue=6&amp;publication_year=2010&amp;pages=887-892&amp;pmid=20648283&amp;doi=10.1039/c0nr00039f&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref173">
<cite>Wu S.-H., Hung Y., Mou C.-Y.. Mesoporous silica
nanoparticles as nanocarriers. Chem. Commun. 2011;47(36):9972–9985. doi: 10.1039/c1cc11760b.</cite> [<a href="https://doi.org/10.1039/c1cc11760b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21716992/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Commun.&amp;title=Mesoporous%20silica%20nanoparticles%20as%20nanocarriers&amp;author=S.-H.%20Wu&amp;author=Y.%20Hung&amp;author=C.-Y.%20Mou&amp;volume=47&amp;issue=36&amp;publication_year=2011&amp;pages=9972-9985&amp;pmid=21716992&amp;doi=10.1039/c1cc11760b&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref174">
<cite>Baghirov H., Karaman D., Viitala T., Duchanoy A., Lou Y.-R., Mamaeva V., Pryazhnikov E., Khiroug L., de Lange
Davies C., Sahlgren C., Rosenholm J. M.. Feasibility
study of the permeability and uptake of mesoporous silica nanoparticles
across the blood–brain barrier. PLoS
One. 2016;11(8):e0160705.  doi: 10.1371/journal.pone.0160705.</cite> [<a href="https://doi.org/10.1371/journal.pone.0160705" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4993362/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27547955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Feasibility%20study%20of%20the%20permeability%20and%20uptake%20of%20mesoporous%20silica%20nanoparticles%20across%20the%20blood%E2%80%93brain%20barrier&amp;author=H.%20Baghirov&amp;author=D.%20Karaman&amp;author=T.%20Viitala&amp;author=A.%20Duchanoy&amp;author=Y.-R.%20Lou&amp;volume=11&amp;issue=8&amp;publication_year=2016&amp;pages=e0160705&amp;pmid=27547955&amp;doi=10.1371/journal.pone.0160705&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref175">
<cite>Chen Z.-A., Wu C.-H., Wu S.-H., Huang C.-Y., Mou C.-Y., Wei K.-C., Yen Y., Chien I.-T., Runa S., Chen Y.-P., Chen P.. Receptor Ligand-Free
Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted
Drug Delivery across the Blood–Brain Barrier. ACS Nano. 2024;18:12716–12736. doi: 10.1021/acsnano.3c08993.</cite> [<a href="https://doi.org/10.1021/acsnano.3c08993" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11112986/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38718220/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Receptor%20Ligand-Free%20Mesoporous%20Silica%20Nanoparticles:%20A%20Streamlined%20Strategy%20for%20Targeted%20Drug%20Delivery%20across%20the%20Blood%E2%80%93Brain%20Barrier&amp;author=Z.-A.%20Chen&amp;author=C.-H.%20Wu&amp;author=S.-H.%20Wu&amp;author=C.-Y.%20Huang&amp;author=C.-Y.%20Mou&amp;volume=18&amp;publication_year=2024&amp;pages=12716-12736&amp;pmid=38718220&amp;doi=10.1021/acsnano.3c08993&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref176">
<cite>Zhu Y., Liang J., Gao C., Wang A., Xia J., Hong C., Zhong Z., Zuo Z., Kim J., Ren H.. et al. Multifunctional ginsenoside
Rg3-based liposomes for
glioma targeting therapy. J. Controlled Release. 2021;330:641–657. doi: 10.1016/j.jconrel.2020.12.036.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2020.12.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33359582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Multifunctional%20ginsenoside%20Rg3-based%20liposomes%20for%20glioma%20targeting%20therapy&amp;author=Y.%20Zhu&amp;author=J.%20Liang&amp;author=C.%20Gao&amp;author=A.%20Wang&amp;author=J.%20Xia&amp;volume=330&amp;publication_year=2021&amp;pages=641-657&amp;pmid=33359582&amp;doi=10.1016/j.jconrel.2020.12.036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref177">
<cite>Shi D., Mi G., Shen Y., Webster T. J.. Glioma-targeted
dual functionalized thermosensitive Ferri-liposomes for drug delivery
through an in vitro blood–brain barrier. Nanoscale. 2019;11(32):15057–15071. doi: 10.1039/C9NR03931G.</cite> [<a href="https://doi.org/10.1039/C9NR03931G" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31369016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale&amp;title=Glioma-targeted%20dual%20functionalized%20thermosensitive%20Ferri-liposomes%20for%20drug%20delivery%20through%20an%20in%20vitro%20blood%E2%80%93brain%20barrier&amp;author=D.%20Shi&amp;author=G.%20Mi&amp;author=Y.%20Shen&amp;author=T.%20J.%20Webster&amp;volume=11&amp;issue=32&amp;publication_year=2019&amp;pages=15057-15071&amp;pmid=31369016&amp;doi=10.1039/C9NR03931G&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref178">
<cite>Wang X., Meng N., Wang S., Zhang Y., Lu L., Wang R., Ruan H., Jiang K., Wang H., Ran D.. et al. Non-immunogenic, low-toxicity and effective glioma
targeting MTI-31 liposomes. J. Controlled Release. 2019;316:381–392. doi: 10.1016/j.jconrel.2019.11.005.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2019.11.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31730912/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Non-immunogenic,%20low-toxicity%20and%20effective%20glioma%20targeting%20MTI-31%20liposomes&amp;author=X.%20Wang&amp;author=N.%20Meng&amp;author=S.%20Wang&amp;author=Y.%20Zhang&amp;author=L.%20Lu&amp;volume=316&amp;publication_year=2019&amp;pages=381-392&amp;pmid=31730912&amp;doi=10.1016/j.jconrel.2019.11.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref179">
<cite>Shi H., Sun S., Xu H., Zhao Z., Han Z., Jia J., Wu D., Lu J., Liu H., Yu R.. Combined delivery
of Temozolomide and siPLK1 using targeted nanoparticles to enhance
Temozolomide sensitivity in glioma. Int. J.
Nanomed. 2020;15:3347–3362. doi: 10.2147/ijn.s243878.</cite> [<a href="https://doi.org/10.2147/ijn.s243878" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7229804/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32494134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Nanomed.&amp;title=Combined%20delivery%20of%20Temozolomide%20and%20siPLK1%20using%20targeted%20nanoparticles%20to%20enhance%20Temozolomide%20sensitivity%20in%20glioma&amp;author=H.%20Shi&amp;author=S.%20Sun&amp;author=H.%20Xu&amp;author=Z.%20Zhao&amp;author=Z.%20Han&amp;volume=15&amp;publication_year=2020&amp;pages=3347-3362&amp;pmid=32494134&amp;doi=10.2147/ijn.s243878&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref180">
<cite>Miura Y., Takenaka T., Toh K., Wu S., Nishihara H., Kano M. R., Ino Y., Nomoto T., Matsumoto Y., Koyama H.. et al. Cyclic RGD-linked polymeric
micelles for targeted delivery of platinum anticancer drugs to glioblastoma
through the blood–brain tumor barrier. ACS Nano. 2013;7(10):8583–8592. doi: 10.1021/nn402662d.</cite> [<a href="https://doi.org/10.1021/nn402662d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24028526/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&amp;title=Cyclic%20RGD-linked%20polymeric%20micelles%20for%20targeted%20delivery%20of%20platinum%20anticancer%20drugs%20to%20glioblastoma%20through%20the%20blood%E2%80%93brain%20tumor%20barrier&amp;author=Y.%20Miura&amp;author=T.%20Takenaka&amp;author=K.%20Toh&amp;author=S.%20Wu&amp;author=H.%20Nishihara&amp;volume=7&amp;issue=10&amp;publication_year=2013&amp;pages=8583-8592&amp;pmid=24028526&amp;doi=10.1021/nn402662d&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref181">
<cite>Han S., Zheng H., Lu Y., Sun Y., Huang A., Fei W., Shi X., Xu X., Li J., Li F.. A novel synergetic
targeting strategy for glioma therapy employing borneol combination
with angiopep-2-modified, DOX-loaded PAMAM dendrimer. J. Drug Targeting. 2018;26(1):86–94. doi: 10.1080/1061186X.2017.1344849.</cite> [<a href="https://doi.org/10.1080/1061186X.2017.1344849" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28635335/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Drug%20Targeting&amp;title=A%20novel%20synergetic%20targeting%20strategy%20for%20glioma%20therapy%20employing%20borneol%20combination%20with%20angiopep-2-modified,%20DOX-loaded%20PAMAM%20dendrimer&amp;author=S.%20Han&amp;author=H.%20Zheng&amp;author=Y.%20Lu&amp;author=Y.%20Sun&amp;author=A.%20Huang&amp;volume=26&amp;issue=1&amp;publication_year=2018&amp;pages=86-94&amp;pmid=28635335&amp;doi=10.1080/1061186X.2017.1344849&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref182">
<cite>Lu Y., Han S., Zheng H., Ma R., Ping Y., Zou J., Tang H., Zhang Y., Xu X., Li F.. A novel RGDyC/PEG
co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting
delivery system. Int. J. Nanomed. 2018;13:5937–5952. doi: 10.2147/IJN.S175418.</cite> [<a href="https://doi.org/10.2147/IJN.S175418" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6173183/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30323584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Nanomed.&amp;title=A%20novel%20RGDyC/PEG%20co-modified%20PAMAM%20dendrimer-loaded%20arsenic%20trioxide%20of%20glioma%20targeting%20delivery%20system&amp;author=Y.%20Lu&amp;author=S.%20Han&amp;author=H.%20Zheng&amp;author=R.%20Ma&amp;author=Y.%20Ping&amp;volume=13&amp;publication_year=2018&amp;pages=5937-5952&amp;pmid=30323584&amp;doi=10.2147/IJN.S175418&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref183">
<cite>Li Y., He H., Jia X., Lu W.-L., Lou J., Wei Y.. A dual-targeting nanocarrier based on poly (amidoamine)
dendrimers
conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials. 2012;33(15):3899–3908. doi: 10.1016/j.biomaterials.2012.02.004.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2012.02.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22364698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=A%20dual-targeting%20nanocarrier%20based%20on%20poly%20(amidoamine)%20dendrimers%20conjugated%20with%20transferrin%20and%20tamoxifen%20for%20treating%20brain%20gliomas&amp;author=Y.%20Li&amp;author=H.%20He&amp;author=X.%20Jia&amp;author=W.-L.%20Lu&amp;author=J.%20Lou&amp;volume=33&amp;issue=15&amp;publication_year=2012&amp;pages=3899-3908&amp;pmid=22364698&amp;doi=10.1016/j.biomaterials.2012.02.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref184">
<cite>Lin E.-Y., Chen Y.-S., Li Y.-S., Chen S.-R., Lee C.-H., Huang M.-H., Chuang H.-M., Harn H.-J., Yang H.-H., Lin S.-Z.. et al. Liposome
consolidated
with cyclodextrin provides prolonged drug retention resulting in increased
drug bioavailability in brain. Int. J. Mol.
Sci. 2020;21(12):4408.  doi: 10.3390/ijms21124408.</cite> [<a href="https://doi.org/10.3390/ijms21124408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7352271/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32575820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Liposome%20consolidated%20with%20cyclodextrin%20provides%20prolonged%20drug%20retention%20resulting%20in%20increased%20drug%20bioavailability%20in%20brain&amp;author=E.-Y.%20Lin&amp;author=Y.-S.%20Chen&amp;author=Y.-S.%20Li&amp;author=S.-R.%20Chen&amp;author=C.-H.%20Lee&amp;volume=21&amp;issue=12&amp;publication_year=2020&amp;pages=4408&amp;pmid=32575820&amp;doi=10.3390/ijms21124408&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref185">
<cite>Fang J. H., Lai Y. H., Chiu T. L., Chen Y. Y., Hu S. H., Chen S. Y.. Magnetic Core–Shell
Nanocapsules
with Dual-Targeting Capabilities and Co-Delivery of Multiple Drugs
to Treat Brain Gliomas. Adv. Healthcare Mater. 2014;3(8):1250–1260. doi: 10.1002/adhm.201300598.</cite> [<a href="https://doi.org/10.1002/adhm.201300598" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24623647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Healthcare%20Mater.&amp;title=Magnetic%20Core%E2%80%93Shell%20Nanocapsules%20with%20Dual-Targeting%20Capabilities%20and%20Co-Delivery%20of%20Multiple%20Drugs%20to%20Treat%20Brain%20Gliomas&amp;author=J.%20H.%20Fang&amp;author=Y.%20H.%20Lai&amp;author=T.%20L.%20Chiu&amp;author=Y.%20Y.%20Chen&amp;author=S.%20H.%20Hu&amp;volume=3&amp;issue=8&amp;publication_year=2014&amp;pages=1250-1260&amp;pmid=24623647&amp;doi=10.1002/adhm.201300598&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref186">
<cite>Jensen S. A., Day E. S., Ko C. H., Hurley L. A., Luciano J. P., Kouri F. M., Merkel T. J., Luthi A. J., Patel P. C., Cutler J. I.. et al. Spherical nucleic acid
nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci. Transl. Med. 2013;5(209):209ra152.  doi: 10.1126/scitranslmed.3006839.</cite> [<a href="https://doi.org/10.1126/scitranslmed.3006839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4017940/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24174328/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Transl.%20Med.&amp;title=Spherical%20nucleic%20acid%20nanoparticle%20conjugates%20as%20an%20RNAi-based%20therapy%20for%20glioblastoma&amp;author=S.%20A.%20Jensen&amp;author=E.%20S.%20Day&amp;author=C.%20H.%20Ko&amp;author=L.%20A.%20Hurley&amp;author=J.%20P.%20Luciano&amp;volume=5&amp;issue=209&amp;publication_year=2013&amp;pages=209ra152&amp;pmid=24174328&amp;doi=10.1126/scitranslmed.3006839&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref187">
<cite>Sallem F., Haji R., Vervandier-Fasseur D., Nury T., Maurizi L., Boudon J., Lizard G., Millot N.. Elaboration of trans-resveratrol derivative-loaded
superparamagnetic iron oxide nanoparticles for glioma treatment. Nanomaterials. 2019;9(2):287.  doi: 10.3390/nano9020287.</cite> [<a href="https://doi.org/10.3390/nano9020287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6409721/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30781702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomaterials&amp;title=Elaboration%20of%20trans-resveratrol%20derivative-loaded%20superparamagnetic%20iron%20oxide%20nanoparticles%20for%20glioma%20treatment&amp;author=F.%20Sallem&amp;author=R.%20Haji&amp;author=D.%20Vervandier-Fasseur&amp;author=T.%20Nury&amp;author=L.%20Maurizi&amp;volume=9&amp;issue=2&amp;publication_year=2019&amp;pages=287&amp;pmid=30781702&amp;doi=10.3390/nano9020287&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref188">
<cite>Zhao J., Li D., Ma J., Yang H., Chen W., Cao Y., Liu P.. Increasing the accumulation
of aptamer AS1411 and verapamil conjugated silver nanoparticles in
tumor cells to enhance the radiosensitivity of glioma. Nanotechnology. 2021;32(14):145102.  doi: 10.1088/1361-6528/abd20a.</cite> [<a href="https://doi.org/10.1088/1361-6528/abd20a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33296880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanotechnology&amp;title=Increasing%20the%20accumulation%20of%20aptamer%20AS1411%20and%20verapamil%20conjugated%20silver%20nanoparticles%20in%20tumor%20cells%20to%20enhance%20the%20radiosensitivity%20of%20glioma&amp;author=J.%20Zhao&amp;author=D.%20Li&amp;author=J.%20Ma&amp;author=H.%20Yang&amp;author=W.%20Chen&amp;volume=32&amp;issue=14&amp;publication_year=2021&amp;pages=145102&amp;pmid=33296880&amp;doi=10.1088/1361-6528/abd20a&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref189">
<cite>Zhang Y., Fu X., Jia J., Wikerholmen T., Xi K., Kong Y., Wang J., Chen H., Ma Y., Li Z.. et al. Glioblastoma
therapy using codelivery of cisplatin
and glutathione peroxidase targeting siRNA from iron oxide nanoparticles. ACS Appl. Mater. Interfaces. 2020;12(39):43408–43421. doi: 10.1021/acsami.0c12042.</cite> [<a href="https://doi.org/10.1021/acsami.0c12042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32885649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl.%20Mater.%20Interfaces&amp;title=Glioblastoma%20therapy%20using%20codelivery%20of%20cisplatin%20and%20glutathione%20peroxidase%20targeting%20siRNA%20from%20iron%20oxide%20nanoparticles&amp;author=Y.%20Zhang&amp;author=X.%20Fu&amp;author=J.%20Jia&amp;author=T.%20Wikerholmen&amp;author=K.%20Xi&amp;volume=12&amp;issue=39&amp;publication_year=2020&amp;pages=43408-43421&amp;pmid=32885649&amp;doi=10.1021/acsami.0c12042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref190">
<cite>Shahmabadi H. E., Movahedi F., Esfahani M. K. M., Alavi S. E., Eslamifar A., Anaraki G. M., Akbarzadeh A.. Efficacy of
Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma. Tumor Biol. 2014;35:4799–4806. doi: 10.1007/s13277-014-1630-9.</cite> [<a href="https://doi.org/10.1007/s13277-014-1630-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24443270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Tumor%20Biol.&amp;title=Efficacy%20of%20Cisplatin-loaded%20polybutyl%20cyanoacrylate%20nanoparticles%20on%20the%20glioblastoma&amp;author=H.%20E.%20Shahmabadi&amp;author=F.%20Movahedi&amp;author=M.%20K.%20M.%20Esfahani&amp;author=S.%20E.%20Alavi&amp;author=A.%20Eslamifar&amp;volume=35&amp;publication_year=2014&amp;pages=4799-4806&amp;pmid=24443270&amp;doi=10.1007/s13277-014-1630-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref191">
<cite>Madani F., Morovvati H., Webster T. J., Asaadi S. N., Rezayat S. M., Hadjighassem M., Khosravani M., Adabi M.. Combinatorial chemotherapy via poloxamer 188 surface-modified PLGA
nanoparticles that traverse the blood–brain-barrier in a glioblastoma
model. Sci. Rep. 2024;14:19516.  doi: 10.1038/s41598-024-69888-1.</cite> [<a href="https://doi.org/10.1038/s41598-024-69888-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11341868/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39174603/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Combinatorial%20chemotherapy%20via%20poloxamer%20188%20surface-modified%20PLGA%20nanoparticles%20that%20traverse%20the%20blood%E2%80%93brain-barrier%20in%20a%20glioblastoma%20model&amp;author=F.%20Madani&amp;author=H.%20Morovvati&amp;author=T.%20J.%20Webster&amp;author=S.%20N.%20Asaadi&amp;author=S.%20M.%20Rezayat&amp;volume=14&amp;publication_year=2024&amp;pages=19516&amp;pmid=39174603&amp;doi=10.1038/s41598-024-69888-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref192">
<cite>Su Z., Xing L., Chen Y., Xu Y., Yang F., Zhang C., Ping Q., Xiao Y.. Lactoferrin-modified
poly (ethylene glycol)-grafted BSA nanoparticles as a dual-targeting
carrier for treating brain gliomas. Mol. Pharmaceutics. 2014;11(6):1823–1834. doi: 10.1021/mp500238m.</cite> [<a href="https://doi.org/10.1021/mp500238m" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24779677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Pharmaceutics&amp;title=Lactoferrin-modified%20poly%20(ethylene%20glycol)-grafted%20BSA%20nanoparticles%20as%20a%20dual-targeting%20carrier%20for%20treating%20brain%20gliomas&amp;author=Z.%20Su&amp;author=L.%20Xing&amp;author=Y.%20Chen&amp;author=Y.%20Xu&amp;author=F.%20Yang&amp;volume=11&amp;issue=6&amp;publication_year=2014&amp;pages=1823-1834&amp;pmid=24779677&amp;doi=10.1021/mp500238m&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref193">
<cite>Wang J., Liu Y., Morsch M., Lu Y., Shangguan P., Han L., Wang Z., Chen X., Song C., Liu S.. et al. Brain-Targeted Aggregation-Induced-Emission
Nanoparticles with Near-Infrared Imaging at 1550 nm Boosts Orthotopic
Glioblastoma Theranostics. Adv. Mater. 2022;34(5):2106082.  doi: 10.1002/adma.202106082.</cite> [<a href="https://doi.org/10.1002/adma.202106082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34713508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Mater.&amp;title=Brain-Targeted%20Aggregation-Induced-Emission%20Nanoparticles%20with%20Near-Infrared%20Imaging%20at%201550%20nm%20Boosts%20Orthotopic%20Glioblastoma%20Theranostics&amp;author=J.%20Wang&amp;author=Y.%20Liu&amp;author=M.%20Morsch&amp;author=Y.%20Lu&amp;author=P.%20Shangguan&amp;volume=34&amp;issue=5&amp;publication_year=2022&amp;pages=2106082&amp;pmid=34713508&amp;doi=10.1002/adma.202106082&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref194">
<cite>Dube T., Kumar N., Bishnoi M., Panda J. J.. Dual blood–brain
barrier–glioma targeting peptide–poly (levodopamine)
hybrid nanoplatforms as potential near infrared phototheranostic agents
in glioblastoma. Bioconjugate Chem. 2021;32(9):2014–2031. doi: 10.1021/acs.bioconjchem.1c00321.</cite> [<a href="https://doi.org/10.1021/acs.bioconjchem.1c00321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34461019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioconjugate%20Chem.&amp;title=Dual%20blood%E2%80%93brain%20barrier%E2%80%93glioma%20targeting%20peptide%E2%80%93poly%20(levodopamine)%20hybrid%20nanoplatforms%20as%20potential%20near%20infrared%20phototheranostic%20agents%20in%20glioblastoma&amp;author=T.%20Dube&amp;author=N.%20Kumar&amp;author=M.%20Bishnoi&amp;author=J.%20J.%20Panda&amp;volume=32&amp;issue=9&amp;publication_year=2021&amp;pages=2014-2031&amp;pmid=34461019&amp;doi=10.1021/acs.bioconjchem.1c00321&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref195">
<cite>Mansur A. A., Paiva M. R., Cotta O. A., Silva L. M., Carvalho I. C., Capanema N. S., Carvalho S. M., Costa É. A., Martin N. R., Ecco R.. et al. Carboxymethylcellulose
biofunctionalized ternary quantum dots for subcellular-targeted brain
cancer nanotheranostics. Int. J. Biol. Macromol. 2022;210:530–544. doi: 10.1016/j.ijbiomac.2022.04.207.</cite> [<a href="https://doi.org/10.1016/j.ijbiomac.2022.04.207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35513094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Biol.%20Macromol.&amp;title=Carboxymethylcellulose%20biofunctionalized%20ternary%20quantum%20dots%20for%20subcellular-targeted%20brain%20cancer%20nanotheranostics&amp;author=A.%20A.%20Mansur&amp;author=M.%20R.%20Paiva&amp;author=O.%20A.%20Cotta&amp;author=L.%20M.%20Silva&amp;author=I.%20C.%20Carvalho&amp;volume=210&amp;publication_year=2022&amp;pages=530-544&amp;pmid=35513094&amp;doi=10.1016/j.ijbiomac.2022.04.207&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref196">
<cite>Liyanage P. Y., Zhou Y., Al-Youbi A. O., Bashammakh A. S., El-Shahawi M. S., Vanni S., Graham R. M., Leblanc R. M.. Pediatric
glioblastoma target-specific efficient delivery of gemcitabine across
the blood–brain barrier via carbon nitride dots. Nanoscale. 2020;12(14):7927–7938. doi: 10.1039/D0NR01647K.</cite> [<a href="https://doi.org/10.1039/D0NR01647K" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32232249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale&amp;title=Pediatric%20glioblastoma%20target-specific%20efficient%20delivery%20of%20gemcitabine%20across%20the%20blood%E2%80%93brain%20barrier%20via%20carbon%20nitride%20dots&amp;author=P.%20Y.%20Liyanage&amp;author=Y.%20Zhou&amp;author=A.%20O.%20Al-Youbi&amp;author=A.%20S.%20Bashammakh&amp;author=M.%20S.%20El-Shahawi&amp;volume=12&amp;issue=14&amp;publication_year=2020&amp;pages=7927-7938&amp;pmid=32232249&amp;doi=10.1039/D0NR01647K&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref197">
<cite>Perini G., Palmieri V., Ciasca G., D’Ascenzo M., Primiano A., Gervasoni J., De Maio F., De Spirito M., Papi M.. Enhanced chemotherapy
for glioblastoma multiforme mediated by functionalized
graphene quantum dots. Materials. 2020;13(18):4139.  doi: 10.3390/ma13184139.</cite> [<a href="https://doi.org/10.3390/ma13184139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7560355/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32957607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Materials&amp;title=Enhanced%20chemotherapy%20for%20glioblastoma%20multiforme%20mediated%20by%20functionalized%20graphene%20quantum%20dots&amp;author=G.%20Perini&amp;author=V.%20Palmieri&amp;author=G.%20Ciasca&amp;author=M.%20D%E2%80%99Ascenzo&amp;author=A.%20Primiano&amp;volume=13&amp;issue=18&amp;publication_year=2020&amp;pages=4139&amp;pmid=32957607&amp;doi=10.3390/ma13184139&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref198">
<cite>Zhou Y., Liyanage P. Y., Devadoss D., Guevara L. R. R., Cheng L., Graham R. M., Chand H. S., Al-Youbi A. O., Bashammakh A. S., El-Shahawi M. S., Leblanc R. M.. Nontoxic amphiphilic
carbon dots as promising drug nanocarriers across the blood–brain
barrier and inhibitors of β-amyloid. Nanoscale. 2019;11(46):22387–22397. doi: 10.1039/C9NR08194A.</cite> [<a href="https://doi.org/10.1039/C9NR08194A" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31730144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale&amp;title=Nontoxic%20amphiphilic%20carbon%20dots%20as%20promising%20drug%20nanocarriers%20across%20the%20blood%E2%80%93brain%20barrier%20and%20inhibitors%20of%20%CE%B2-amyloid&amp;author=Y.%20Zhou&amp;author=P.%20Y.%20Liyanage&amp;author=D.%20Devadoss&amp;author=L.%20R.%20R.%20Guevara&amp;author=L.%20Cheng&amp;volume=11&amp;issue=46&amp;publication_year=2019&amp;pages=22387-22397&amp;pmid=31730144&amp;doi=10.1039/C9NR08194A&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref199">
<cite>Qiao L., Sun T., Zheng X., Zheng M., Xie Z.. Exploring the optimal ratio of d-glucose/l-aspartic
acid for targeting
carbon dots toward brain tumor cells. Mater.
Sci. Eng., C. 2018;85:1–6. doi: 10.1016/j.msec.2017.12.011.</cite> [<a href="https://doi.org/10.1016/j.msec.2017.12.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29407137/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mater.%20Sci.%20Eng.,%20C&amp;title=Exploring%20the%20optimal%20ratio%20of%20d-glucose/l-aspartic%20acid%20for%20targeting%20carbon%20dots%20toward%20brain%20tumor%20cells&amp;author=L.%20Qiao&amp;author=T.%20Sun&amp;author=X.%20Zheng&amp;author=M.%20Zheng&amp;author=Z.%20Xie&amp;volume=85&amp;publication_year=2018&amp;pages=1-6&amp;pmid=29407137&amp;doi=10.1016/j.msec.2017.12.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref200">
<cite>Qian M., Du Y., Wang S., Li C., Jiang H., Shi W., Chen J., Wang Y., Wagner E., Huang R.. Highly crystalline
multicolor carbon
nanodots for dual-modal imaging-guided photothermal therapy of glioma. ACS Appl. Mater. Interfaces. 2018;10(4):4031–4040. doi: 10.1021/acsami.7b19716.</cite> [<a href="https://doi.org/10.1021/acsami.7b19716" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29328618/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Appl.%20Mater.%20Interfaces&amp;title=Highly%20crystalline%20multicolor%20carbon%20nanodots%20for%20dual-modal%20imaging-guided%20photothermal%20therapy%20of%20glioma&amp;author=M.%20Qian&amp;author=Y.%20Du&amp;author=S.%20Wang&amp;author=C.%20Li&amp;author=H.%20Jiang&amp;volume=10&amp;issue=4&amp;publication_year=2018&amp;pages=4031-4040&amp;pmid=29328618&amp;doi=10.1021/acsami.7b19716&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref201">
<cite>Li S., Amat D., Peng Z., Vanni S., Raskin S., De Angulo G., Othman A. M., Graham R. M., Leblanc R. M.. Transferrin
conjugated nontoxic carbon dots for doxorubicin delivery to target
pediatric brain tumor cells. Nanoscale. 2016;8(37):16662–16669. doi: 10.1039/C6NR05055G.</cite> [<a href="https://doi.org/10.1039/C6NR05055G" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27714111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale&amp;title=Transferrin%20conjugated%20nontoxic%20carbon%20dots%20for%20doxorubicin%20delivery%20to%20target%20pediatric%20brain%20tumor%20cells&amp;author=S.%20Li&amp;author=D.%20Amat&amp;author=Z.%20Peng&amp;author=S.%20Vanni&amp;author=S.%20Raskin&amp;volume=8&amp;issue=37&amp;publication_year=2016&amp;pages=16662-16669&amp;pmid=27714111&amp;doi=10.1039/C6NR05055G&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref202">
<cite>Liu S., Zhong Z., Zhang C., Zhou Y., Fu C., Xu X.. Targeted therapy for the treatment of gliomas with multifunctional
orange emissive carbon dots. Nanoscale Adv. 2022;4(3):894–903. doi: 10.1039/D1NA00722J.</cite> [<a href="https://doi.org/10.1039/D1NA00722J" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9418263/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36131815/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale%20Adv.&amp;title=Targeted%20therapy%20for%20the%20treatment%20of%20gliomas%20with%20multifunctional%20orange%20emissive%20carbon%20dots&amp;author=S.%20Liu&amp;author=Z.%20Zhong&amp;author=C.%20Zhang&amp;author=Y.%20Zhou&amp;author=C.%20Fu&amp;volume=4&amp;issue=3&amp;publication_year=2022&amp;pages=894-903&amp;pmid=36131815&amp;doi=10.1039/D1NA00722J&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref203">
<cite>Wang Y., Huo T., Jiang H., Xie Y., Zhang X., Nie H., Yang Y., Qian M., Li W., Hao T.. et al. Sugar-originated carbon nanodots selectively
damage the tumor and enhance the sensitivity of chemotherapy. Nano Today. 2021;38:101200.  doi: 10.1016/j.nantod.2021.101200.</cite> [<a href="https://doi.org/10.1016/j.nantod.2021.101200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Today&amp;title=Sugar-originated%20carbon%20nanodots%20selectively%20damage%20the%20tumor%20and%20enhance%20the%20sensitivity%20of%20chemotherapy&amp;author=Y.%20Wang&amp;author=T.%20Huo&amp;author=H.%20Jiang&amp;author=Y.%20Xie&amp;author=X.%20Zhang&amp;volume=38&amp;publication_year=2021&amp;pages=101200&amp;doi=10.1016/j.nantod.2021.101200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref204"><cite>

Cilingir, E. K.
; 
Hettiarachchi, S. D.
; 
Zhou, Y.
; 
Ferreira, B. C.
; 
Vanni, S.
; 
Leblanc, R. M.
; 
Graham, R. M.
. 
Cell-nucleus
Targeted Peptide Tethered Quadruple Carbon Dots for Treatment of High-grade
Gliomas. 2022.</cite></li>
</ol></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from ACS Omega are provided here courtesy of <strong>American Chemical Society</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1021/acsomega.5c02206"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ao5c02206.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (13.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12332557/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12332557/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332557%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332557/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12332557/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12332557/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40787345/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12332557/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40787345/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12332557/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12332557/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="KzX3M9q7foB0kMvtnv8cVf7jqzhJ0shfwwDHuxsyjpLe5wExBbQC3JeaJ7yCCXv8">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
